Risk Evaluation Rule User Guide -
Primary Authorized Official
Environmental Protection Agency
Office of Pollution Prevention and Toxics
Contract # GS00Q09BGD0022
Task Order # 47QFCA-18-F-0009
Project Title: EPA CDX
Version 2.0
January 16, 2020
New Chemical Data Collection:
OMB Control No. 2070-0012 and EPA ICR No. 0574
Existing Chemical Data Collection:
OMB Control No. 2070-0038 and EPA ICR No. 1188
TSCA Fees Payment:
OMB Control No. 2070-0208; EPA ICR No. 2569

-------
CDXr
Table of Contents
Table of Contents	i
List of Exhibits	iv
1	Introduction	1
2	System Requirements	2
2.1	Supported Browsers	2
2.2	Screen Resolution	2
3	Primary Authorized Official (AO) Functions	3
3.1	Log into Risk Evaluation Application	4
3.2	Risk Evaluation Home Screen Navigation	7
3.3	Submission History	8
3.4	User Management	10
3.5	Create Passphrase	12
3.6	Enter Passphrase	14
3.7	Action Bar	15
4	Chemical Substance Risk Evaluation Request	18
4.1	Create a Manufacturer Requested Risk Evaluation	18
4.2	Contact	18
4.3	Submitting on Behalf of Consortium	23
4.4	United States Agent	32
4.5	Chemical Substance or Category	34
4.6	Document Upload	45
4.7	Fees Certification	49
4.8	Submitting Official Information	50
4.9	Submission of Referenced Information	53
4.10	Instructions for Substantiating Confidential Business Information (CBI) Claims	54
4.11	Attach Documents for CBI Substantiation	58
5	Withdrawal Request	60
5.1	Create a Withdrawal Request	60
5.2	Contact Information	60
5.3	Original Submitter Information	63
5.4	Submitting Official Information	65
5.5	Instructions for Substantiating Confidential Business Information (CBI) Claims	67
6	Initial Response	68
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
i

-------
CDXr
6.1	Create an Initial Response	68
6.2	Contact	68
6.3	United States Agent	71
6.4	Company	73
6.5	Response Information	76
6.6	Submitting Official Information	79
6.7	Submission of Referenced Information	82
6.8	Instructions for Substantiating Confidential Business Information (CBI) Claims	83
6.9	Attach Documents for CBI Substantiation	87
7	EPA Initiated Risk Evaluation Request	89
7.1	Create a EPA Initiated Risk Evaluation	89
7.2	Contact	89
7.3	Submitting on Behalf of Consortium	93
7.3	United States Agent	103
7.4	Chemical Substance or Category	105
7.5	Document Upload (Optional)	108
7.6	Fees Certification	112
7.7	Submitting Official Information	113
7.8	Submission of Referenced Information	116
7.9	Instructions for Substantiating Confidential Business Information (CBI) Claims	117
7.10	Attach Documents for CBI Substantiation	121
8	Preview	123
9	Validate	125
10	Submit to EPA via CDX	126
10.1	TSCA Certification	126
10.2	Risk Evaluation Certification	127
10.3	Validation	127
10.4	Risk Evaluation PDF Generation	128
10.5	CROMERR Certification	129
10.6	eSignature Widget	130
10.7	Submission Finished	131
11	Download Copy of Record	132
12	EPA Communications	134
12.1 CSPP Payment Processor	140
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020

-------
	
12.2 Invoice Communications	144
13	Create An Amendment	149
14	AppendixA. Document Types and Subtypes	150
Risk Evaluation Rule User Guide	January 16, 2020
Primary Authorized Official	iii

-------
CDXr
List of Exhibits
Exhibit 3-1 Risk Evaluation User Roles Matrix	4
Exhibit 3-2 Chemical Information Submission System Screen (Scroll 1)	5
Exhibit 3-3 Chemical Information Submission System Screen (Scroll 2)	6
Exhibit 3-4 Risk Evaluation Home Screen	8
Exhibit 3-5 Risk Evaluation Submission History Section	10
Exhibit 3-6 User Management Screen	12
Exhibit 3-7 Create Passphrase Screen	13
Exhibit 3-8 Enter Passphrase Screen	14
Exhibit 3-9 Action Bar - Save	15
Exhibit 3-10 Action Bar-Preview	15
Exhibit 3-11 Action Bar-Validate	16
Exhibit 3-12 Action Bar - Submit	16
Exhibit 3-13 CDX Links	17
Exhibit 4-1 Contact Screen (Scroll 1)	20
Exhibit 4-2 Contact Screen (Scroll 2)	21
Exhibit 4-3 Contact Screen (Scroll 3)	22
Exhibit 4-4 Submitting on Behalf of Consortium Screen (Scroll 1)	24
Exhibit 4-5 Submitting on Behalf of Consortium Screen (Scroll 2)	25
Exhibit 4-6 Submitting on Behalf of Consortium Screen (Scroll 3)	26
Exhibit 4-7 Small Business Concern Definition Window (Scroll 1)	28
Exhibit 4-8 Small Business Concern Definition Window (Scroll 2)	29
Exhibit 4-9 Small Business Concern Definition Window (Scroll 3)	30
Exhibit 4-10 Small Business Concern Definition Window (Scroll 4)	31
Exhibit 4-11 United States Agent Screen (Scroll 1)	33
Exhibit 4-12 United States Agent Screen (Scroll 2)	34
Exhibit 4-13 Chemical Substance or Category Screen (Scroll 1)	37
Exhibit 4-14 Chemical Substance or Category Screen (Scroll 2)	38
Exhibit 4-15 Chemical Substance or Category Screen (Scroll 3)	39
Exhibit 4-16 Attach Document Pop-Up Window (Chemical Substance or Category Screen)	41
Exhibit 4-17 Search Substance Registry Services (SRS) Window	43
Exhibit 4-18 Create New Chemical Window	44
Exhibit 4-19 Document Upload Screen (Scroll 1)	46
Exhibit 4-20 Document Upload Screen (Scroll 2)	47
Exhibit 4-21 Attach Document Window	48
Exhibit 4-22 Risk Evaluation Request Fee Structure	49
Exhibit 4-23 Fees Certification Screen	50
Exhibit 4-24 Submitting Official Information Screen (Scroll 1)	52
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
iv

-------
CDXr
Exhibit 4-25 Submitting Official Information Screen (Scroll 2)	53
Exhibit 4-26 Submission of Referenced Information Screen	54
Exhibit 4-27 Instructions for Substantiating Confidential Business Information (CBI) Claims
Screen (Scroll 1)	56
Exhibit 4-28 Instructions for Substantiating Confidential Business Information (CBI) Claims
Screen (Scroll 2)	57
Exhibit 4-29 Instructions for Substantiating Confidential Business Information (CBI) Claims
Screen (Scroll 3)	58
Exhibit 4-30 Attach Documents for CBI Substantiation Window	59
Exhibit 5-1 Withdrawal Request - Contact Information Screen (Scroll 1)	61
Exhibit 5-2 Withdrawal Request - Contact Information Screen (Scroll 2)	62
Exhibit 5-3 Withdrawal Request - Contact Information Screen (Scroll 3)	62
Exhibit 5-4 Withdrawal Request - Original Submitter Information Screen (Scroll 1)	64
Exhibit 5-5 Withdrawal Request - Original Submitter Information Screen (Scroll 2)	64
Exhibit 5-6 Withdrawal Request - Original Submitter Information Screen (Scroll 3)	65
Exhibit 5-7 Withdrawal Request - Submitting Official Information Screen (Scroll 1)	66
Exhibit 5-8 Withdrawal Request - Submitting Official Information Screen (Scroll 2)	67
Exhibit 6-1 Initial Response - Contact Screen (Scroll 1)	69
Exhibit 6-2 Initial Response - Contact Screen (Scroll 2)	70
Exhibit 6-3: Initial Response - United States Agent Screen (Scroll 1)	72
Exhibit 6-4 Initial Response - United States Agent Screen (Scroll 2)	73
Exhibit 6-5 Initial Response - Company Screen (Scroll 1)	75
Exhibit 6-6 Initial Response - Company Screen (Scroll 2)	76
Exhibit 6-7 Response Information - Screen (Scroll 1)	78
Exhibit 6-8 Initial Response - Response Information Screen (Scroll 2)	79
Exhibit 6-9 Initial Response - Submitting Official Information Screen (Scroll 1)	81
Exhibit 6-10 Initial Response - Submitting Official Information Screen (Scroll 2)	82
Exhibit 6-11 Initial Response - Submission of Referenced Information Screen	83
Exhibit 6-12 Initial Response - Instructions for Substantiating Confidential Business Information
(CBI) Claims Screen (Scroll 1)	85
Exhibit 6-13 Initial Response - Instructions for Substantiating Confidential Business Information
(CBI) Claims Screen (Scroll 2)	86
Exhibit 6-14 Initial Response - Instructions for Substantiating Confidential Business Information
(CBI) Claims Screen (Scroll 3)	87
Exhibit 6-15 Attach Documents for CBI Substantiation Window	88
Exhibit 7-1 EPA Initiated Risk Evaluation - Contact Screen (Scroll 1)	91
Exhibit 7-2 EPA Initiated Risk Evaluation - Contact Screen (Scroll 2)	91
Exhibit 7-3 EPA Initiated Risk Evaluation - Contact Screen (Scroll 3)	93
Exhibit 7-4 EPA Initiated Risk Evaluation - Consortium Member Pop Up Window (Scroll 1)	95
Exhibit 7-5 EPA Initiated Risk Evaluation - Consortium Member Pop Up Window (Scroll 2)	96
Risk Evaluation Rule User Guide	January 16, 2020
Primary Authorized Official	v

-------
CDXr
Exhibit 7-6 EPA Initiated Risk Evaluation - Consortium Member Screen (Scroll 3)	97
Exhibit 7-7 EPA Initiated Risk Evaluation - Small Business Concern Definition Window (Scroll 1)99
Exhibit 7-8 EPA Initiated Risk Evaluation - Small Business Concern Definition Window (Scroll 2)100
Exhibit 7-9 EPA Initiated Risk Evaluation - Small Business Concern Definition Window (Scroll 3)101
Exhibit 7-10 EPA Initiated Risk Evaluation - Small Business Concern Definition Window (Scroll
4)	102
Exhibit 7-11 EPA Initiated Risk Evaluation - United States Agent Screen (Scroll 1)	104
Exhibit 7-12 EPA Initiated Risk Evaluation - United States Agent Screen (Scroll 2)	105
Exhibit 7-13 EPA Initiated Risk Evaluation - Chemical Substance or Category Screen (Scroll 1)107
Exhibit 7-14 EPA Initiated Risk Evaluation - Document Upload Screen (Scroll 1)	109
Exhibit 7-15 EPA Initiated Risk Evaluation - Document Upload Screen (Scroll 2)	110
Exhibit 7-16 EPA Initiated Risk Evaluation - Attach Document Window	111
Exhibit 7-17 EPA Initiated Risk Evaluation - Risk Evaluation Request Fee Structure	112
Exhibit 7-18 EPA Initiated Risk Evaluation - Fees Certification Screen	113
Exhibit 7-19 EPA Initiated Risk Evaluation - Submitting Official Information Screen (Scroll 1)115
Exhibit 7-20 EPA Initiated Risk Evaluation - Submitting Official Information Screen (Scroll 2) 116
Exhibit 7-21 EPA Initiated Risk Evaluation - Submission of Referenced Information Screen ..117
Exhibit 7-22 EPA Initiated Risk Evaluation - Instructions for Substantiating Confidential
Business Information (CBI) Claims Screen (Scroll 1)	119
Exhibit 7-23 EPA Initiated Risk Evaluation - Instructions for Substantiating Confidential
Business Information (CBI) Claims Screen (Scroll 2)	120
Exhibit 7-24 EPA Initiated Risk Evaluation - Instructions for Substantiating Confidential
Business Information (CBI) Claims Screen (Scroll 3)	121
Exhibit 7-25 EPA Initiated Risk Evaluation - Attach Documents for CBI Substantiation Window122
Exhibit 8-1 Preview Risk Evaluation PDF	124
Exhibit 9-1 TSCA Risk Evaluation Validation Window	125
Exhibit 10-1 TSCA Certification Screen	126
Exhibit 10-2 Risk Evaluation Certification Screen	127
Exhibit 10-3 Validation Screen	128
Exhibit 10-4 PDF Generation Screen	129
Exhibitl0-5 CROMERR Certification Window	130
Exhibit 10-6 eSignature Widget Window	130
Exhibit 10-7 Submission Finished Screen	131
Exhibit 11-1 Download Copy of Record Screen	132
Exhibit 12-1 New EPA Communication Email Notification	134
Exhibit 12-2 New EPA Communication CDX Inbox Notification	135
Exhibit 12-3 TSCA Risk Evaluation Home Screen	136
Exhibit 12-4 Enter Passphrase Screen	137
Exhibit 12-5 Cross-Media Electronic Reporting Regulation (CROMERR) Certification Window137
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
vi

-------
CDXr
Exhibit 12-6 eSignature Widget	138
Exhibit 12-7 Download Copy of Record Screen	140
Exhibit 12-8 CSPP Payment Processor (ACH Payment)	142
Exhibit 12-9 CSPP Payment Processor (Credit/Debit Card)	143
Exhibit 12-10 Successful Payment	144
Exhibit 12-11 Invoice Communication Email	145
Exhibit 12-12 CDX Inbox Invoice Communication	146
Exhibit 12-13 Risk Evaluation Request Fee Invoice PDF	147
Exhibit 12-14 Risk Evaluation Request Payment Receipt	148
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
vii

-------
CDXr
1 Introduction
This document presents the user guide for the Office of Pollution Prevention and Toxics (OPPT)
Risk Evaluation Rule application submission process. This document is the user guide for the
Primary Authorized Official (AO) of the Risk Evaluation Rule application.
The Risk Evaluation Rule application is the electronic, web-based tool provided by the United
States Environmental Protection Agency (EPA) for the submission of Risk Evaluation data and
responses to FR Notices. As a Primary AO, you can create, modify, and/or submit a
Manufacturer Risk Evaluation request, EPA Initiated Risk Evaluation, and an Initial Response.
You can also pay invoices and receive EPA communications. You can also delete request and
responses, submit a Withdrawal Request, create amendments, and download the Copy of Record
(CoR).
For questions concerning the Toxic Substances Control Act (TSCA) Risk Evaluation software
requirements, please contact the Central Data Exchange (CDX) Help Desk at
helpdesk@epacdx.net or call 1-888-890-1995 between the hours of 8 am - 6 pm Eastern
Standard Time (EST).
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
1

-------
CDXr
2 System Requirements
To use the Risk Evaluation Rule application to submit a Risk Evaluation request, the following
are required:
•	An e-mail account
•	JavaScript enabled web browser
•	Internet access
•	Adobe Acrobat Reader 5.0 or higher
•	CDX username and password
2.1	Supported Browsers
One of the following supported browsers is required to access the Risk Evaluation Rule
application:
•	Vendor supported versions of Internet Explorer (IE) or Edge
Go to the following link to download:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads
•	Vendor supported versions of Mozilla Firefox
Go to the following link to download:
https://www.mozilla.org/en-US/firefox/new/
•	Vendor supported versions of Safari
Go to the following link to download:
https://support.apple.com/downloads/
•	Vendor supported versions of Google Chrome
Go to the following link to download:
http://www.google.com/chrome
2.2	Screen Resolution
Screen resolution should be set to 1024 x 768 or greater.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
2

-------
CDXr
3 Primary Authorized Official (AO) Functions
This section describes how to:
•	Access the application
•	Navigate the Risk Evaluation 'Home' screen
•	Assign Supports to complete a form
•	Start and complete the Risk Evaluation request
•	Start and complete EPA's Initiated Risk Evaluation
•	Start and complete the Withdrawal Request
•	Start and complete an Initial Response
•	Download a Copy of Record
•	Create an amendment
The Primary AO is responsible for the submission of Risk Evaluation requests. As a Primary
AO, you can create a new form. You are also responsible for submitting amendments, unlocking
submissions, and deleting forms. You can assign Supports (or other authorized individuals) to
edit and complete a form on your behalf.
You can save the form at any point during the data entry process. The save functionality allows
you to return to that same form at any point in the future. Additionally, a PDF version of the
form can be previewed at any point.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
3

-------
CDXs
Exhibit 3-1 displays a table of the user role capabilities within the Risk Evaluation Rule
application.
Exhibit 3-1 Risk Evaluation User Roles Matrix
Legend
X=Can Perform Function
//
/




non-US
Create ail original main forms
Submit original main forms
Submit amendments (by editing the main forms)
Unlock all forms
Edit unlocked forms
Delete forms
Assign Supports
Recieve EPA Communications
Pay Invoices
Create all original main forms
Submit original main forms
Submit amendments (by editing the main forms)
Unlock all main forms
Edit unlocked main forms
Delete forms
3.1 Log into Risk Evaluation Application
After you create an account in CDX, click the 'Primary Authorized Official' link for the
Chemical Safety and Pesticide Programs (CSPP) data flow to navigate to the 'Chemical
Information Submission System' screen.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
4

-------
CD)fr
Exhibit 3-2 shows a screen capture of the 'Chemical Information Submission System' screen
(Scroll 1):
Exhibit 3-2 Chemical Information Submission System Screen (Scroll 1)
A Logged in as: Jane Doe, Primary Authorized Official
Log Out
CHEMICAL INFORMATION SUBMISSION SYSTEM
TSCA Risk Evaluation Rule
OK
The Toxic Substances Control Act as amended by the Frank R. Lautenberg Chemical Safety tor the 21 st Century Act (TSCA)
requires EPA conduct risk evaluations on existing chemicals to determine if the chemical presents an unreasonable risk to
health or the environment, under the conditions of use. While EPA ultimately determines which chemicals undergo evaluation,
TSCA does allow manufacturers, of a given chemical or category of chemicals, to request EPA conduct a risk evaluation on the
chemical or category. Requests for an EPA-conducted risk evaluation will be considered following the completion of this CDX
form.
EPA risk evaluations are required to be conducted on chemicals under their conditions of use, so the requesting manufacturer
{s) must request the condition(s) of use for which the risk evaluation be conducted, with the understanding that EPA may
determine other uses are necessary to consider in the risk evaluation. Conditions of use, as defined by TSCA, are the
circumstances "under which a chemical substance Is intended, known, or reasonably foreseen to be manufactured, processed,
distributed in commerce, used or disposed of."
The requester must provide a list of all the necessary existing information that is relevant to whether the chemical substance,
under the condition(s) of use identified the manufacturers), presents an unreasonable risk of injury to health or the
environment, that will allow the Agency to complete the risk evaluation. The list must be accompanied by an explanation as to
why such information is adequate to permit EPA to complete a risk evaluation addressing the circumstances identified by the
manufacturer(s). The request does not need to include copies of the information; citations are sufficient, if the information is
publicly available. The request must include or reference all the information on the health and environmental hazard(s), human
and environmental exposure(s), and exposed population(s) relevant to the conditions of use identified in the request. At a
minimum, this must include all the following as relevant to the circumstances identified:
•	The chemical substance's hazard and exposure potential;
•	The chemical substance's persistence and bioaccumulation;
•	Potentially exposed or susceptible subpopulations which the manufacturer(s) believes is relevant to the EPA risk
evaluation;
•	Whether there is any storage of the chemical substance near significant sources of drinking water, including the storage
facility location and the nearby drinking water source(s);
•	The chemical substance's production volume or significant changes in production volume: and
•	Any other information relevant to the potential risks of the chemical substance under the circumstances identified in the
request.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
5

-------
CD)fr
Exhibit 3-3 shows a screen capture of the 'Chemical Information Submission System' screen
(Scroll 2):
Exhibit 3-3 Chemical Information Submission System Screen (Scroll 2)

Logged in as: Jane Doe, Primary Authorized Official
Log Out
minimum, this must include all the following as relevant to the circumstances identified:
The chemical substance's hazard and exposure potential;
The chemical substance's persistence and bioaccumulation:
Potentially exposed or susceptible subpopulations which the manufacturer(s) believes is relevant to the EPA risk
evaluation;
Whether there is any storage of the chemical substance near significant sources of drinking water, Including the storage
facility location and the nearby drinking water source(s);
The chemical substance's production volume or significant changes In production volume; and
Any other information relevant to the potential risks of the chemical substance under the circumstances identified in the
request.
The request must include a commitment to provide to EPA any referenced Information upon request. The request may also
include any information that will Inform EPA's determination as to whether restrictions imposed by one or more States have the
potential to have a significant impact on interstate commerce or health or the environment and that as a consequence, the
request is entitled to be preferentially considered for a risk evaluation.
Paperwork Reduction Act Notice
Request for Risk Evaluation: Responses to this collection of information are voluntary but must comply with EPA's procedural
requirements in order to be eligible for EPA consideration (40 CFR 702). This collection of information is approved by OMB
under the Paperwork Reduction Act, 44 U.S.C. 3501 et seq. (OMB Control No. 2070-0202; EPA ICR No. 2559). The annual
public reporting and recordkeeping burden for this collection of information is estimated to average 96 hours per response.
TSCA User Fee Payment: Responses to this collection of information are mandatory (40 CFR 700.45). This collection of
information is approved by OMB under the Paperwork Reduction Act, 44 U.S.C. 3501 et seq. (OMB Control No. 2070-0208;
EPA ICR No. 2569). The annual public reporting and recordkeeping burden for this collection of information is estimated to
range between 5 and 10 minutes per response.
Burden is defined in 5 CFR 1320.3(b). An agency may not conduct or sponsor, and a person is not required to, respond to a
collection of information unless it displays a currently valid OMB control number. You may send comments regarding the EPA's
need for this information, the accuracy of the provided burden estimates, and any suggested methods for minimizing
respondent burden, including through the use of automated collection techniques to the Director, Collection Strategies Division,
U.S. Environmental Protection Agency (2822T), 1200 Pennsylvania Ave., NW, Washington, D.C. 20460. Please include the
OMB Control No. in any correspondence. Send only comments to this address.
Navigation: To access the Risk Evaluation 'Home' screen, select 'TSCA Risk Evaluation Rule'
from the submission type drop-down menu and click the 'OK' button.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
6

-------
CDXr
3.2 Risk Evaluation Home Screen Navigation
You can access the Risk Evaluation 'Home' screen by selecting 'TSCA Risk Evaluation Rule'
from the submission type drop-down menu on the 'Chemical Information Submission System'
screen and clicking the 'OK' button.
The Risk Evaluation 'Home' screen is the first screen within the Risk Evaluation application. It
displays the 'Create New Request or Response,' 'Useful Resources,' and 'Submission History'
sections and displays a link to the 'User Management' page.
There is a ten (10) minute logout timer for this application; the application will automatically log
you out after ten minutes of inactivity and navigate you back to the CDX login screen.
•	Create New Request or Response: Click the 'Create' button to navigate to the 'Create
Passphrase' screen to create the form selected from the 'Form Type' drop-down menu.
•	Useful Resources: Click the links within the 'Useful Resources' section.
•	Submission History: Modify or delete a Risk Evaluation request using the 'Submission
History' section. For additional details about the 'Submission History' section, please refer to
Section 3.3.
•	User Management: Click the 'User Management' link to navigate to the 'User
Management' screen. You can manage the access rights of Supports per form alias using the
'User Management' screen. For additional details about the 'User Management' screen, refer
to Section 3.4.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
7

-------
CDXr
Exhibit 3-4 shows a screen capture of the Risk Evaluation 'Home' screen:
Exhibit 3-4 Risk Evaluation Home Screen
HOME USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized C
TSCA Risk Evaluation
Create New Request or Response
Submission History
Create a Risk Evaluation Request or Response to an EPA
Request
Initial Response: Select this form type if you are manufacturer/importer
required to respond to a preliminary list published by EPA in the Federal
Register. Please note that consortium leaders who are not a
manufacturer/importer do not need to submit this form.
EPA Initiated Risk Evaluation: Select this form type if you are
manufacturer/importer and/or consortium leader responding to the finalized
Risk Evaluation Request published by EPA in the Federal Register.
Manufacturer Requested Risk Evaluation: Select this form type to begin
creating a request for EPA to conduct a Risk Evaluation on the chemical(s)
you manufacture/import.
Withdrawal Request: Select this form type to begin creating a request for
withdrawal of an EPA Initiated Risk Evaluation or Manufacturer Requested
Risk Evaluation. Please note that you may withdraw your request at any
time after the request is made, and within 30 days of receiving EPA's
notification that the request is granted.
Please select the appropriate form type and click the 'Create' button.
EPA Initiated Risk Evaluation	[v]
Show 10 [v] entries
Form
Case
Submission


Alias J1
Form Type Number
Date
Status
Action
EIRE-
EPA Initiated Risk

In
X
20191212-
Evaluation

Progress

10:58:25




IR-20191217-
Initial Response

In
X
11:54:28


Progress

MRRE-
Manufacturer

In
X
20191216-
Requested Risk

Progress

16:09:00
Evaluation



WR-
Withdrawal

In
X
20191219-
Request

Progress

12:58:15





Export Options: XML
CSV PDF
Excel

Useful Resources
•	Risk Evaluation User Guide
•	Risk Evaluation Rule
•	Risk Evaluations for Existing Chemicals under TSCA
•	TSCA Risk Evaluation Guidance
Raise a Bug CDX Links - CDX Helpdesk (888) 890-199ฃ
3.3 Submission History
Only one Risk Evaluation request is created per form alias, which helps differentiate between
forms. Each column within the table of the 'Submission History' section can be sorted by
clicking the individual column headers.
Start New Form: To create a new EPA Initiated Risk Evaluation, Initial Response,
Manufacturer Requested Evaluation, or Withdrawal Request select the form type from the 'Form
Type' drop-down menu and click the 'Create' button. You are required to create a passphrase
that will be associated with that particular form. Make sure to create a passphrase that you will
remember, as it cannot be retrieved or reset. Refer to Section 3.5 for further instructions on
creating a passphrase.
Edit an 'In Progress' Form: To modify an existing Risk Evaluation request, click the 'Form
Alias' link for a form with a status of 'In Progress.' You are required to enter the passphrase
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
8

-------
CDXr
associated with that particular form to access and edit the form. It is possible for more than one
user to modify a form simultaneously; the user that clicks the ' Save' button first will have his/her
changes saved.
Amend a submitted form: To edit an already submitted Risk Evaluation request (i.e., to create
an amendment), you must first unlock the particular submission by clicking the 'Lock' icon ( ฆ )
under the 'Action' column. You will be required to enter the passphrase associated with that
particular submission to gain access and continue amending the submission. All further changes
that are made will be submitted as an amendment. Refer to Section 13 for further instructions on
creating an amendment.
Pay an invoice: To pay an invoice for a Risk Evaluation request, click the 'Unpaid Invoice' icon
($) to begin the process of accessing the 'Copy of Record' screen to pay an invoice.
The 'Submission History' table displays the following fields and columns of information:
•	Show Entries: Select a value from the 'Entries' drop-down menu to specify the number of
entries that display on the current page.
•	Search: Enter search criteria to filter the submissions within the 'Submission History' table.
•	Form Alias: Displays the form alias of a Risk Evaluation request. Click the form alias link to
navigate to the 'Enter Passphrase' page and complete/edit a request.
•	Form Type: Displays 'EPA Initiated Risk Evaluation', 'Initial Response', 'Manufacturer
Requested Evaluation', and 'Withdrawal Request.'
•	Case Number: Displays the case number of a completed submission in the following format:
, , and . The ' YY' represents the
calendar year in which the request was submitted, and the 'XXXX' represents the order in
which the request was received. Each submitted request generates a single case number.
•	Submission Date: Displays the date that a form was successfully submitted to EPA via
CDX. This date populates only after the request has been submitted.
•	Status: Displays the status of a Risk Evaluation request (e.g., 'In Progress,' 'Submitted,'
'Completed,' 'Completed - Awaiting Payment,' or 'Completed - Payment Received').
•	Action: Click the 'Copy of Record' icon ( ) to navigate to the 'Enter Passphrase' screen to
continue to the 'Copy of Record' screen. The 'Copy of Record' icon displays only after the
request has been completed. Click the 'Delete' icon (<^) to delete an in-progress request.
Click the 'Lock' icon ( ฆ ) to unlock a request for an amendment. The request remains
unlocked and will display the 'Unlocked' icon ( ฆ ) until the request is resubmitted by the
AO. Click the red 'Unpaid Invoice' icon ($) to access the 'Copy of Record' screen to pay a
fee, when applicable. The 'Unpaid Invoices' icon displays only after personnel sends an
invoice. After a user pays the invoice, the icon disappears.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
9

-------
CDX.
•	Export Options: Click the 'XML,' 'CSV,' 'PDF,' or 'Excel' button to download the
'Submission History' table as an .xml, csv, pdf, or .xlsx file, respectively.
•	Previous: Click the 'Previous' button to navigate to the previous set of submissions currently
displayed (if applicable).
•	Next: Click the 'Next' button to navigate to the subsequent set of submissions (if applicable).
Exhibit 3-5 shows a screen capture of the Risk Evaluation 'Submission History' section:
Exhibit 3-5 Risk Evaluation Submission History Section
HOME USER MANAGEMENT
TSCA Risk Evaluation
Create New Request or Response
Submission History
A Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Officials
Create a Risk Evaluation Request or Response to an EPA Request
Initial Response: Select this form type if you are manufacturer/importer required to
respond to a preliminary list published by EPA in the Federal Register. Please note
that consortium leaders who are not a manufacturer/importer do not need to submit
this form.
EPA Initiated Risk Evaluation: Select this form type if you are
manufacturer/importer and/or consortium leader responding to the finalized Risk
Evaluation Request published by EPA in the Federal Register.
Manufacturer Requested Risk Evaluation: Select this form type to begin creating a
request for EPA to conduct a Risk Evaluation on the chemical(s) you
manufacture/import.
Withdrawal Request: Select this form type to begin creating a request for
withdrawal of an EPA Initiated Risk Evaluation or Manufacturer Requested Risk
Evaluation Please note that you may withdraw your request at any time after the
request is made, and within 30 days of receiving EPA's notification that the request is
granted.
Please select the appropriate form type and click the 'Create' button.
EPA Initiated Risk Evaluation	[v] | I
Useful Resources
•	Risk Evaluation User Guide
•	Risk Evaluation Rule
•	Risk Evaluations for Existing Chemicals under TSCA
•	TSCA Risk Evaluation Guidance
Show 10 [Vj entries
Form Alias |=
Form Type
Case
Number
Submission
Date
Status
Action
RER-
20170608-
16:14:24
Manufacturer
Requested Risk
Evaluation
MRRE-17-
0053
07/19/2017
In Progress

RER-
20170823-
11:37:06
Manufacturer
Requested Risk
Evaluation


Processing
ฑ
RER-
20170911-
09:47:09
Manufacturer
Requested Risk
Evaluation
MRRE-17-
0071
09/11/2017
Completed

RER-
20180907-
10:48:16
Manufacturer
Requested Risk
Evaluation
MRRE-18-
0183
09/07/2018
Completed -
Awaiting
Payment
ฑ $ a
RER-
20180919-
16:18:15
Manufacturer
Requested Risk
Evaluation
MRRE-18-
0215
09/19/2018
Completed -
Payment
Received
ฑm
RER-
20181024-
14:10:06
Manufacturer
Requested Risk
Evaluation
MRRE-18-
0256
10/25/2018
Completed -
Awaiting
Payment
ฑE*j| $ gg
RER-
20181025-
11:51:53
Manufacturer
Requested Risk
Evaluation
MRRE-18-
0257
10/25/2018
In Progress
ฑ m
RER-
20181105-
10:32:09
Manufacturer
Requested Risk
Evaluation


In Progress
X
WR-20171109-
Withdrawal Request


In Progress
X
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Navigation: Click the 'User Management' link to access the 'User Management' screen to
assign Primary Supports or Primary Agents/Consultants (if applicable).
3.4 User Management
You can access the 'User Management' screen by clicking the 'User Management' link on the
application header of the Risk Evaluation 'Home' screen.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
10

-------
CDXr
On the 'User Management' screen, you have the ability to assign/un-assign one or more Primary
Supports or Primary Agents/Consultants to have access to modify any of the Risk Evaluation
requests you have created.
Form Alias: A form alias is unavailable in this drop-down menu until one has been created.
Select a form alias from the drop-down menu to begin assigning Supports or Primary
Agents/Consultants. Once a form alias has been selected, the 'Assign Users' group box will
update to display only the Supports or Primary Agents/Consultants who have identified you as
their AO during CDX registration, or a user you have specified that is able to submit on your
behalf.
Form Information: This field displays information pertaining to the form selected from the
'Form Alias' drop-down menu.
Form Alias: Displays the form alias that a Risk Evaluation request is given.
Assign Supports: This box shows all the Supports or Primary Agents/Consultants you can
assign/un-assign to complete a Risk Evaluation request for the form alias selected. To move
support persons from the 'Unassigned' group box to the 'Assigned' group box, highlight an
individual or multiple Support(s) or Primary Agent(s)/Consultant(s) and click the 'Add ป'
button.
•	Unassigned: This box/field contains the registered Support(s) and/or Primary
Agent(s)/Consultant(s) associated with the AO who can potentially be assigned to access and
edit the selected request. To move support persons from the 'Unassigned' group box to the
'Assigned' group box, highlight an individual or multiple support persons and click the 'Add
ป' button. To highlight multiple support persons hold down the  key on your
keyboard while clicking each Support and/or Primary Agent/Consultant. To highlight
multiple consecutive support persons, hold down the  key on your keyboard while
clicking the first and last Support and/or Primary Agent/Consultant in the list.
•	Assigned: This box/field contains the registered Support(s) and/or Primary
Agent(s)/Consultant(s) given permission, by the AO, to access and edit the selected request.
This group box shows all support persons assigned to complete the Risk Evaluation request
for a single form alias. To move Supports and/or Primary Agents/Consultants from the
'Assigned' group box to the 'Unassigned' group box highlight individual or multiple support
persons and click the 'ซ Remove' button. To highlight multiple support persons hold down
the  key on your keyboard while clicking each Support and/or Primary
Agent/Consultant. To highlight multiple consecutive support persons, hold down the 
key on your keyboard while clicking the first and last Support and/or Primary
Agent/Consultant in the list.
•	Add ป: Click the button to move selected Supports and/or Primary Agents/Consultants
from the 'Unassigned' box to the 'Assigned' box.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
11

-------
CDXr
•	ซ Remove: Click the button to move selected Supports and/or Primary Agents/Consultants
from the 'Assigned' box to the 'Unassigned' box.
•	Save: Click the button to save the selection.
Exhibit 3-6 shows a screen capture of the 'User Management' screen:
Exhibit 3-6 User Management Screen
HOME USER MANAGEMENT
ฑ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
User Management
The Authorized Official is responsible for restricting a Support's access to select forms by assigning or un-assigning them. The Support can access and edit only
those forms for which the Authorized Official has granted access. Select a specific form from the Form ID drop-down menu and assign a Support to the form by
highlighting the individual and clicking the Add button. To un-assign a Support, highlight the individual and click the Remove button. To highlight and assign or
un-assign multiple Supports, hold down the Ctrl or Shift keys on the keyboard and click each Support before moving. You must click the Save button after each
assignment.
Form	T
Alias:
Form Information
Assign Supports
Unassigned
ฆ
Add ป
I

ฆ
M Remove
ฆ

ฆ
Save
1
Assigned
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Home' link located within the application header to navigate to the Risk
Evaluation 'Home' screen.
3.5 Create Passphrase
To start a new Request or Response, select 'EPA Initiated Risk Evaluation,' 'Initial Response,'
'Manufacturer Requested Evaluation,' or 'Withdrawal Request' from the 'Form Type' drop-
down menu, and click the 'Create' button on the Risk Evaluation 'Home' screen to navigate to
the 'Create Passphrase' screen, which allows you to create a passphrase and associate that
passphrase with your newly created request.
The application uses the passphrase as an encryption key to protect the contents of the request.
You are responsible for remembering the passphrase and distributing it to the appropriate
individuals.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
12

-------
CDXr
If you lose or forget your passphrase, you will not be able to access your Risk Evaluation Form
to print, submit, or make changes. You will need to complete a new Risk Evaluation Form and
create a new passphrase for the form. For security reasons, the system administrator will not
have access to your passphrase and will not be able to retrieve it or reset it.
•	New Passphrase: Enter a passphrase that is between 8 to 20 characters. For maximum
security, your passphrase should contain a combination of letters and numbers. Your
passphrase should not contain special characters (for example, +, ?, and *). As a Primary
user, you are responsible for remembering your passphrase and distributing it to only
authorized individuals. The passphrase is used as an encryption key to protect the contents of
the form data.
•	Confirm Passphrase: Enter the same passphrase that was entered into the 'New Passphrase'
field. The same passphrase may be associated with multiple forms. The user can choose to
have the same passphrase for all forms. Supports do not have the ability to start a new form
or create a passphrase for a form.
Exhibit 3-7 shows a screen capture of the 'Create Passphrase' screen:
Exhibit 3-7 Create Passphrase Screen
HOME USER MANAGEMENT
A. Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
TSCA Risk Evaluation
New Passphrase
Confirm Passphrase
A You are responsible for remembering your
passphrase!
If you lose or forget your passphrase, you will not be able to access your
Risk Evaluation Form to print, submit, or make changes. You will need to
complete a new Risk Evaluation Form and create a new passphrase for
the form. For security reasons, the system administrator will not have
access to your passphrase and will not be able to retrieve it or reset it.
Raise a Bug CDX Links- CDX Helpdesk: (888)890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
13

-------
CDXr
Navigation: For a new EPA Initiated Risk Evaluation, Initial Response, Manufacturer Requested
Evaluation, or Withdrawal Request, create a passphrase and click the 'Continue' button to
navigate to the 'Contact' screen.
3.6 Enter Passphrase
To edit a form, click the 'Form Alias' link for a Risk Evaluation request with a status of 'In
Progress.' The 'Enter Passphrase' screen requires you to enter the passphrase that is associated
with the request.
•	Form Alias: Displays the form alias that is used to identify the request.
•	Enter Passphrase: Enter the same passphrase that was used to originally create the request.
For security reasons, the system administrator does not have access to the passphrase and
cannot retrieve it or reset it to a new one. If a user has forgotten the passphrase, a new request
will need to be created with a new passphrase.
Exhibit 3-8 shows a screen capture of the 'Enter Passphrase' screen:
Exhibit 3-8 Enter Passphrase Screen
HOME USER MANAGEMENT
A Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
TSCA Risk Evaluation RER-20170821-16:00:15
Enter Passphrase
Form Alias
RER-20170821-16:00:15
Enter Passphrase
A You are responsible for remembering your
passphrase!
If you lose or forget your passphrase, you will not be able to access your
Risk Evaluation Form to print, submit, or make changes. You will need to
complete a new Risk Evaluation Form and create a new passphrase for
the form. For security reasons, the system administrator will not have
access to your passphrase and will not be able to retrieve it or reset it.
Raise a Bug CDX Links- CDX Helpdesk: (888)890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
14

-------
CDXr
Navigation: Enter the passphrase that you originally created and associated with the request and
click the 'Continue' button to navigate to the 'Contact' screen in a Manufacturer Requested Risk
Evaluation form.
3.7 Action Bar
The action bar is located at the top and bottom of the form on each screen. You can perform the
following functions using the action bar:
•	Home: Click the 'Home' link to navigate to the Risk Evaluation 'Home' screen.
•	User ID: Click the user ID link in the top right-hand corner to log out of the application.
The following exhibits, Exhibit 3-9, Exhibit 3-10, Exhibit 3-11, and Exhibit 3-12 show screen
captures for the action bar:
•	Save: Click the 'Save' link at any stage of completing a Risk Evaluation request to save the
form. To generate and access links to other pages of the request within the navigation header,
you must click the 'Save' link within the action bar. After you click the 'Save' link, you will
receive a message indicating that all data entered in the request has been saved successfully.
The save function does not validate any entered data. Click the 'Previous' and 'Next' buttons
on a form to save the data entered within a request. Click the 'X' button in the upper right-
hand corner of the form in your browser to close the request without saving.
Exhibit 3-9 Action Bar - Save
H Save


a
Preview ~Validate 05 Submit


• Preview: Click the 'Preview' link to preview the request. After you click the 'Preview' link,
you will be given the option to view a regular version of the PDF(s) or a sanitized version of
the PDF(s). Choosing either option will generate a watermarked PDF containing each
chemical substance identified within the request. Refer to Section 5 for more information on
previewing a request.
Exhibit 3-10 Action Bar - Preview



H Save
a
Preview ~\falidate Q Submit



• Validate: Click the 'Validate' link at any stage of completing a Risk Evaluation request. A
'TSCA Risk Evaluation' window generates when you click the 'Validate' link if you disable
the pop-up blocker within your internet browser. The 'TSCA Risk Evaluation' pop-up
window displays a report of all warning messages. Refer to Section 9 for more information
on validating a request.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
15

-------
CDXr
Exhibit 3-11 Action Bar-Validate



H Save

Preview ~Validate Q Submit



• Submit: Click the 'Submit' link to submit a Risk Evaluation request after completing all
sections of a Risk Evaluation request. After you click the 'Submit' link a pop-up message
displays to confirm the submission process. The request validates during the submission
process and displays any applicable warning or error messages. Refer to Section 9 for further
instructions on validation errors. You can continue with the submission process only after
clearing all validation errors. Upon successful submission of the request, the application
generates and sends an email indicating the successful submission of the request to the
submitter's email address. Refer to Section 10 for more information on submitting a Risk
Evaluation request.
Exhibit 3-12 Action Bar - Submit
H Save


a
Preview ~Validate 05 Submit


• CDX Links: Click any of the 'CDX Links,' located at the bottom of each screen within the
'CDX Links' drop-down menu, at any stage of completing a Risk Evaluation request.
o Click the 'CDX Homepage' link to navigate to the 'CDX' homepage.
o Click the 'MyCDX Homepage' link to navigate to the 'MyCDX' page.
o Click the 'EPA Homepage' link to navigate to EPA's Homepage.
o Click the 'Terms and Conditions' link to navigate to the 'CDX Terms and
Conditions' screen.
o Click the 'Privacy Notice' link to navigate to the 'CDX Privacy and Security
Notice' screen.
Exhibit 3-13 shows a screen capture of the action bar 'CDX Links':
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
16

-------
CDXr
Exhibit 3-13 CDX Links

CDX Homepage
MyCDX Homepage
EPA Homepage
Terms and Conditions
Privacy Notice

Raise a Bug CDX Links ^
CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
17

-------
CDXr
4 Chemical Substance Risk Evaluation Request
The purpose of the Risk Evaluation request is to determine whether a chemical substance
presents an unreasonable risk to health or the environment, under the conditions of use, including
an unreasonable risk to a relevant potentially exposed or susceptible subpopulation. Users can
complete the request to solicit a Risk Evaluation for their manufactured chemical(s).
Each risk evaluation request must include a list of all the existing information that is relevant to
whether the chemical substance, under the conditions of use identified by the manufacturer,
presents an unreasonable risk of injury to health or the environment. The request does not need
to include copies of the information; citations are sufficient, if the information is publicly
available. The request must include or reference all available information on health and
environmental hazard(s) of the chemical substance, human and environmental exposure(s), and
exposed population(s), as relevant to the conditions of use identified in the request.
At a minimum this information must include: hazard and exposure potential, persistence and
bioaccumulation, potentially exposed or susceptible subpopulations the requestor believes to be
relevant, whether there is any storage of the chemical substance near significant sources of
drinking water (this could include a storage facility), production volume or significant changes to
production volume, and any other information relevant to the potential risks of the chemical
substance.
4.1	Create a Manufacturer Requested Risk Evaluation	
To create a new Risk Evaluation request, navigate to the Risk Evaluation 'Home' screen and
select 'Manufacturer Requested Evaluation' from the 'Form Type' drop-down menu. Refer to
Section 3.2 for additional details regarding the Risk Evaluation 'Home' screen.
Refer to Section 3.5 for additional details regarding the passphrase creation process.
4.2	Contact
You can navigate to the 'Contact' screen by clicking the 'Create' button and creating a new
passphrase, or by accessing a Risk Evaluation request that is 'In Progress' and entering the
passphrase associated with the selected request.
The 'Contact' screen provides fields to input identifying information for a technical contact. You
will have the option to assign a 'Submission Alias' to identify the request. A unique submission
alias is helpful when a user or company has multiple requests and/or when you must differentiate
between requests to the help desk. Upon navigating to the 'Contact' screen, the system auto-
generates a default alias comprised of a form type, date stamp, and time stamp in the following
format: 
. • Submission Alias: Enter the submission alias. Upon navigating to the screen, the application displays an auto-generated editable submission alias in the following format: . This is a required field. Risk Evaluation Rule User Guide Primary Authorized Official January 16, 2020 18

-------
CDXr
•	N/A: Select the 'N/A' radio button to indicate that the form will be submitted on behalf of
the reporting organization. Selecting this radio button generates the 'Fees Certification' page.
•	This is a submission on behalf of a consortium: Select the 'This is a submission on behalf
of a consortium to indicate that the request is submitted on behalf of a consortium. Selecting
this radio button generates the 'Submitting on Behalf of Consortium' screen.
•	CBI: Check the 'CBI' checkbox to claim the contact information as confidential.
•	Copy from CDX: Click the 'Copy from CDX' link to copy CDX registration information.
•	First Name: Enter the first name of the contact. This is a required field.
•	Last Name: Enter the last name of the contact. This is a required field.
•	Position: Enter the job title of the contact.
•	Company Name: Enter the company name of the contact. This is a required field.
•	Additional Companies: Enter an additional company in this field, if applicable.
•	Add: Click the button to add the company entry into the 'Additional Companies' table.
•	Additional Company Name: Displays the additional company name(s) associated with the
contact.
•	Action: Click the 'Delete" icon (X) to remove an additional company name.
•	Phone Number: Enter the phone number of the contact. This is a required field.
•	Phone Number Extension: Enter the extension to the phone number, if applicable.
•	Email Address: Enter the email address of the contact.
•	Mailing Address 1: Enter the mailing address of the contact. This is a required field.
•	Mailing Address 2: Enter the second line of the mailing address of the contact, if applicable.
•	City: Enter the city of the mailing address of the contact. This is a required field.
•	State: Select the state of the mailing address of the contact. This is a required field if 'United
States' is identified as the country.
•	Postal Code: Enter the postal code of the mailing address of the contact. This is a required
field.
•	Country: Select the country of the mailing address of the contact from the drop-down menu.
Selecting a non-US country generates the 'United States Agent' screen. This is a required
field.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
19

-------
CD)fr
Exhibit 4-1 shows a screen capture of the 'Contact' screen (Scroll 1):
Exhibit 4-1 Contact Screen (Scroll 1)
HOME USER MANAGEMENT
TSCA Risk Evaluation RER-20181031-09:30:37
Step 1	Step 2	Step 3	Step 4
ฃ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
Step 5
Step 6
1 Chemical Substance Document Upload
Fees Certification
Submitting Official Information
Certification
or Category



Contact
- Submission Alias
RER-20181031-09:30:37
Please do not include CBI information in the Submission Alias fiel<
O N/A
O This is a submission on behalf of a consortium
Contact (U.S./non-U.S.)	~ CBI
Copy From CDX
*	First Name
*	Last Name
Position
- Company Name
H Save ~Validate O Preview ฉSubmit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
20

-------
CDXr
Exhibit 4-2 shows a screen capture of the 'Contact' screen (Scroll 2):
Exhibit 4-2 Contact Screen (Scroll 2)
USER MANAGEMENT
A Jane Doe, Jane's Company (Primary Authorized Official)
Additional Companies
If the contact identified on this page represents more than one company, enter
additional company names below. Please note that listing company names in
this field does not constitute a consortium submission.
Add
Additional Company Name 4
1 Action
No additional companies found

* Phone Number
Phone Number must be at least 10 digits and conts
Phone Number Extension
* Email Address
HSave ~Validate Q Preview 0 Submit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
21

-------
CDXr
Exhibit 4-3 shows a screen capture of the 'Contact' screen (Scroll 3):
Exhibit 4-3 Contact Screen (Scroll 3)
HOME USER MANAGEMENT
ฑ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official

V^-Y11ione Number

Phone Number must be at least 10 digits and contain only numbers.
Phone Number Extension

* Email Address

* Mailing Address 1

Mailing Address 2

* City


* State


Please select a state ... [vj


* Postal Code


+ Country


United States [v]


Continue



H save ~ Validate Q Preview 0 Submit
Raise a Bug CDX Links CDX Helpdesk: (888) 890-199!
5
Navigation: Click the 'Continue' button to navigate to the 'Chemical Substance or Category'
screen if a U.S. contact is identified and the request is submitted on behalf of the reporting
organization. Click the 'Continue' button to navigate to the 'Submitting on Behalf of
Consortium' screen if the request is submitted on behalf of a consortium. You can also access
this screen by clicking the 'Chemical Substance or Category' or 'Submitting on Behalf of
Consortium' link, respectively, within the navigation header. Click the 'Continue' button to
navigate to the 'United States Agent' screen if a non-U. S. contact is identified. You can also
access this screen by clicking the 'U.S. Agent' link within the navigation header.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
22

-------
CDXr
4.3 Submitting on Behalf of Consortium
You can navigate to the 'Submitting on Behalf of Consortium' screen by selecting the 'This is a
submission on behalf of a consortium' radio button and clicking the 'Continue' button on the
'Contact' screen.
The 'Submitting on Behalf of Consortium' screen provides fields to capture consortium
information and individual consortium members. The user populating the form is identified as a
consortium member by default upon navigating to the 'Submitting on Behalf of Consortium'
page. A minimum of two consortium members is required.
•	Consortium Name: Enter the name of the consortium. This is a required field.
•	Consortium CBI: Check the 'CBI' checkbox to claim the consortium as confidential.
•	Add Consortium Member: Click the 'Add Consortium Member' button to generate an
additional set of consortium input fields. At least two (2) consortium members are required to
be identified.
•	First Name: Enter the first name of the consortium member. This is a required field.
•	Last Name: Enter the last name of the consortium member. This is a required field.
•	Position: Enter the job title of the consortium member.
•	Company Name: Enter the company name of the consortium member. This is a required
field.
•	Phone Number: Enter the phone number of the consortium member. This is a required field.
•	Phone Number Extension: Enter the extension to the phone number, if applicable.
•	Email Address: Enter the email address of the consortium member. This is a required field.
•	Mailing Address 1: Enter the mailing address of the consortium member. This is a required
field.
•	Mailing Address 2: Enter the second line of the mailing address of the consortium member,
if applicable.
•	City: Enter the city of the mailing address of the consortium member. This is a required
field.
•	State: Select the state of the mailing address of the consortium member. This is a required
field.
•	Postal Code: Enter the postal code of the mailing address of the consortium member. This is
a required field.
•	Country: Select the country of the mailing address of the consortium member. This is a
required field.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
23

-------
CD)fr
•	My company is a "small business concern" as defined under 40 CFR 700.43: Select the
radio button to indicate that the consortium is a small business concern. A fee certification
statement is required to be selected.
•	My company is not a "small business concern" as defined under 40 CFR 700.43: Select
the radio button to indicate that the consortium member does not represent a small business
concern. A fee certification statement is required to be selected.
Exhibit 4-114 shows a screen capture of the 'Submitting on Behalf of Consortium' screen (Scroll
1):
Exhibit 4-4 Submitting on Behalf of Consortium Screen (Scroll 1)
HOME USER MANAGEMENT
X Jane Doe. TEST ORGANIZATION LLC (Primary Authorized Officii
TSCA Risk Evaluation
RER-20181031-09:30:37


Step 1
Step 2
Step 3 Step 4
step 5
Step 6
Contact
Submitting on
Behalf of
Consortium
Chemical Substance Document
or Category Upload
Submitting Official
Information
Certification
Submitting on Behalf of Consortium
Consortium Name
Consortium CBI
A business concern selection must be made for each member of the consortium
The business concern selection is an un-editable choice for previously identified consortium members within an amendment.
Add Consortium Member
' Jane Doe TEST ORGANIZATION LLC
Jane
*	Last Name
Doe
Position
*	Company Name
TEST ORGANIZATION LLC
H Save ~Validate QPreview ฉSubmit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-199ฃ
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
24

-------
CDXr
Exhibit 4-125 shows a screen capture of the 'Submitting on Behalf of Consortium' screen (Scroll
2):
Exhibit 4-5 Submitting on Behalf of Consortium Screen (Scroll 2)
HOME USER MANAGEMENT
*	Phone Number
I 5555555555
Phone Number must be at least 1
Phone Number Extension
*	Email Address
Casey.Yeh@cgifederal.com
*	Mailing Address 1
1025 LEESBURG PIKE
Mailing Address 2
City
FALLS CHURCH
ฑ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized OfficiE
State
Virginia
0
Postal Code
22033
Country
United States	[v]
+ Fees Certification
As required by 40 CFR 700.45, fees are
applicable to anv person who manufactur
H Save ~Validate OPreview ฉSubmit
Raise a Bug CDX Links ^ CDX Helpdesk: (888) 890-199^
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
25

-------
CDXr
Exhibit 4-6 shows a screen capture of the 'Submitting on Behalf of Consortium' screen (Scroll
3):
Exhibit 4-6 Submitting on Behalf of Consortium Screen (Scroll 3)
HOME USER MANAGEMENT
ฑ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Officio
- State
Virginia
Postal Code
22033
Country
United States
Fees Certification
0
0
As required by 40 CFR 700.45, fees are
applicable to any person who manufactures
(including imports) a chemical substance that is
the subject of a risk evaluation under TSCA
section 6(b).
Select the following Fees Certification statement
that applies to the selected consortium member:
O My company is a "small business concern" as
defined under 40 CFR 700.43.
O My company is not a "small business concern" as
defined under 40 CFR 700.43.
'The criteria for a "small business concern"has been changed in the final fees rule. View the updated definition of a small business concern.
A PDF version of the final fees rule is available at https://www.epa.gov/sites/production/files/2018-09/documents/2018-09-27_prepubcopy_tsca-fees-finalrule.pdf.
Cancel I Save
H Save ~Validate OPreview ฉSubmit
Raise a Bug CDX Links ^ CDX Helpdesk: (888) 890-199^
Navigation: Click the 'Save' button to save the consortium member information. Click the
'Continue' button to navigate to the 'Chemical Substance or Category' screen if the request is
submitted on behalf of the reporting organization. You can also access this screen by clicking the
'Chemical Substance or Category' link within the navigation header. Click the 'Continue' button
to navigate to the 'U.S. Agent' screen if a non-U.S. contact is identified. You can also access this
screen by clicking the 'U.S. Agent' link within the navigation header.
4.3.1 Small Business Concern Definition
Click the 'View the updated definition of a small business concern' link to generate the 'Small
Business Concern Definition' window. This window displays a table of the North American
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
26

-------
CDXc
Industry Classification System (NAICS) codes, NAICS descriptions, and applicable small
business concern size in number of employees.
As noted in the definition, if there are codes that are not listed within the NAICS table, a small
business definition applies to 500 or fewer employees that a company "owns or controls."
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
27

-------
CD)fr
Exhibit 4-7 shows a screen capture of the ' Small Business Concern Definition' window (Scroll
1):
Exhibit 4-7 Small Business Concern Definition Window (Scroll 1)
Small Business Concern Definition
40 CFR 700.43
Small business concern means a manufacturer or processor who meets the size
standards identified in the table below. The number of employees indicates the
maximum allowed for a manufacturer or processor to be considered small. If the
North American Industry Classification System (NAICS) code of a manufacturer or
processor is not represented in the table below, it will be considered small if it has
500 or fewer employees. When calculating the number of employees, a
manufacturer or processor must include the employees of all of its "parent
companies" and all companies it "owned or controlled," as defined by 40 CFR
704.3. The number of employees are calculated as the average number of people
employed for eac h pay period of the business' latest 12 calendar months,
regardless of hours worked or temporary status.

Potentially Affected
NAICS
NAICS Description
Small Business
Concern Size
Standards (# of
employees)
324110
Petroleum Refineries
1500 or fewer
325110
Petrochemical
Manufacturing
1000 or fewer
325120
Industrial Gas
Manufacturing
1000 or fewer
325130
Synthetic Dye and
Pigment Manufacturing
1000 or fewer
325180
Other Basic Inorganic
Chemical Manufacturing
1000 or fewer
325193
Ethyl Alcohol
Manufacturing
1000 or fewer



Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
28

-------
CDXs
Exhibit 4-8 shows a screen capture of the ' Small Business Concern Definition' window (Scroll
2):
Exhibit 4-8 Small Business Concern Definition Window (Scroll 2)
Cvclc OuJe,
Intermediate and Gir ^
BDf! 0 3d C i6!T jU
!.'5iJfa:tirnq
1250 or fewer
325159
Alt O'her Basic Organs
C;1&it-ic a VI s n uTac Il m g
1250 or"fevver
521'
Plastics Material arvci
Resin F.'fanufaeturha
1250 c fevve'
325212
Svnlheic Rjobe*
Maru'acturng
1000 crfev;er
iJulLO
32531J

S25314
325320
32541r
32541:
325413
ArtifUia! and Sritlre'jc
-iters -und -ilamen-s
i,fanj'a:tuqn3
Nrjogenoirs -er.,lizeT
'."annfaeturng
Pnosphatt cen>..ze:
Fertilizer xing GnK ;•
?,'i3nufacturho
Ces"ic!de and Cither
Agnc jluna. G'leniral
rJanj'aittrino
Medicinal and Botanical
?v*anu*a€ti;rfiTig
Pharmaceutical
^reparation
Manufaciuring
In Vitro D'agnosrc
Substance
1 0U0 orfeAer
1000 crfevve'
150 or fewer
500 o' fewer
100 :• c" few
1000 or fewer
1250 cr fewe-
1250 crf&we'
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
29

-------
CDXs
Exhibit 4-9 shows a screen capture of the ' Small Business Concern Definition' window (Scroll
3):
Exhibit 4-9 Small Business Concern Definition Window (Scroll 3)
325414
325510
325520
325611
325612
325613
325620
325910
325920
32595"i
325992
325998
Biologic as Product
(except Diagnostic)
Manufacturing
Faint and Coating
Manufacturing
Adhesive Manjfsctunnc
Soap and Other
Detergeฆnt Manufacturf03
Polish and Other
Sanation 3ood
Maru'cCti ric
Surace Act've Agent
t','i?'iu*actitrrno
Islet Preparation
r.''2ndfacturmo
Printing tn*
Manufacturing
Expfcsives
Manufacturing
Custom Compounding cf
Purchased Res=ns
Photographic Fmti.
Paper. Plate and
CherP:ca^ Msnufattur na
A/ other Miscellaneous
Chernica! Psfoaue'. and'
^reparation
Manufactunng
*• 2cซ0 or fevver
*	000 or fewer
500 or fewer
'000 cr fevver
750 cr fewer
750 or 'ewer
1250 or fewer
500 or fevier
750 c\r fewer
503 or fewer
*	500 or fewer
500 cr fewer
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
30

-------
CDX?
Exhibit 4-10 shows a screen capture of the 'Small Business Concern Definition' window (Scroll
4):
Exhibit 4-10 Small Business Concern Definition Window (Scroll 4)
325513
surface Active Agent
Manufacturing
>0 or fewer
O'lp c~ in
ilL
Toilet Preparation
Manufacturing
'250 or fevve'
J25910
Prim ng Ink
b-anufactunno
>00 c fewer
32d92C
r.'anjfetunq
d0 o: fewer
32599"'
Custom Ccrr.poiinc'ing o*
Purchases Res o?
? 00 c fewer
32t992
Photographs Fmi
Chem'caf Marmfactt;rLna
i-5'00 cr fewer
325958
AS Oiher Miscellaneous
Chemical Procuc: arc
Preparation
Manufacturing
500 c fewer
424S9C
Other Cnerricaf and
Allied Products Merchant
Wholesale's
1 o0 of fewer
42471C
Petroleum Bulk Station's
an3 Terminate
500 or fewer
-24720
Petroleum and
Pe'.rolejrri Products
Merchant Wholesalers
20D cfev.er
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
31

-------
CDXr
Navigation: Click the 'X' icon in the upper right-hand corner to close the 'Small Business
Concern Definition' window.
4.4 United States Agent	
You can navigate to the 'United States Agent' screen by identifying a non-U. S. contact and
clicking the 'Continue' button on the 'Contact' screen.
The 'United States Agent' screen provides fields to input identifying information for a U.S.
agent.
•	CBI: Check the 'CBI' checkbox to claim the agent information as confidential.
•	First Name: Enter the first name of the agent. This is a required field.
•	Last Name: Enter the last name of the agent. This is a required field.
•	Position: Enter the job title of the agent.
•	Company Name: Enter the company name of the agent. This is a required field.
•	Phone Number: Enter the phone number of the agent. This is a required field.
•	Phone Number Extension: Enter the extension to the phone number, if applicable.
•	Email Address: Enter the email address of the agent. This is a required field.
•	Mailing Address 1: Enter the mailing address of the agent. This is a required field.
•	Mailing Address 2: Enter the second line of the mailing address of the agent, if applicable.
•	City: Enter the city of the mailing address of the agent. This is a required field.
•	State: Select the state of the mailing address of the agent. This is a required field.
•	Postal Code: Enter the postal code of the mailing address of the agent. This is a required
field.
•	Country: Displays 'United States.'
Exhibit 4-11 shows a screen capture of the 'United States Agent' screen (Scroll 1):
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
32

-------
CDXr
Exhibit 4-11 United States Agent Screen (Scroll 1)


HOME
USER MANAGEMEN1
X Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official
TSCA Risk Evaluation RER-20181024-14:10:06
Step 1 Step 2 Step 3 Step 4 Step 5 Step 6 Step 7
Contact
U.S. Agent
Chemical Substance Document Upload Fees Certification Submitting Official Certificat
or Category Information
United States Agent
~ CBI
- First Name
- Last Name
Position
- Company Name
- Phone Number
Phone Number Extension
- Email Address
* Mailing Address 1
Exhibit 4-12 shows a screen capture of the 'United States Agent' screen (Scroll 2):
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
33

-------
CDXr
Exhibit 4-12 United States Agent Screen (Scroll 2)
X Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Officia
Phone Number
Phone Number Extension
- Email Address
*	Mailing Address 1
Mailing Address 2
*	City
*	State
Please select a state ...
*	Postal Code
* Country
United States
Previous
Continue
Navigation: Click the 'Continue' button to navigate to the 'Chemical Substance or Category'
screen if the request is submitted on behalf of the reporting organization. You can also access
this screen by clicking the 'Chemical Substance or Category' link within the navigation header.
4.5 Chemical Substance or Category
You can access the 'Chemical Substance or Category' screen by clicking the 'Continue' button
from the 'Contact' screen if identifying a U.S. contact. If identifying a non-U.S. contact within
the 'Contact' screen, you can access this screen by clicking the 'Continue' button from the
'United States Agent' screen. You can also access this screen by clicking the 'Chemical
Substance or Category' link within the navigation header.
The 'Chemical Substance or Category' screen displays the following fields and columns of
information:
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
34

-------
CDXr
•	Chemical Type: Select 'Chemical Category' from the 'Chemical Type' drop-down menu to
indicate that the chemical substances included will be classified under a single chemical
category. Select 'Chemical Substance' to identify one chemical substance for evaluation.
•	Chemical Category Description: Enter a description of the chemical category; either
chemicals or a chemical category must be identified. 'Chemical category' means a group of
chemical substances the members of which are similar in molecular structure, in physical,
chemical, or biological properties, in use, or in mode of entrance into the human body or into
the environment, or the members of which are in some other way suitable for classification as
such for purposes of this Act, except that such term does not mean a group of chemical
substances which are grouped together solely on the basis of their being new chemical
substances. This is a required field (if displayed).
•	Search: Enter criteria to filter the attached documents.
•	Document Type: Displays the document type of the uploaded chemical category attachment.
A chemical category rationale document and either chemicals or a chemical category
substance list document is required if the user is reporting a chemical category.
•	File Name: Displays the file name of the uploaded chemical category attachment. Click the
link to navigate to the 'Attach Document' window with uploaded document information.
•	File Description: Displays the description of the uploaded chemical category attachment.
•	Page Count: Displays the number of pages the uploaded chemical category attachment
contains.
•	Date: Displays the date the chemical category attachment is uploaded.
•	CBI: Displays a ' Y' or an 'N' to indicate the confidentiality status of the uploaded
attachment.
•	Action: Click the 'Delete' icon (X) to remove the uploaded chemical category document.
•	Attach Chemical Category Document: Click this link to navigate to the 'Attach Document'
pop-up window and upload a new document. You are required to upload a 'Chemical
Category Rationale' document if you selected 'Chemical Category' from the 'Chemical
Type' drop-down menu on the 'Chemical Substance or Category' screen. Refer to Section
4.5.1 for further details on the 'Attach Document' window.
•	Search: Enter criteria to filter the identified chemical substances.
•	CASRN: Displays the Chemical Abstract Services Registry Number (CASRN) (if
applicable) of the identified chemical substance.
•	PMN No.: Displays the Premanufacture (PMN) Number (if applicable) of an identified
chemical substance.
•	Acc. No.: Displays the Accession Number (if applicable) of an identified chemical substance.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
35

-------
CDXr
•	Chemical Name (TSCA Inventory): Displays the chemical name of an identified chemical
substance.
•	Chemical Name (Generic): Displays the generic name of an identified chemical substance.
•	Action: Click the 'Edit' icon (<•' ) to enable the chemical fields and modify the chemical
information. Click the 'Delete" icon (X) to remove the identified chemical substance.
•	Add Chemical: Click the 'Add Chemical' button to enable the chemical information fields.
•	Search SRS: Click the 'Search SRS' button to generate the 'Search Substance Registry
Services (SRS)' window. See Section 4.5.2 for additional details about the 'Search SRS'
functionality.
•	CASRN: Displays the Chemical Abstract Services Registry Number (CASRN) of the
identified chemical substance.
•	Chemical Name: Displays the chemical name of the identified chemical substance.
•	Trade Name: Enter the trade name of the identified chemical substance. This is a required
field.
•	Molecular Structure: Enter the molecular structure of the identified chemical substance.
This is a required field.
•	Cancel: Click the 'Cancel' button to close the chemical information fields.
•	Save: Click the 'Save' button to save the entered chemical substance information.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
36

-------
CD)fr
Exhibit 4-13 shows a screen capture of the 'Chemical Substance or Category' screen (Scroll 1):
Exhibit 4-13 Chemical Substance or Category Screen (Scroll 1)
HOME USER MANAGEMENT
ฑ. Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)




TSCA Risk Evaluation
RER-20181031-09:30:37


Step 1 Step 2
Step 3 Step 4
Step 5
Step 6
Contact Submitting on Behalf
of Consortium
1 Chemical Substance 1
1 or Category
Submitting Official
Information
Certification
Chemical Substance or Category
Chemical Type
Chemical Substance	[v]
* Chemicals
CASRN 1= PMN No.	Acc. No.
Chemical Name (TSCA Inventory)
No chemical information found
Chemical Name (Generic)	Action
H Save ~Validate O Preview ฉSubmit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Exhibit 4-14 shows a screen capture of the 'Chemical Substance or Category' screen (Scroll 2):
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
37

-------
CD)fr
Exhibit 4-14 Chemical Substance or Category Screen (Scroll 2)
HOME USER MANAGEMENT
TSCA Risk Evaluation RER-20181031-09:30:37
Step 1	Step 2	Step 3	Step 4
A Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Officia
Step 5
Contact
Submitting on Behalf
Chemical Substance
Document
Submitting Official
Certification

of Consortium
or Category
Upload
Information

Chemical Substance or Category
Chemical Type
Chemical Category	[v]
- Chemical Category Description
The term "category of chemical substances" means a group of chemical substances the members of which are similar in molecular structure, in physical, chemical, or
biological properties, in use. or in mode of entrance into the human body or into the environment, or the members of which are in some other way suitable for
classification as such for purposes of this Act, except that such term does not mean a group of chemical substances which are grouped together solely on the basis of
their being new chemical substances.
- Chemical Category Attachments
Document
Type U	File Name	File Description	Page Count	Date	CBI	Action
No chemical category document found.
<
O Attach Chemical Category Document
* Chemicals
H Save ~Validate OPreview ฉSubmit
CDX Helpdesk: (888) 890-199
i
Exhibit 4-15 shows a screen capture of the 'Chemical Substance or Category' screen (Scroll 3):
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
38

-------
CDXr
Exhibit 4-15 Chemical Substance or Category Screen (Scroll 3)
fej
CIS;*!
USER MANAGEMENT
ฑ, Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Officia
^on as such for purposes of this Act, except that such term does not mean <
their being new chemical substances.
group of chemical substances which are grouped together solely on the basis of
Chemical Category Attachments
Document
Type U	File Name
File Description	Page Count
No chemical category document found.
O Attach Chemical Category Document
CASRN U PMN No.	Acc. No.
Chemical Name (TSCA Inventory)
No chemical information found
Chemical Name (Generic)
Add Chemical
H Save ~Validate QPreview ฉSubmit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-199ฃ
Navigation: Click the 'Next' button to navigate to the 'Document Upload' screen. You can also
access this screen by clicking the 'Document Upload' link within the navigation header.
4.5.1 Attach Document
The 'Attach Document' window displays the following fields of information:
•	CBI: Check this checkbox to claim the uploaded document as confidential.
•	Document Type: Select the type of document you are uploading from this drop-down menu.
Refer to Appendix A. Document Types and Subtypes for a list of all the document types
available in this drop-down menu. This is a required field.
•	Document Subtype: Select the subtype of the document you are uploading from this drop-
down menu, if applicable. Refer to Appendix A. Document Types and Subtypes for a list of
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
39

-------
CDXr
all the document subtypes available in this drop-down menu. This is a required field, if
shown.
•	Description: Enter a description for the uploaded document. This is a required field.
•	Page Count: Enter the number of pages the attached document contains.
•	Attachment: Click the 'Browse' button to search for and select a document to attach.
•	Sanitized Attachment: Click the 'Browse' button to search for and select a sanitized
document to attach.
•	Save Document: Click the button to save and upload the selected document.
•	Close: Click this button to close the 'Attach Document' pop-up window and return to the
'Chemical Substance or Category' screen without saving any information.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
40

-------
CD)fr
Exhibit 4-16 shows a screen capture of the 'Attach Document' pop-up window within the
'Chemical Substance or Category' screen:
Exhibit 4-16 Attach Document Pop-Up Window (Chemical Substance or Category Screen)
CBI claims for information found within documents attached to support the request for risk
evaluation must be substantiated when the information is submitted. Any substantiation of
confidential information included in an attached document should be included in the
substantiation document required on the Instructions for Substantiating Confidential
Business Information (CBI) Claims' screen.
~ CBI
*	Document Type
Please select a doc u ment type ...	T
*	Description
Page Count
- Attachment
Attach Document
Browse
Save Document
Close
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
41

-------
CDXc
4.5.2 Search Substance Registry Services (SRS)
The 'Search SRS' button displays on the 'Chemical Substance or Category' screen to identify
chemicals in SRS.
Search SRS: Click the 'Search SRS' button to generate the 'Search Substance Registry Services
(SRS)' pop-up window. You can search for the reported chemical(s) by either the 'CASRN,'
'TSCA Inventory Name,' 'Accession Number,' or'Generic Name.'
The system allows you to save each chemical by clicking the 'Save' button located at the bottom
of the 'Search Substance Registry Services (SRS)' pop-up window. Once you select the specified
chemical substance and click the 'Save' button, the chemical information saves and populates
into the chemical substance fields.
•	CASRN: Select the 'CASRN' radio button to search by the Chemical Abstracts Service
Registry Number of the chemical; this field accommodates dashes.
•	TSCA Inventory Name: Select the 'TSCA Inventory Name' radio button to search by the
inventory name of the chemical.
•	Accession Number: Select the 'Accession Number' radio button to search by the accession
number of the chemical.
•	Generic Name: Select the 'Generic Name' radio button to search by the generic chemical
name.
•	Begins With/Matches Exactly/Contains: Select an option to apply a specific filter to the
entered search criteria.
•	Search: Click the 'Search' button to search SRS using the entered search criteria.
•	Create New Chemical: To identify a new chemical, click the 'Create New Chemical'
button. Refer to Section 4.5.3 for further details on the process of creating a new chemical.
•	Close: Click this button to close the 'Search Substance Registry Services (SRS)' window and
return to the 'Chemical Substance or Category' screen without saving any information.
•	Save: Click the 'Save' button to return to the 'Chemical Substance or Category' screen and
populate the selected chemical into the chemical substance fields.
Exhibit 4-17 shows a screen capture of the 'Search Substance Registry Services (SRS)' window:
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
42

-------
CDXr
Exhibit 4-17 Search Substance Registry Services (SRS) Window
Search Substance Registry Services (SRS)
Enter search terms here ...
•CASRN	OTSCA Inventory Name ฉAccession Number	OGeneric Naine
Begins With [v]
Create New Chemical Close
Navigation: Click the 'Save' button to return to the 'Chemical Substance or Category' screen
and populate the selected chemical into the chemical substance fields.
4.5.3 Create New Chemical
The 'Create New Chemical' button displays on the 'Search Substance Registry Services (SRS)'
window to identify new chemicals.
•	Create New Chemical: Click the 'Create New Chemical' button to generate the 'Create
New Chemical' window. You can enter chemical information into the 'Chemical Name,'
'CASRN,' 'PMN Number,' 'Generic Name,' 'PMNNumber,' and/or'Accession Number'
fields.
•	Chemical Name: Enter the name of the identified chemical substance.
•	CBI: Check the 'CBI' checkbox to claim the chemical name as confidential; this is disabled
if a CASRN is entered.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
43

-------
CDXr
•	CASRN: Enter the CASRN of the entered chemical substance; either the 'CASRN,' 'PMN
Number,' or 'Accession Number' must be entered. The 'CBI' checkbox is disabled if a
CASRN is identified.
•	Generic Name: Enter the generic name of the entered chemical substance.
•	PMN Number: Enter the PMN Number of the entered chemical substance; either the
'CASRN,' 'PMN Number,' or 'Accession Number' must be entered.
•	Accession Number: Enter the Accession Number of the entered chemical substance; either
the 'CASRN,' 'PMN Number,' or 'Accession Number' must be entered.
•	OK: Click the 'OK' button to return to the 'Chemical Substance or Category' screen and
populate the entered chemical information into the chemical substance fields.
•	Close: Click the 'Close' button to close the 'Create New Chemical' window and return to the
'Search Substance Registry Services (SRS)' window without saving the entered data.
Exhibit 4-18 shows a screen capture of the 'Create New Chemical' window:
Exhibit 4-18 Create New Chemical Window
Create New Chemical

* Chemical Name
~ CBI
CASRN
Generic Name
PMN Number
Accession Number
Close
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
44

-------
CDXr
4.6 Document Upload
You can access the 'Document Upload' screen by clicking the 'Next' button from the 'Chemical
Substance or Category' screen. You can also access this screen by clicking the 'Document
Upload' link within the navigation header.
A condition of use rationale document is required to be uploaded within a Risk Evaluation
request.
•	Condition of Use: Enter text including a rationale for the conditions of use. The term
'condition of use' means the circumstances, as determined by the Administrator, under which
a chemical substance is intended, known, or reasonably foreseen to be manufactured,
processed, or distributed in commerce, used or disposed of. This is a required field.
•	Search: Enter criteria to filter the uploaded document(s).
•	Document Type: Displays the document type of the uploaded document.
•	File Name: Displays the file name of the uploaded document.
•	File Description: Displays the description of the uploaded document.
•	Page Count: Displays the number of pages in the uploaded document.
•	Date: Displays the date that the uploaded document was attached.
•	CBI: Displays a ' Y' or an 'N' to indicate the confidentiality status of the uploaded
document.
•	Action: Click the 'Delete' icon (X) to remove the uploaded document.
•	Attach Document: Click the 'Attach Document' link to generate the 'Attach Document'
window. Refer to Section 4.5.1 for further details on the 'Attach Document' window.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
45

-------
CD)fr
Exhibit 4-19 shows a screen capture of the 'Document Upload' screen (Scroll 1):
Exhibit 4-19 Document Upload Screen (Scroll 1)
HOME USER MANAGEMENT
TSCA Risk Evaluation RER-20170912-16:21:24
Step 1	Step 2	Step 3	Step 4	Step 5
A Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
Step 6
Step 7
Contact U.S.
Chemical Substance or Category
Document
Submitting Official Information
Certificatic Substantiating CBI
Agent

Upload

Claims
Document Upload
Please upload all necessary information for EPA to conduct the risk evaluation.
- Condition of Use
Upload a document identifying the conditions of use for which the risk evaluation is requested
including a rationale for their consideration.
Document Upload
Document Type U
File Description
No document information found
Page
Count
H save */ Validate Q Preview 0 Submit
Raise a Bug CDX Links - CDX Helpdeslc (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
46

-------
CDXr
Exhibit 4-20 shows a screen capture of the 'Document Upload' screen (Scroll 2):
Exhibit 4-20 Document Upload Screen (Scroll 2)


HOME
USER MANAGEMENT

ฑ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)

L U.O.
Agent

Upload
oumiiiiLiny wni^iai ii iiui inauui i Li ii a in ouudiai main ly v_di
Claims
Document Upload
Please upload all necessary information for EPA to conduct the risk evaluation.
- Condition of Use
Upload a document identifying the conditions of use for which the risk evaluation is requested
including a rationale for their consideration.
Document Upload
Document Type Ik
File Name
File Description
Page
Count
Date
CBI
Action
No document information found
O Attach Document
Next
H Save ~ Validate Q Preview B Submit
Raise a Bug
CDX Links -
CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Next' button to navigate to the 'Submitting Official Information' screen
if this form is submitted on behalf of a consortium. You can also access this screen by clicking
the 'Submitting Official Information' link within the navigation header. Click the 'Next' button
to navigate to the 'Fees Certification' screen if this form is submitted on behalf of the reporting
organization. You can also access this screen by clicking the 'Fees Certification' link within the
navigation header.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
47

-------
CD)fr
Exhibit 4-21 shows a screen capture of the 'Attach Document' window:
Exhibit 4-21 Attach Document Window
Attach Document

CBI claims for information found within documents attached to support the request for risk
evaluation must be substantiated when the information is submitted. Any substantiation of
confidential information included in an attached document should be included in the
substantiation document required on the Instructions for Substantiating Confidential
Business Information (CBI) Claims' screen.
~ CBI
* Document Type
Condition of Use Rationale
0
The term "conditions of use" means the circumstances, as determined by the .Administrator,
under which a chemical substance is intended, known, or reasonably foreseen to be
manufactured, processed, or distributed in commerce, used or disposed of. 15 U.S.C. 2602
(4).
* Description
Page Count
* Attachment
Save Document
Close
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
48

-------
CDXr
Navigation: Click the 'Save Document' button to upload the selected attachment to the
'Documents' table.
4.7 Fees Certification
The 'Fees Certification' screen presents radio buttons to indicate the applicable fee certification
statement.
You can access the 'Fees Certification' screen by selecting the 'N/A' radio button within the
'Contact' screen and clicking the 'Continue' button from the 'Chemical Substance or Category'
screen.
The purpose of the 'Fees Certification' screen is to inform EPA of the fee amount that a primary
submitter pays on behalf of the reporting organization based on the business size. The
certification statement selected on the 'Fees Certification' screen is non-editable when amending
a Risk Evaluation Request. See Section 4.3.1 for additional information regarding the definition
of a small business concern.
Exhibit 4-22 shows the fee structure implemented for Risk Evaluation Requests:
Exhibit 4-22 Risk Evaluation Request Fee Structure
Business Concern
Fee Category
Fee Amount
Not a small business
concern
| EPA-initiated Risk
| Evaluation
• $1,350,000

| Manufacturer-requested
| risk evaluation on a
I chemical in the TSCA
I Work Plan
• Initial $1,250,000 payment + final invoice to recover
50% of Actual Costs

| Manufacturer-requested
I risk evaluation on a
| chemical not in the TSCA
| Work Plan
• Initial $2,500,000 payment+ final invoice to total 100%
of Actual Costs
Small business
| EPA-initiated Risk
| Evaluation
• $270,000

| Manufacturer-requested
| risk evaluation on a
| chemical in the TSCA
| Work Plan
• Initial $1,250,000 payment + final invoice to recover
50% of Actual Costs

| Manufacturer-requested
| risk evaluation on a
| chemical not in the TSCA
| Work Plan
• Initial $2,500,000 payment+ final invoice to total 100%
of Actual Costs
The following certification statements display:
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
49

-------
CD)fr
•	My company is a "small business concern" as defined under 40 CFR 700.43: Select this
radio button to indicate that the reporting organization is a small business concern.
•	My company is not a "small business concern" as defined under 40 CFR 700.43: Select
this radio button to indicate that the reporting organization is not a small business concern.
Exhibit 4-23 shows a screen capture of the 'Fees Certification' screen:
Exhibit 4-23 Fees Certification Screen
HOME USER MANAGEMENT
ฑ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
TSCA Risk Evaluation RER-20181024-14:10:06
Step 1	Step 2	Step 3	Step 4
Contact Chemical	Document Upload
Substance or
Category
Fees Certification
Step 5
Submitting Official
Information
Step S
Certification
Fees Certification
As required by 40 CFR 700.45, fees are applicable to any person who manufactures (including imports) a chemical substance that is the subject of a risk evaluation under
TSCA section 6(b).
Fees Certification
Select the following Fees Certification statement that applies. This selection cannot be modified after initial submission.
O My company is a "small business concern" as defined under 40 CFR 700.43.
O My company is not a "small business concern" as defined under 40 CFR 700.43.
'The criteria for a "small business concern"has been changed in the final fees rule. View the updated definition of a small business concern.
A PDF version of the final fees rule is available at https://www.epa .gov/sites/production/files/2018-Q9/documents/2018-09-27_prepubcopy_tsca-fees-finalrule.pdf.
H Save ~Validate OPreview ฉSubmit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Next' button to navigate to the 'Submitting Official Information' screen.
You can also access this screen by clicking the 'Submitting Official Information' link within the
navigation header.
4.8 Submitting Official Information
You can access the 'Submitting Official Information' screen by clicking the 'Next' button from
the 'Fees Certification' screen if the request is submitted on behalf of the reporting
organization.You can also access this screen by clicking the 'Submitting Official Information'
link within the navigation header.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
50

-------
CDXr
The information below has been pre-populated from CDX registration. If the information listed
is incorrect please make the appropriate edits to your user information in CDX registration.
•	Submitter is CBI: Check the 'CBI' checkbox to claim the submitter information as
confidential.
•	First Name: Displays the first name of the submitter.
•	Middle Initial: Displays the middle initial of the submitter.
•	Last Name: Displays the last name of the submitter.
•	Company Name: Displays the company name of the submitter.
•	Phone Number: Displays the phone number of the submitter.
•	Email Address: Displays the email address of the submitter.
•	Mailing Address 1: Displays line 1 of the mailing address of the submitter.
•	City: Displays the city of the mailing address of the submitter.
•	State: Displays the state of the mailing address of the submitter.
•	Postal Code: Displays the postal code of the mailing address of the submitter.
•	Country: Displays the country of the mailing address of the submitter.
•	This confirmation is required to proceed with the submission process: Check the legal
verification checkbox to begin the submission process; this is required and gets reset when
accessing the form.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
51

-------
CD)fr
Exhibit 4-24 shows a screen capture of the 'Submitting Official Information' screen (Scroll 1):
Exhibit 4-24 Submitting Official Information Screen (Scroll 1)

HOME USER MANAGEMENT
TSCA Risk Evaluation RER-20170912-16:21:24
Step 1	Step 2	Step 3	Step 4
Contact U.S.	Chemical Substance or Category
i Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
U.S.
Agent
Document |
Upload
Step 5
Submitting Official Information
Step 6
Step 7
Certificatio Substantiating CBI
Claims
Submitting Official Information
The information below has been pre-populated from CDX registration. If the information listed is incorrect please make the appropriate edits to your user
information in CDX registration.
Check the associated checkbox to confirm your acknowledgement of the legally responsible certification statement and activate the 'Continue' button.
O Submitter is CBI

First Name:
Jane
Middle Initial:
E
Last Name:
Doe
Company Name:
TEST ORGANIZATION LLC
Phone Number:
5555555555
Email:
Jane.Doe@test.com
Mailing Address 1:
1025 LEESBURG PIKE
City:
FALLS CHURCH
State:
VA
H save ~ Validate O Preview ฉSubmit
Raise a Bug CDX Links -ฆ CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
52

-------
CDXr
Exhibit 4-25 shows a screen capture of the 'Submitting Official Information' screen (Scroll 2):
Exhibit 4-25 Submitting Official Information Screen (Scroll 2)
-S
USER MANAGEMENT
ฑ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
infonffation in CDX registration.
Check the associated checkbox to confirm your acknowledgement of the legally responsible certification statement and activate the 'Continue' button.
~ Submitter is CBI

First Name:
Jane
Middle Initial:
E
Last Name:
Doe
Company Name:
TEST ORGANIZATION LLC
Phone Number:
5555555555
Email:
Jane.Doe@test.com
Mailing Address 1:
1025 LEESBURG PIKE
City:
FALLS CHURCH
State:
VA
Postal Code:
22033
Country:
US
This confirmation is required to proceed with the submission process
Please confirm that you are the legally responsible party from the submitting company. @
Previous
H save ~Validate O Preview ฉSubmit	Raise a Bug CDX Links - CDX Helpdeslc (888)890-1995
Navigation: Click the 'Continue' button to navigate to the 'Submission of Referenced
Information' screen. You can also access this screen by clicking the 'Certification' link within
the navigation header.
4.9 Submission of Referenced Information
You can access the 'Submission of Referenced Information' screen by clicking the 'Continue'
button from the 'Submitting Official Information' screen. You can also access this screen by
clicking the 'Certification' link within the navigation header.
The purpose of the 'Submission of Referenced Information' screen is for users to commit to
providing EPA referenced information contained in this Risk Evaluation request.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
53

-------
CD)fr
Exhibit 4-26 shows a screen capture of the 'Submission of Referenced Information' screen:
Exhibit 4-26 Submission of Referenced Information Screen
iw
HOME USER MANAGEMENT
TSCA Risk Evaluation RER-20170912-16:21:24
Step 1	Step 2	Step 3	Step 4
J. Jane Doe. TEST ORGANIZATION LLC (Primary Authorized Official)
Step 5
Step 6
Contact
U.S.
Agent
Chemical Substance or Category
Document Submitting Official Information
Upload
Step 7
Substantiating CBI
Claims
Submission of Referenced Information
Upon request. I commit to provide to EPA any referenced information contained in this request.
I certify that to the best of my knowledge and belief:
1	The company named in this request manufactures the chemical substance identified for risk evaluation
2	All information provided in the notice is complete and accurate as of the date of the request.
3. I have either identified or am submitting all information in my possession, control, and a description of all other data known to or reasonably ascertainable
by me as required for this request under this part. I am aware it is unlawful to knowingly submit incomplete, false and/or misleading information in this
request and there are significant criminal penalties for such unlawful conduct, including the possibility of fine and imprisonment.
This confirmation is required to proceed with the submission process
I certify to the above statements. ฎ
H Save ~ Validate O Preview 0$ Submit
Raise a Bug CDX LinksCDX Helpdesk: (888)890-1995
Navigation: If any CBI claims were made, check the certification checkbox and click the
'Continue' button to navigate to the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen. You can also access this screen by clicking the
'Substantiating CBI Claims' link within the navigation header. If no CBI claims were made,
check the certification checkbox and click the 'Start Submission Process' button to initiate the
submission process.
4.10 Instructions for Substantiating Confidential Business Information (CBI) Claims
EPA modified the electronic reporting applications for TSCA submissions to accept CBI
substantiations for CBI claims made during the creation of electronic submissions. Other than
information exempt from substantiation under TSCA Section 14(c)(2), users who wish to assert
CBI claims for data within a submission must substantiate those claims at the time of submission
as required by TSCA Section 14(c)(3).
You can access the 'Instructions for Substantiating Confidential Business Information (CBI)
Claims' screen by claiming information as CBI within a form and clicking the 'Continue' button
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
54

-------
CDXr
from the 'Submission of Referenced Information' screen. You can also access this screen by
clicking the 'Substantiating CBI Claims' link within the navigation header. This screen will not
generate until a CBI claim is made within a submission. Information claimed CBI must either be
substantiated or claimed exempt pursuant to TSCA Section 14(c)(2) at the time of submission.
To substantiate a CBI claim, upload documentation asserting your claim(s) on the 'Instructions
for Substantiating CBI Claims' screen within the form. You may also opt-out of substantiation
on the 'Instructions for Substantiating CBI Claims' screen if, for example, you believe your CBI
claim is exempt under TSCA Section 14(c)(2). Common exemption reasons can be found at
https://www.epa.gov/tsca-cbi/what-information-include-cbi-substantiations. To opt-out of
substantiation at the time of submission, all CBI claims within a submission must be exempt.
•	Substantiation Opt-Out: Check this checkbox to opt out of providing CBI substantiation.
You will be required to provide reasoning if you choose to opt out.
•	Substantiation Opt-Out Reason: Enter reasoning for opting out of CBI substantiation. This
is a required field.
•	Attach Document for CBI Substantiation: Click the 'Attach Document for CBI
Substantiation' link to generate the 'Attach Documents for CBI Substantiation' pop-up
window.
If you are unfamiliar with substantiating CBI claims or require assistance preparing
substantiation documents, EPA offers a link to templates and other information for substantiating
CBI claims on the 'Instructions for Substantiating Confidential Business Information (CBI)
Claims' screen. It is suggested that you right-click the link and open in a new tab or new window
so you do not leave your submission as this may affect your saved data.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
55

-------
CD)fr
Exhibit 4-27 shows a screen capture of the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen (Scroll 1):
Exhibit 4-27 Instructions for Substantiating Confidential Business Information (CBI)
Claims Screen (Scroll 1)
HOME USER MANAGEMENT
TSCA Risk Evaluation RER-20170912-16:21:24
Step 1	Step 2	Step 3	Step 4
Step 5
X. Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
Step 6
Contact
U.S.
Chemical Substance or Category
Document Submitting Official Information
Certificatic
Substantiating CBI

Agent

Upload

Claims
Instructions for Substantiating Confidential Business Information (CBI) Claims
in submitting a claim of confidentiality, a person must certify the accuracy of the following statements concerning all
information claimed as confidential:
I hereby certify to the best of my knowledge and belief that all information entered on this form is complete and accurate. I
further certify that, pursuant to 15 U.S.C. 2613(c), for all claims for confidentiality made with this submission, all
information submitted to substantiate such claims is true and correct, and that it is true and correct that
i.	My company has taken reasonable measures to protect the confidentiality of the information;
ii.	I have determined that the information is not required to be disclosed or otherwise made available to the public
under other Federal law;
iii.	I have a reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the
competitive position of my company; and
iv.	I have a reasonable basis to believe that the information is not readily discoverable through reverse engineering
The Frank R. Lautenberg Chemical Safety for the 21st Century Act created a number of new requirements for those making
confidential business information (CBI) claims in TSCA submissions. Among these requirements is an obligation to
substantiate most CBI claims at the time of submission.
Information which may be claimed as CBI without substantiation is identified at TSCA 14(c)(2). This information includes:
A Specific information describing the processes used in manufacture or processing of a chemical substance, mixture, or
article;
B Marketing and sales information;
C.	Information identifying a supplier or customer;
D.	In the case of a mixture, details of the full composition of the mixture and the respective percentages of constituents;
M save ~Validate O Preview ฉSubmit	Raise a Bug CDX Links* CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
56

-------
CD)fr
Exhibit 4-28 shows a screen capture of the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen (Scroll 2).
Exhibit 4-28 Instructions for Substantiating Confidential Business Information (CBI)
Claims Screen (Scroll 2)
USER MANAGEMENT
X. Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
.^^omTafiorHclentiiyin^^u^
D.	In the case of a mixture, details of the full composition of the mixture and the respective percentages of constituents.
E.	Specific information regarding the use, function, or application of a chemical substance or mixture in a process, mixture,
or article;
F.	Specific production or import volumes of the manufacturer or processor; and
G.	Prior to the date on which a chemical substance is first offered for commercial distribution, the specific chemical identity'
of the chemical substance, including the chemical name, molecular formula, Chemical Abstracts Service number, and
other information that would identify the specific chemical substance, if the specific chemical identity was claimed as
confidential at the time it was submitted in a notice under TSCA 5.
For other submissions where the submitter has claimed information as CBI, the submitter will be required to upload a
document substantiating those CBI claims at the time of submission. The substantiation document should provide EPA any
information believed to support the validity of the CBI claims. In order to assist submitters in substantiating their CBI claims.
EPA has developed substantiation templates that may be used as a starting point in preparing their CBI substantiations
Submitters are encouraged to use these substantiation template documents, but are not required to do so. The templates and
other information relating to substantiating CBI claims can be found at https://www.epa.gov/tsca-cbi/what-information-include-
cbi-substantiations.
The Agency is required to review and make a determination on the validity of many CBI claims. Failure to substantiate a CBI
claim or a substantiation that does not adequately justify the claim may result in a denial of claims and subsequent public
release of information. If you have any questions concerning the options or the substantiation process, please contact:
•	Scott Sherlock, 202-564-8257, sherlock.scott@epa.gov
•	Jessica Barkas, 202-250-8880, barkas.jessica@epa.gov
if you believe all of the information you have claimed as CBI is exempt from substantiation under TSCA section 14(c)(2) or has
been previously substantiated, select the following "Substantiation Opt Out" checkbox and provide a detailed explanation why
you believe substantiation is not required.
bfl Substantiation Opt-Out
Substantiation Opt-Out Reason
H save ~ Validate Q Preview 0 Submit
Raise a Bug CDX Links * CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
57

-------
CD)fr
Exhibit 4-29 shows a screen capture of the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen (Scroll 3):
Exhibit 4-29 Instructions for Substantiating Confidential Business Information (CBI)
Claims Screen (Scroll 3)
X. Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
HOME
USER MANAGEMENT
E. Specific information regarding the use, function, or application of a chemical substance or mixture in a process, mixture.
or article;
F.	Specific production or import volumes of the manufacturer or processor; and
G.	Prior to the date on which a chemical substance is first offered for commercial distribution, the specific chemical identity
of the chemical substance, including the chemical name, molecular formula, Chemical Abstracts Service number, and
other information that would identify the specific chemical substance, if the specific chemical identity was claimed as
confidential at the time it was submitted in a notice under TSCA 5.
For other submissions where the submitter has claimed information as CBI, the submitter will be required to upload a
document substantiating those CBI claims at the time of submission. The substantiation document should provide EPA any
information believed to support the validity of the CBI claims. In order to assist submitters in substantiating their CBI claims,
EPA has developed substantiation templates that may be used as a starting point in preparing their CBI substantiations.
Submitters are encouraged to use these substantiation template documents, but are not required to do so. The templates and
other information relating to substantiating CBI claims can be found at https:/Mw.epa.gov/tsca-cbi/what-inforrnation-include-
cbi-substantiations.
The Agency is required to review and make a determination on the validity of many CBI claims. Failure to substantiate a CBI
claim or a substantiation that does not adequately justify the claim may result in a denial of claims and subsequent public
release of information. If you have any questions concerning the options or the substantiation process, please contact:
•	Scott Sherlock, 202-564-8257, sherlock.scott@epa.gov
•	Jessica Barkas, 202-250-8880, barkas.jessica@epa.gov
If you believe all of the information you have claimed as CBI is exempt from substantiation under TSCA section 14(c)(2) or has
been previously substantiated, select the following "Substantiation Opt Out" checkbox and provide a detailed explanation why
you believe substantiation is not required.
Uploaded File Name: CBI Doc 3docx
CBI: V
Action: Edit | Delete
^ Previous J Start Submission Process
M save ~Validate O Preview 0 Submit	Raise a Bug CDX Links* CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Start Submission Process' button to begin the submission process.
4.11 Attach Documents for CBI Substantiation
You can access the 'Attach Documents for CBI Substantiation' window by clicking the 'Attach
Document for CBI Substantiation' link within the 'Instructions for Substantiating Confidential
Business Information (CBI) Claims' screen.
•	Document Type: 'CBI Substantiation' is stored in the 'Document Type' drop-down menu.
•	Page Count: Enter the number of pages in the attached document.
•	Attachment: Click the 'Browse' button to search for and select a document to attach. This is
a required field.
•	I claim the attachment as CBI: Check the 'I claim the attachment as CBI' checkbox to
claim the document as confidential.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
58

-------
CDXr
•	Sanitized Attachment: Click the 'Browse' button to search for and select a sanitized
document to attach. This is a required field, if it displays.
•	Save Document: Click the 'Save Document' button to save the uploaded CBI substantiation
document(s).
•	Close: Click the 'Close' button to close the 'Attach Documents for CBI Substantiation'
window without saving any uploaded attachment information.
Exhibit 4-30 shows a screen capture of the 'Attach Documents for CBI Substantiation' window:
Exhibit 4-30 Attach Documents for CBI Substantiation Window
Attach Documents for CBI Substantiation
Document "type
CBI Substantiation

Page Count
Attachment
•f I claim the attachment as CBI
Sanitized Attachment
Save Document
Close
Navigation: Click the 'Save Document' button to upload the substantiation document and
navigate back to the 'Instructions for Substantiating Confidential Business Information (CBI)
Claims' screen.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
59

-------
CDXr
5 Withdrawal Request
You can withdraw a manufacturer-requested risk evaluation at any time after the request is
submitted, and within 30 days of receiving EPA's notification that the request is granted.
5.1	Create a Withdrawal Request
To create a new Withdrawal Request, navigate to the Risk Evaluation 'Home' screen and select
'Withdrawal Request' from the 'Form Type' drop-down menu. Refer to Section 3.2 for
additional details regarding the Risk Evaluation 'Home' screen.
Refer to Section 3.5 for additional details regarding the passphrase creation process.
5.2	Contact Information	
You can navigate to the 'Contact Information' screen by clicking the 'Create' button and
creating a new passphrase, or by accessing a Withdrawal Request that is 'In Progress' and
entering the passphrase associated with the selected request.
The 'Contact Information' screen provides fields to input identifying information for a technical
contact. You will have the option to assign a 'Submission Alias' to identify the request. A unique
submission alias is helpful when a user or company has multiple requests and/or when you must
differentiate between requests to the help desk. Upon navigating to the 'Contact Information'
screen, the system auto-generates a default alias comprised of a form type, date stamp, and time
stamp in the following format: .
•	Case Number: Enter the case number of the Manufacturer-Requested Risk Evaluation that
you would like to withdraw from EPA review. The case number must be in the format 'RER-
YY-####.' Type-ahead suggestions will appear in a drop-down for any of your submitted
Risk Evaluation requests. This is a required field.
•	Submission Alias: Enter the submission alias. Upon navigating to the screen, the application
displays an auto-generated editable submission alias in the following format: . This is a required field.
•	CBI: Check the 'CBI' checkbox to claim the contact information as confidential.
•	Copy from CDX: Click the 'Copy from CDX' link to copy CDX registration information.
•	First Name: Enter the first name of the contact. This is a required field.
•	Last Name: Enter the last name of the contact. This is a required field.
•	Position: Enter the job title of the contact.
•	Company Name: Enter the company name of the contact. This is a required field.
•	Phone Number: Enter the phone number of the contact. This is a required field.
•	Phone Number Extension: Enter the extension to the phone number, if applicable.
•	Email Address: Enter the email address of the contact. This is a required field.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
60

-------
CD)fr
•	Mailing Address 1: Enter the mailing address of the contact. This is a required field.
•	Mailing Address 2: Enter the second line of the mailing address of the contact, if applicable.
•	City: Enter the city of the mailing address of the contact. This is a required field.
•	State: Select the state of the mailing address of the contact. This is a required field if 'United
States' is identified as the country.
•	Postal Code: Enter the postal code of the mailing address of the contact. This is a required
field.
•	Country: Select the country of the mailing address of the contact from the drop-down menu.
This is a required field.
Exhibit 5-1 shows a screen capture of the Withdrawal Request 'Contact Information' screen
(Scroll 1):
Exhibit 5-1 Withdrawal Request - Contact Information Screen (Scroll 1)
HOME USER MANAGEMENT
TSCA Risk Evaluation WR-20181106-17:19:13
Contact Information
Original Submitter Information
Submitting Official Information
Contact Information
Withdrawal Statement
Can I withdraw a manufacturer-requested risk evaluation?
You may withdraw your request at any time after the request Is made, and within 30 days of receiving EPA's notification that the request Is granted.
Case Number
Enter the case number of the Risk Evaluation Request
you would like to withdraw from EPA review
Submission Alias
WR-20181106-17:19:13
Contact (U.S./non-U.S.)	H CBI
Copy From CDX
H Save ~Validate 0Preview CJ Submit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
61

-------
CD)fr
Exhibit 5-2 shows a screen capture of the Withdrawal Request 'Contact Information' screen
(Scroll 2):
Exhibit 5-2 Withdrawal Request - Contact Information Screen (Scroll 2)
IM>-
Copy From CDX
- First Name
HOME USER MANAGEMENT
ฃ Jane Doe. TEST (Primary Authorized Official)
- Company Name
Phone Number
Phone Number Extension
Email Address
Mailinq Address 1
HSave ~Validate Preview C5 Submit
Raise a Bug CDX Unks - CDX Helpdesk: (888) 890-1995
Exhibit 5-3 shows a screen capture of the Withdrawal Request 'Contact Information' screen
(Scroll 3):
Exhibit 5-3 Withdrawal Request - Contact Information Screen (Scroll 3)
HOME USSR MANAGEMENT
Jane Doe, TEST (Primary Authorized Officii
Mailing Address 1
Mailing Address 2
State
Please select a state
Country
United States
HSave ~ Validate <1 Preview CJSubmit
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
62

-------
CDXr
Navigation: Click the 'Continue' button to navigate to the 'Original Submitter Information'
screen.
5.3 Original Submitter Information
You can navigate to the 'Original Submitter Information' screen by clicking the 'Continue'
button within the 'Contact Information' screen. You can also access this screen by clicking the
'Original Submitter Information' link within the navigation header.
The purpose of the 'Original Submitter Information' screen is to capture the information of the
Authorized Official who submitted the original Risk Evaluation Request for which you are filing
a Withdrawal Request.
•	Copy from CDX: Click the 'Copy from CDX' link to copy CDX registration information.
•	First Name: Enter the first name of the original submitter. This is a required field.
•	Last Name: Enter the last name of the original submitter. This is a required field.
•	Position: Enter the job title of the original submitter.
•	Company Name: Enter the company name of the original submitter. This is a required field.
•	Phone Number: Enter the phone number of the original submitter. This is a required field.
•	Phone Number Extension: Enter the extension to the phone number, if applicable.
•	Email Address: Enter the email address of the original submitter. This is a required field.
•	Mailing Address 1: Enter the mailing address of the original submitter. This is a required
field.
•	Mailing Address 2: Enter the second line of the mailing address of the original submitter, if
applicable.
•	City: Enter the city of the mailing address of the original submitter. This is a required field.
•	State: Select the state of the mailing address of the original submitter. This is a required field
if 'United States' is identified as the country.
•	Postal Code: Enter the postal code of the mailing address of the original submitter. This is a
required field.
•	Country: Select the country of the mailing address of the original submitter from the drop-
down menu. This is a required field.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
63

-------
CD)fr
Exhibit 5-4 shows a screen capture of the Withdrawal Request 'Original Submitter
Information' screen (Scroll 1):
Exhibit 5-4 Withdrawal Request - Original Submitter Information Screen (Scroll 1)
IIP
HOME USER MANAGEMENT
X Jane Doe. TEST (Primary Authorized Official)
TSCA Risk Evaluation WR-20181106-17:19:13
Contact Information
Original Submitter Information
Original Submitter Information
Submitting Official Information
Please enter the information of the Authorized Official who submitted the original Risk Evaluation Request for which you are filing a Withdrawal Request.
Company Contact (U.SJnon-U.S.)	@ CBI
Copy From CDX
- First Name
Position
- Company Name
HSave ~Validate O Preview CJ Submit
Raise a Bug CDX Unks - CDX Heipdesk: (888) 890-1995
Exhibit 5-5 shows a screen capture of the Withdrawal Request 'Original Submitter
Information' screen (Scroll 2):
Exhibit 5-5 Withdrawal Request - Original Submitter Information Screen (Scroll 2)
Company Name
HOME USER MANAGEMENT
e Doe, TEST (Primary Authorized Official)
Phone Number
Phone Number Extension
Email Address
Mailing Address 1
Mailing Address 2
State
Please select a state .
* This field is required.
H Save ~ Validate Q Preview CJ Submit
Raise a Bug CDX Unks - CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
64

-------
CDXr
Exhibit 5-6 shows a screen capture of the Withdrawal Request 'Original Submitter
Information' screen (Scroll 3):
Exhibit 5-6 Withdrawal Request - Original Submitter Information Screen (Scroll 3)
HOME USER MANAGEMENT
X Jane Doe. TEST (Primary Authorized Official)
Email Address
Mailing Address 1
Mailing Address 2
State
Please select a state..
' This field Is required.
Country
United State
HSave ~Validate OPreview 0Submit
Raise a Bug CDX Links - CDX Hetpdesk: (888) 890-1995
Navigation: Click the 'Continue' button to navigate to the 'Submitting Official Information'
screen.
5.4 Submitting Official Information
You can access the 'Submitting Official Information' screen by clicking the 'Continue' button
from the 'Original Submitter Information' screen. You can also access this screen by clicking the
' Submitting Official Information' link within the navigation header.
The information below has been pre-populated from CDX registration. If the information listed
is incorrect, please make the appropriate edits to your user information in CDX registration.
•	Submitter is CBI: Check the 'CBI' checkbox to claim the submitter information as
confidential.
•	First Name: Displays the first name of the submitter.
•	Middle Initial: Displays the middle initial of the submitter.
•	Last Name: Displays the last name of the submitter.
•	Company Name: Displays the company name of the submitter.
•	Phone Number: Displays the phone number of the submitter.
•	Email Address: Displays the email address of the submitter.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
65

-------
CD)fr
•	Mailing Address 1: Displays line 1 of the mailing address of the submitter.
•	City: Displays the city of the mailing address of the submitter.
•	State: Displays the state of the mailing address of the submitter.
•	Postal Code: Displays the postal code of the mailing address of the submitter.
•	Country: Displays the country of the mailing address of the submitter.
•	This confirmation is required to proceed with the submission process: Check the legal
verification checkbox to begin the submission process; this is required and gets reset when
accessing the form.
Exhibit 5-7 shows a screen capture of the Withdrawal Request 'Submitting Official
Information' screen (Scroll 1):
Exhibit 5-7 Withdrawal Request - Submitting Official Information Screen (Scroll 1)
TSCA Risk Evaluation WR-20181106-17:19:13
Contact Information
Original Submitter Information
Submitting Official Information
Substantiating CBI Claims
Submitting Official Information
The information below has been pre-populated from CDX registration ff the information listed is incorrect please make the appropriate edits to your user information in CDX registration
Check the associated checkbox to confirm your acknowledgement of the legally responsible certification statement and activate the 'Continue' button.
V Submitter Is CBI
First Name:
Last Name:
Company Name:
Phone Number:
Email:
Mailing Address 1:
City:
State:
Postal Code:
Jane
Doe
TEST
3373333333
janedoe@test.com
TEST
TEST
XX
H Save ~Validate Q Preview Q Submit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
66

-------
CDXr
Exhibit 5-8 shows a screen capture of the Withdrawal Request 'Submitting Official Information'
screen (Scroll 2):
Exhibit 5-8 Withdrawal Request - Submitting Official Information Screen (Scroll 2)
HOME USER MANAGEMENT
The information below has been pre-populated from CDX registration. If the information listed is incorrect please make the appropriate edits to your user information in CDX registration.
Check the associated checkbox to confirm your acknowledgement of the legally responsible certification statement and activate the 'Continue' button.
a Submitter is CBI
First Name:

Doe, TEST (Primary Auth
Last Name:
Company Name:
Phone Number:
Email:
Mailing Address 1:
City:
State:
Postal Code:
Country:
Jane
Doe
TEST
3373333333
jane.doe@test.com
TEST
TEST
XX
This confirmation is required to proceed with the submission process
Please confirm that you are the legally responsible party from the submitting company.
Ptev :us
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Navigation: If any CBI claims were made, check the legal verification checkbox and click the
'Continue' button to navigate to the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen. You can also access this screen by clicking the
'Substantiating CBI Claims' link within the navigation header. If no CBI claims were made,
check the legal verification checkbox and click the 'Start Submission Process' button to begin
the submission process.
5.5 Instructions for Substantiating Confidential Business Information (CBI) Claims
You can access the 'Instructions for Substantiating Confidential Business Information (CBI)
Claims' screen by claiming information as CBI within a Withdrawal Request and clicking the
'Continue' button from the 'Submitting Official Information' screen. You can also access this
screen by clicking the 'Substantiating CBI Claims' link within the navigation header. This screen
will not generate until a CBI claim is made within a form. Information claimed CBI must either
be substantiated or claimed exempt pursuant to TSCA Section 14(c)(2) at the time of submission.
For more information regarding CBI substantiation, please refer to Section 4.10.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
67

-------
CDXr
6 Initial Response
The purpose of the Initial Response is for a manufacturer or importer to respond to a preliminary
list published by the EPA in the federal register. Consortium leaders who are not the
manufacturer or importer do not need to submit this form.
6.1	Create an Initial Response	
To create a new Initial Response, navigate to the Risk Evaluation 'Home' screen and select
'Initial Response' from the 'Form Type' drop-down menu. Refer to Section 3.2 for additional
details regarding the Risk Evaluation 'Home' screen.
Refer to Section 3.5 for additional details regarding the passphrase creation process.
6.2	Contact
You can navigate to the 'Contact' screen by clicking the 'Create' button and creating a new
passphrase, or by accessing an Initial Response that is 'In Progress' and entering the passphrase
associated with the selected request.
The 'Contact' screen provides fields to input identifying information for a technical contact. You
will have the option to assign a 'Submission Alias' to identify the request. A unique submission
alias is helpful when a user or company has multiple requests and/or when you must differentiate
between requests to the help desk. Upon navigating to the 'Contact' screen, the system auto-
generates a default alias comprised of a form type, date stamp, and time stamp in the following
format: .
•	Submission Alias: Enter the submission alias. Upon navigating to the screen, the application
displays an auto-generated editable submission alias in the following format: . This is a required field.
•	CBI: Check the 'CBI' checkbox to claim the contact information as confidential.
•	Copy from CDX: Click the 'Copy from CDX' link to copy CDX registration information.
•	First Name: Enter the first name of the contact. This is a required field.
•	Last Name: Enter the last name of the contact. This is a required field.
•	Position: Enter the job title of the contact.
•	Company Name: Enter the company name of the contact. This is a required field.
•	Phone Number: Enter the phone number of the contact. This is a required field.
•	Phone Number Extension: Enter the extension to the phone number, if applicable.
•	Email Address: Enter the email address of the contact.
•	Mailing Address 1: Enter the mailing address of the contact. This is a required field.
•	Mailing Address 2: Enter the second line of the mailing address of the contact, if applicable.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
68

-------
CDXr
•	City: Enter the city of the mailing address of the contact. This is a required field.
•	State: Select the state of the mailing address of the contact. This is a required field if 'United
States' is identified as the country.
•	Postal Code: Enter the postal code of the mailing address of the contact. This is a required
field.
•	Country: Select the country of the mailing address of the contact from the drop-down menu.
Selecting a non-US country generates the 'United States Agent' screen. This is a required
field.
Exhibit 6-1 shows a screen capture of the Initial Response 'Contact' screen (Scroll 1):
Exhibit 6-1 Initial Response - Contact Screen (Scroll 1)
HOME USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized Offi
TSCA Risk Evaluation IR-20191218-19:56:57
Step 1	Step 2	Step 3
Company
Response
Information
step 4
Submitting Official
Information
step 5
Certification
Contact
* Submission Alias
IR-20191218-19:56:57
Please do not include CBI information in the Submission Alias field.
Contact (U.S./non-U.S.)
Copy From CDX
~ CBI
* Last Name
Company Name
Phone Number
Phone Number must be at least
H Save ~ Validate Q Preview C5 Submit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-199ฃ
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
69

-------
CDXr
Exhibit 6-2 shows a screen capture of the Initial Response 'Contact' screen (Scroll 2):
Exhibit 6-2 Initial Response - Contact Screen (Scroll 2)
USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized C
Phone Number
Phone Number must be at least 1
Phone Number Extension
s and contain only numbers.
Email Address
Mailing Address 1
Mailing Address 2
City
Please select a state ...	[v]
* Postal Code
* Country
United States	[v]
Continue
H save ~Validate O Preview B Submit	Raise a Bug CDX Links - CDX Helpdesk: (888) 890-199t
Navigation: Click the 'Continue' button to navigate to the 'Chemical Substance or Category'
screen if a U.S. contact is identified and the request is submitted on behalf of the reporting
organization. Click the 'Continue' button to navigate to the 'Submitting on Behalf of
Consortium' screen if the request is submitted on behalf of a consortium. You can also access
this screen by clicking the 'Chemical Substance or Category' or 'Submitting on Behalf of
Consortium' link, respectively, within the navigation header. Click the 'Continue' button to
navigate to the 'United States Agent' screen if a non-U. S. contact is identified. You can also
access this screen by clicking the 'U.S. Agent' link within the navigation header.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
70

-------
CDXr
6.3 United States Agent
You can navigate to the 'United States Agent' screen by identifying a non-U. S. contact and
clicking the 'Continue' button on the 'Contact' screen.
The 'United States Agent' screen provides fields to input identifying information for a U.S.
agent.
•	CBI: Check the 'CBI' checkbox to claim the agent information as confidential.
•	First Name: Enter the first name of the agent. This is a required field.
•	Last Name: Enter the last name of the agent. This is a required field.
•	Position: Enter the job title of the agent.
•	Company Name: Enter the company name of the agent. This is a required field.
•	Phone Number: Enter the phone number of the agent. This is a required field.
•	Phone Number Extension: Enter the extension to the phone number, if applicable.
•	Email Address: Enter the email address of the agent. This is a required field.
•	Mailing Address 1: Enter the mailing address of the agent. This is a required field.
•	Mailing Address 2: Enter the second line of the mailing address of the agent, if applicable.
•	City: Enter the city of the mailing address of the agent. This is a required field.
•	State: Select the state of the mailing address of the agent. This is a required field.
•	Postal Code: Enter the postal code of the mailing address of the agent. This is a required
field.
•	Country: Displays 'United States.'
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
71

-------
CDXr
Exhibit 6-3 shows a screen capture of the Initial Response 'United States Agent' screen (Scroll
1):
Exhibit 6-3: Initial Response - United States Agent Screen (Scroll 1)
HOME USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized Offici
TSCA Risk Evaluation IR-20191218-19:56:57
Step 1	Step 2	Step 3
Contact	Company
Step 4
Response
Information
Step 5
Submitting Official
Information
step 6
Certification
United States Agent
~ CBI
Company Name
Phone Number
Phone Number must be 10 digits and contain only numbers.
Phone Number Extension
Email Address
H Save ~Validate GiPreview ฉSubmit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
72

-------
CDXr
Exhibit 6-4shows a screen capture of the Initial Response 'United States Agent' screen (Scroll
2):
Exhibit 6-4 Initial Response - United States Agent Screen (Scroll 2)
HOME USER MANAGEMENT
lone Number
X Jane Doe, Jane's Company (Primary Authorized Officia
Phone Number must be 10 digits and contain only numbers.
Phone Number Extension
Email Address
Mailing Address 1
Mailing Address 2
City
State
Please select a state..
0
• Country
United States
H Save ~ Validate Q Preview G Submit
Raise a Bug CDX Links- CDX Helpdeslc (888) 890-1995
Navigation: Click the 'Continue' button to navigate to the 'Company' screen. You can also
access this screen by clicking the 'Company' link within the navigation header.
6.4 Company
You can access the 'Company' screen by clicking the 'Continue' button from the 'Contact'
screen if identifying a U.S. contact. If identifying a non-U.S. contact within the 'Contact' screen,
you can access this screen by clicking the 'Continue' button from the 'United States Agent'
screen. You can also access this screen by clicking the 'Company' link within the navigation
header.
The 'Company' screen displays the following fields and columns of information:
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
73

-------
CDXr
•	Company Name: Enter the name of the company of the contact. This is a required field.
•	CBI: Check the 'CBI' checkbox to claim the company information as confidential.
•	Mailing Address 1: Enter the mailing address of the company. This is a required field.
•	Mailing Address 2: Enter the second line of the mailing address of the company, if
applicable.
•	City: Enter the city of the mailing address of the company. This is a required field.
•	State: Select the state of the mailing address of the company. This is a required field if
'United States' is identified as the country.
•	Postal Code: Enter the postal code of the mailing address of the company. This is a required
field.
•	Country: Displays 'United States.'
•	Company Size Certification: Select a radio button option for the company size certification.
See Section 4.3 for the fee structure. See Section 4.3.1for Small Business Concern
definition. This is required.
•	Will you be joining a consortium?: Select a radio button option. This is required.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
74

-------
CDXr
Exhibit 6-5shows a screen capture of the Initial Response 'Company' screen (Scroll 1):
Exhibit 6-5 Initial Response - Company Screen (Scroll 1)
HOME USER MANAGEMENT
TSCA Risk Evaluation IR-20191218-23:02:14
Step 1	Step 2	Step 3
Contact
Company
Manufacturer/Importer (in U.S.)
* Company Name
Step 4
Submitting Official
Information
X Jane Doe, Jane's Company (Primary Authorized C
Step 5
Certification
~ CBI
* Mailing Address 1
Mailing Address 2


* City
* State


Please select a state ...
Bj
* Postal Code
* Country


United States
~b1
Company Size Certification
O The company named above is not a "small business concern" as defined under 40 CFR 700.43.
O The company named above is a "small business concern" as defined under 40 CFR 700.43.
* The criteria for a "small business concern" has been changed in the final fees rule. View the full definition of a small
H Save ~Validate Preview C5 Submit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
75

-------
CDXr
Exhibit 6-6 shows a screen capture of the Initial Response 'Company' screen (Scroll 2):
Exhibit 6-6 Initial Response - Company Screen (Scroll 2)

HOME USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized Officia
Company Name
Mailing Address 1
~ CBI
Mailing Address 2

* City
* State


Please select a state ...
B |
* Postal Code
* Country


United States

Company Size Certification
O The company named above is not a "small business concern" as defined under 40 CFR 700.43.
O The company named above is a "small business concern" as defined under 40 CFR 700.43.
* The criteria for a "small business concern" has been changed in the final fees rule. View the full definition of a small
business concern. A PDF version of the final fees rule is available at https://www.regulations.gov/contentStreamer?
documentld=EPA-HQ-OPPT-2016-0401-0072&contentType=pdf.
Will you be joining a consortium?
O Yes
O No
O Not sure
Previous
H Save 
-------
CDXr
•	Risk Evaluation Activity: Select the Risk Evaluation Activity you are responding to in the
drop-down. This is required.
•	Response Options: Select one response option. Select' Self-Identification' if you are
representing a company that is a manufacturer or importer of the chemical substance subject
to the Risk Evaluation Activity. Select 'Certification of No Manufacture' if you are
representing a company that was included in error on EPA's Preliminary List of responsible
fee payers for the Risk Evaluation Activity. Select 'Certification of Cessation' if you are
representing a company that was manufacturer or importer of the chemical substance subject
to this Risk Evaluation Activity. A selection is required.
•	Additional Information and Attachments (Only if Requested by Agency): Use this
section to submit additional information regarding your initial response.
•	File Name: Displays the file name of the uploaded document.
•	File Description: Displays the description of the uploaded document.
•	Page Count: Displays the number of pages in the uploaded document.
•	Date: Displays the date that the uploaded document was attached.
•	CBI: Displays a ' Y' or an 'N' to indicate the confidentiality status of the uploaded
document. Action: Click the 'Delete' icon (**) to remove the uploaded document.
•	Attach Document: Click the 'Attach Document' link to generate the 'Attach Document'
window.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
77

-------
CD)fr
Exhibit 6-7 shows a screen capture of the 'Response Information' screen (Scroll 1):
Exhibit 6-7 Response Information - Screen (Scroll 1)
HOME USER MANAGEMENT
A Jane Doe, Jane's Company (Primary Authorized C
TSCA Risk Evaluation IR-20191218-23:02:14
Step 1	Step 2	Step 3
Contact	Company
Response
Information
Step 4
Submitting Official
Information
Step 5
Certification
Response Information
Please select the Risk Evaluation Activity you are responding to in the drop-down below.
* Risk Evaluation Activity
a
Response Options*
O Self-Identification - 40 CFR 700.45(b)(5): I represent a company that is a manufacturer or importer of the chemical substance subject to this Risk Evaluation Activity. I understand the
fee obligation for this activity.
The company was included on the Preliminary List.
The company was not included on the Preliminary List.
O Certification of No Manufacture - 40 CFR 700.45{b){5)(iii): I represent a company that was included in error on EPA's Preliminary List of responsible fee payers for this Risk
Evaluation Activity. I certify that the company has not manufactured or imported the chemical substance subject to the Risk Evaluation Activity at any point in the five-year period
preceding publication of the Preliminary List. The company is not subject to fee obligations for this activity.
O Certification of Cessation - 40 CFR 700.45(b)(5)(ii): I represent a company that was a manufacturer or importer of the chemical substance subject to this Risk Evaluation Activity. I
certify that the company has ceased manufacturing/importing the chemical substance prior to initiation of the prioritization process for the chemical substance (March 21, 2019) and
further certify that the company will not manufacture or import the chemical substance again for at least five years from the date of this certification. The company is not subject to fee
obligations for this activity.
Additional Information and Attachments (Only if Requested by Agency)
Use this section to submit additional information regarding your initial response. Click the 'Attach Document' link to include attachments.
Search:
H Save ~ Validate d Preview 0 Submit
Raise a Bug CDX Links - CDX Helpdeslt (888) 890-199E
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
78

-------
CDXr
Exhibit 6-8 shows a screen capture of the 'Response Information' screen (Scroll 2):
Exhibit 6-8 Initial Response - Response Information Screen (Scroll 2)
HOME USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized C
nse Options*
C Self-Identification - 40 CFR 700.45(b)(5): I represent a company that is a manufacturer or importer of the chemical substance subject to this Risk Evaluation Activity. I understand the
fee obligation for this activity.
O The company was included on the Preliminary List.
O The company was not included on the Preliminary List.
G Certification of No Manufacture - 40 CFR 700.45{b)(5)(iii): I represent a company that was included in error on EPA's Preliminary List of responsible fee payers for this Risk
Evaluation Activity. I certify that the company has not manufactured or imported the chemical substance subject to the Risk Evaluation Activity at any point in the five-year period
preceding publication of the Preliminary List. The company is not subject to fee obligations for this activity.
C Certification of Cessation - 40 CFR 700.45(b)(5)(ii): I represent a company that was a manufacturer or importer of the chemical substance subject to this Risk Evaluation Activity. I
certify that the company has ceased manufacturing/importing the chemical substance prior to initiation of the prioritization process for the chemical substance (March 21, 2019) and
further certify that the company will not manufacture or import the chemical substance again for at least five years from the date of this certification. The company is not subject to fee
obligations for this activity.
Additional Information and Attachments (Only if Requested by Agency)
Use this section to submit additional information regarding your initial response. Click the 'Attach Document' link to include attachments.
File Name
U File Description
Page Count
Date
CBI
Action
No document information found
O Attach Document
Additional Information
H Save ~ Validate Q Preview Q Submit
Raise a Bug CDX Links * CDX Helpdesk: (888) 890-199ฃ
6.6 Submitting Official Information
You can access the 'Submitting Official Information' screen by clicking the 'Continue' button
from the 'Response Information' screen if the request is submitted on behalf of the reporting
organization. You can also access this screen by clicking the 'Submitting Official Information'
link within the navigation header.
The information below has been pre-populated from CDX registration. If the information listed
is incorrect please make the appropriate edits to your user information in CDX registration.
• Submitter is CBI: Check the 'CBI' checkbox to claim the submitter information as
confidential.
First Name: Displays the first name of the submitter.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
79

-------
CDXr
•	Middle Initial: Displays the middle initial of the submitter.
•	Last Name: Displays the last name of the submitter.
•	Company Name: Displays the company name of the submitter.
•	Phone Number: Displays the phone number of the submitter.
•	Email Address: Displays the email address of the submitter.
•	Mailing Address 1: Displays line 1 of the mailing address of the submitter.
•	City: Displays the city of the mailing address of the submitter.
•	State: Displays the state of the mailing address of the submitter.
•	Postal Code: Displays the postal code of the mailing address of the submitter.
•	Country: Displays the country of the mailing address of the submitter.
•	This confirmation is required to proceed with the submission process: Check the legal
verification checkbox to begin the submission process; this is required and gets reset when
accessing the form.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
80

-------
CD)fr
Exhibit 6-9 shows a screen capture of the Initial Response 'Submitting Official Information'
screen (Scroll 1):
Exhibit 6-9 Initial Response - Submitting Official Information Screen (Scroll 1)


HOME
USER MANAGEMENT
ฑ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
TSCA Risk Evaluation IR-20191217-11:54:28
Step 1 Step 2 Step 3 Step 4 Step 5 Step 6 Step 7
Contact
U.S.
Agent
Chemical Substance or Category Document
Upload
Submitting Official Information
Certificatio Substantiating CBI
Claims
Submitting Official Information
The information below has been pre-populated from CDX registration. If the information listed is incorrect please make the appropriate edits to your user
information in CDX registration.
Check the associated checkbox to confirm your acknowledgement of the legally responsible certification statement and activate the 'Continue* button
~ Submitter is CBI
First Name:
Jane
Middle Initial:
E
Last Name:
Doe
Company Name:
TEST ORGANIZATION LLC
Phone Number:
5555555555
Email:
Jane.Doe@test.com
Mailing Address 1:
1025 LEESBURG PIKE
City:
FALLS CHURCH
State:
VA
H save ~ validate fi Preview ฉSubmit	Raise a Bug CDX Links- CDX Helpdeslc (888)890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
81

-------
CDXr
Exhibit 6-10 shows a screen capture of the Initial Response 'Submitting Official Information'
screen (Scroll 2):
Exhibit 6-10 Initial Response - Submitting Official Information Screen (Scroll 2)
HOME USER MANAGEMENT
ฑ Jane Doe; TEST ORGANIZATION LLC (Primary Authorized Official)
infotlTfation in CDX registration.
Check the associated checkbox to confirm your acknowledgement of the legally responsible certification statement and activate the 'Continue' button.
~ Submitter is CBI

First Name:
Jane
Middle Initial:
E
Last Name:
Doe
Company Name:
TEST ORGANIZATION LLC
Phone Number:
5555555555
Email:
Jane.Doe@test.com
Mailing Address 1:
1025 LEESBURG PIKE
City:
FALLS CHURCH
State:
VA
Postal Code:
22033
Country:
US
This confirmation is required to proceed with the submission process
Please confirm that you are the legally responsible party from the submitting company. @
Previous
H Save ~Validate O Preview ฉSubmit	Raise a Bug CDX Links CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Continue' button to navigate to the 'Submission of Referenced
Information' screen. You can also access this screen by clicking the 'Certification' link within
the navigation header.
6.7 Submission of Referenced Information
You can access the 'Submission of Referenced Information' screen by clicking the 'Continue'
button from the 'Submitting Official Information' screen. You can also access this screen by
clicking the 'Certification' link within the navigation header.
The purpose of the 'Submission of Referenced Information' screen is for users to commit to
providing EPA referenced information contained in this Risk Evaluation request.
\
Exhibit 6-11 shows a screen capture of the Initial Response 'Submission of Referenced
Information' screen:
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
82

-------
CDXr
Exhibit 6-11 Initial Response - Submission of Referenced Information Screen
HOME USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized Official)
TSCA Risk Evaluation IR-20191217-11:54:28
Step 1	Step 2	Step 3	Step 4
Step 5
Step 6
Contact
Company Response Information
Submitting Official
1 Certification
1 Substantiating CBI


Information

Claims
Submission of Referenced Information
Upon request, I commit to provide to EPA any referenced information contained in this request.
I certify that to the best of my knowledge and belief:
1.	The company (or companies) named in this request manufactures the chemical substance identified for risk evaluation.
2.	All information provided in the notice is complete and accurate as of the date of the request.
3.	I have either identified or am submitting all information in my possession, control, and a description of all other data known to or reasonably ascertainable by me as
required for this request under this part. I am aware it is unlawful to knowingly submit incomplete, false and/or misleading information in this request and there are
significant criminal penalties for such unlawful conduct, including the possibility of fine and imprisonment.
This confirmation is required to proceed with the submission process
I certify to the above statements. 0
H Save ~Validate flPreview ฉSubmit
Raise a Bug CDX Links - CDX Helpdeslc (888) 890-1995
Navigation: If any CBI claims were made, check the certification checkbox and click the
'Continue' button to navigate to the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen. You can also access this screen by clicking the
'Substantiating CBI Claims' link within the navigation header. If no CBI claims were made,
check the certification checkbox and click the 'Start Submission Process' button to initiate the
submission process.
6.8 Instructions for Substantiating Confidential Business Information (CBI) Claims
EPA modified the electronic reporting applications for TSCA submissions to accept CBI
substantiations for CBI claims made during the creation of electronic submissions. Other than
information exempt from substantiation under TSCA Section 14(c)(2), users who wish to assert
CBI claims for data within a submission must substantiate those claims at the time of submission
as required by TSCA Section 14(c)(3).
You can access the 'Instructions for Substantiating Confidential Business Information (CBI)
Claims' screen by claiming information as CBI within a form and clicking the 'Continue' button
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
83

-------
CDXr
from the 'Submission of Referenced Information' screen. You can also access this screen by
clicking the 'Substantiating CBI Claims' link within the navigation header. This screen will not
generate until a CBI claim is made within a submission. Information claimed CBI must either be
substantiated or claimed exempt pursuant to TSCA Section 14(c)(2) at the time of submission.
To substantiate a CBI claim, upload documentation asserting your claim(s) on the 'Instructions
for Substantiating CBI Claims' screen within the form. You may also opt-out of substantiation
on the 'Instructions for Substantiating CBI Claims' screen if, for example, you believe your CBI
claim is exempt under TSCA Section 14(c)(2). Common exemption reasons can be found at
https://www.epa.gov/tsca-cbi/what-information-include-cbi-substantiations. To opt-out of
substantiation at the time of submission, all CBI claims within a submission must be exempt.
•	Substantiation Opt-Out: Check this checkbox to opt out of providing CBI substantiation.
You will be required to provide reasoning if you choose to opt out.
•	Substantiation Opt-Out Reason: Enter reasoning for opting out of CBI substantiation. This
is a required field.
•	Attach Document for CBI Substantiation: Click the 'Attach Document for CBI
Substantiation' link to generate the 'Attach Documents for CBI Substantiation' pop-up
window.
If you are unfamiliar with substantiating CBI claims or require assistance preparing
substantiation documents, EPA offers a link to templates and other information for substantiating
CBI claims on the 'Instructions for Substantiating Confidential Business Information (CBI)
Claims' screen. It is suggested that you right-click the link and open in a new tab or new window
so you do not leave your submission as this may affect your saved data.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
84

-------
CD)fr
Exhibit 6-12 shows a screen capture of the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen (Scroll 1):
Exhibit 6-12 Initial Response - Instructions for Substantiating Confidential Business
Information (CBI) Claims Screen (Scroll 1)
USER MANAGEMENT
yf Successfully saved
TSCA Risk Evaluation IR-20191217-11:54:28


Step 1 Step 2 Step 3 Step 4
Step 5
step 6
Contact Company Response Information Submitting Official
Certification
Substantiating CBI

Information

Claims

Instructions for Substantiating Confidential Business Information (CBI) Claims
The Frank R. Lautenberg Chemical Safety for the 21st Century Act created a number of new requirements for those making confidential
business information (CBI) claims in TSCA submissions. Among these requirements is an obligation to substantiate most CBI claims at
the time of submission.
Information which may be claimed as CBI without substantiation is identified at TSCA 14(c)(2). This information includes:
A.	Specific information descnbing the processes used in manufacture or processing of a chemical substance, mixture, or article;
B.	Marketing and sales information;
C.	Information identifying a supplier or customer;
D.	In the case of a mixture, details of the full composition of the mixture and the respective percentages of constituents;
E.	Specific information regarding the use. function, or application of a chemical substance or mixture in a process, mixture, or article;
F.	Specific production or import volumes of the manufacturer or processor; and
G.	Prior to the date on which a chemical substance is first offered for commercial distnbution, the specific chemical identity of the
chemical substance, including the chemical name, molecular formula, Chemical Abstracts Service number, and other information
that would identify the specific chemical substance, if the specific chemical identity was claimed as confidential at the time it was
submitted in a notice under TSCA 5.
For other submissions where the submitter has claimed information as CBI, the submitter will be required to upload a document
substantiating those CBI claims at the time of submission. The substantiation document should provide EPA any information believed to
support the validity of the CBI claims. In order to assist submitters in substantiating their CBI claims, EPA has developed substantiation
templates that may be used as a starting point in preparing their CBI substantiations. Submitters are encouraged to use these
substantiation template documents, but are not required to do so. The templates and other information relating to substantiating CBI
claims can be found at https://www epa.gov/tsca-cbi/what-informatton-include-cbi-substantiations .
The Agency is required to review and make a determination on the validity of many CBI claims. Failure to substantiate a CBI claim or a
substantiation that does not adequately justify the claim may result in a denial of claims and subsequent public release of information. If
you have any questions concerning the options or the substantiation process, please contact:
• Scott Sherlock, 202-564-8257, sherlock.scott@epa.gov
ฆ Jessica Barkas, 202-250-8880. barkas.jessica@epa.gov
H save ~ Validate O Preview B Submit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
85

-------
CD)fr
Exhibit 6-13 shows a screen capture of the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen (Scroll 2).
Exhibit 6-13 Initial Response - Instructions for Substantiating Confidential Business
Information (CBI) Claims Screen (Scroll 2)
Information which may be claimed as CBI without substantiation is identified at TSCA 14(cX2). This information includes:
A.	Specific information describing the processes used in manufacture or processing of a chemical substance, mixture, or article;
B.	Marketing and sales information;
C.	Information identifying a supplier or customer;
D.	In the case of a mixture, details of the full composition of the mixture and the respective percentages of constituents;
E.	Specific information regarding the use, function, or application of a chemical substance or mixture in a process, mixture, or article;
F.	Specific production or import volumes of the manufacturer or processor; and
G.	Prior to the date on which a chemical substance is first offered for commercial distribution, the specific chemical identity of the
chemical substance, including the chemical name, molecular formula, Chemical Abstracts Service number, and other information
that would identify the specific chemical substance, if the specific chemical identity was claimed as confidential at the time it was
submitted in a notice under TSCA 5.
For other submissions where the submitter has claimed information as CBI, the submitter will be required to upload a document
substantiating those CBI claims at the time of submission. The substantiation document should provide EPA any information believed to
support the validity of the CBI claims. In order to assist submitters in substantiating their CBI claims, EPA has developed substantiation
templates that may be used as a starting point in preparing their CBI substantiations. Submitters are encouraged to use these
substantiation template documents, but are not required to do so. The templates and other information relating to substantiating CBI
claims can be found at https://www.epa.gov/tsca-cbi/what-information-include-cbi-substantiations .
The Agency is required to review and make a determination on the validity of many CBI claims. Failure to substantiate a CBI claim or a
substantiation that does not adequately justify the claim may result in a denial of claims and subsequent public release of information. If
you have any questions concerning the options or the substantiation process, please contact:
•	Scott Sherlock, 202-564-8257, sheriock.scott@epa.gov
•	Jessica Barkas, 202-250-8880. barkas.jessica@epa gov
If you believe all of the information you have claimed as CBI is exempt from substantiation under TSCA section 14(c)(2) or has been
previously substantiated, select the following "Substantiation Opt Out" checkbox and provide a detailed explanation why you believe
substantiation is not required.
0 Substantiation Opt-Out
* Substantiation Opt-Out Reason
A Jane Doe, Jane's Company (Primary Authorized
HOME
USER MANAGEMENT
Start Submission Process
H Save ~ Validate Preview CS Submit
CDX Helpdesk: (888) 890-199ฃ
CDX Links
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
86

-------
CDX.
Exhibit 6-14 shows a screen capture of the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen (Scroll 3):
Exhibit 6-14 Initial Response - Instructions for Substantiating Confidential Business
Information (CBI) Claims Screen (Scroll 3)
m
USER MANAGEMENT
rnk R. Lautenberg Chemical Safety for the 21st Century Act created a number of new requirements for those making confidential
business information (CBI) claims in TSCA submissions. Among these requirements is an obligation to substantiate most CBI claims at
the time of submission.
Information which may be claimed as CBI without substantiation is identified at TSCA 14(c)(2). This information includes:
A.	Specific information describing the processes used in manufacture or processing of a chemical substance, mixture, or article;
B.	Marketing and sales information;
C.	Information identifying a supplier or customer;
D.	In the case of a mixture, details of the full composition of the mixture and the respective percentages of constituents;
E.	Specific information regarding the use. function, or application of a chemical substance or mixture in a process, mixture, or article;
F.	Specific production or import volumes of the manufacturer or processor; and
G.	Prior to the date on which a chemical substance is first offered for commercial distribution, the specific chemical identity of the
chemical substance, including the chemical name, molecular formula, Chemical Abstracts Service number, and other information
that would identify the specific chemical substance, if the specific chemical identity was claimed as confidential at the time it was
submitted in a notice under TSCA 5.
For other submissions where the submitter has claimed information as CBI, the submitter will be required to upload a document
substantiating those CBI claims at the time of submission. The substantiation document should provide EPA any information believed to
support the validity of the CBI claims. In order to assist submitters in substantiating their CBI claims, EPA has developed substantiation
templates that may be used as a starting point in preparing their CBI substantiations. Submitters are encouraged to use these
substantiation template documents, but are not required to do so. The templates and other information relating to substantiating CBI
claims can be found at https://www.epa.gov/tsca-cbi/what-infomiation-include-cbi-substantiations
The Agency is required to review and make a determination on the validity of many CBI claims. Failure to substantiate a CBI claim or a
substantiation that does not adequately justify the claim may result in a denial of claims and subsequent public release of information. If
you have any questions concerning the options or the substantiation process, please contact:
•	Scott Sherlock. 202-564-8257, sheriock.scott@epa.gov
*	Jessica Barkas, 202-250-8880, barkas.jessica@epa.gov
If you believe all of the information you have claimed as CBI is exempt from substantiation under TSCA section 14(c)(2) or has been
previously substantiated, select the following "Substantiation Opt Out" checkbox and provide a detailed explanation why you believe
substantiation is not required.
X Jane Doe, Jane's Company (Primary Authorized Official
Uploaded File Name: Test Document3.txt
CBI: N
Action: Edit | Delete
| Start

| H save ~ Validate Q Preview 0 Submit
Raise a Bug
CDX Links -
CDX Helpdesk. (888) 890-199!

Navigation: Click the 'Start Submission Process' button to begin the submission process.
6.9 Attach Documents for CBI Substantiation
You can access the 'Attach Documents for CBI Substantiation' window by clicking the 'Attach
Document for CBI Substantiation' link within the 'Instructions for Substantiating Confidential
Business Information (CBI) Claims' screen.
•	Document Type: 'CBI Substantiation' is stored in the 'Document Type' drop-down menu.
•	Page Count: Enter the number of pages in the attached document.
•	Attachment: Click the 'Browse' button to search for and select a document to attach. This is
a required field.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
87

-------
CDXr
•	I claim the attachment as CBI: Check the 'I claim the attachment as CBI' checkbox to
claim the document as confidential.
•	Sanitized Attachment: Click the 'Browse' button to search for and select a sanitized
document to attach. This is a required field, if it displays.
•	Save Document: Click the 'Save Document' button to save the uploaded CBI substantiation
document(s).
•	Close: Click the 'Close' button to close the 'Attach Documents for CBI Substantiation'
window without saving any uploaded attachment information.
Exhibit 6-15 shows a screen capture of the 'Attach Documents for CBI Substantiation' window:
Exhibit 6-15 Attach Documents for CBI Substantiation Window
Attach Documents for CBI Substantiation

-	Document Type
CBI Substantiation
Page Count
-	Attachment
v I claim the attachment as CBI
Sanitized Attachment
Save Document
Close
Navigation: Click the 'Save Document' button to upload the substantiation document and
navigate back to the 'Instructions for Substantiating Confidential Business Information (CBI)
Claims' screen.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
88

-------
CDXr
7 EPA Initiated Risk Evaluation Request
The purpose of the EPA Initiated Risk Evaluation request is to determine whether a chemical
substance presents an unreasonable risk to health or the environment, under the conditions of
use, including an unreasonable risk to a relevant potentially exposed or susceptible
subpopulation. Select this form type if you are manufacturer/importer and/or consortium leader
responding to the finalized Risk Evaluation Request published by EPA in the Federal Register.
7.1	Create a EPA Initiated Risk Evaluation	
To create a new EPA Initiated Risk Evaluation, navigate to the Risk Evaluation 'Home' screen
and select 'EPA Initiated Risk Evaluation' from the 'Form Type' drop-down menu. Refer to
Section 3.2 for additional details regarding the Risk Evaluation 'Home' screen.
Refer to Section 3.5 for additional details regarding the passphrase creation process.
7.2	Contact
You can navigate to the 'Contact' screen by clicking the 'Create' button and creating a new
passphrase, or by accessing an EPA Initiated Risk Evaluation request that is 'In Progress' and
entering the passphrase associated with the selected request.
The 'Contact' screen provides fields to input identifying information for a technical contact. You
will have the option to assign a 'Submission Alias' to identify the request. A unique submission
alias is helpful when a user or company has multiple requests and/or when you must differentiate
between requests to the help desk. Upon navigating to the 'Contact' screen, the system auto-
generates a default alias comprised of a form type, date stamp, and time stamp in the following
format: .
•	Submission Alias: Enter the submission alias. Upon navigating to the screen, the application
displays an auto-generated editable submission alias in the following format: . This is a required field.
•	N/A: Select the 'N/A' radio button to indicate that the form will be submitted on behalf of
the reporting organization. Selecting this radio button generates the 'Fees Certification' page.
•	This is a submission on behalf of a consortium: Select the 'This is a submission on behalf
of a consortium to indicate that the request is submitted on behalf of a consortium. Selecting
this radio button generates the 'Submitting on Behalf of Consortium' screen.
•	CBI: Check the 'CBI' checkbox to claim the contact information as confidential.
•	Copy from CDX: Click the 'Copy from CDX' link to copy CDX registration information.
•	First Name: Enter the first name of the contact. This is a required field.
•	Last Name: Enter the last name of the contact. This is a required field.
•	Position: Enter the job title of the contact.
•	Company Name: Enter the company name of the contact. This is a required field.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
89

-------
CDXr
•	Additional Companies: Enter an additional company in this field, if applicable.
•	Add: Click the button to add the company entry into the 'Additional Companies' table.
•	Additional Company Name: Displays the additional company name(s) associated with the
contact.
•	Action: Click the 'Delete" icon (X) to remove an additional company name.
•	Phone Number: Enter the phone number of the contact. This is a required field.
•	Phone Number Extension: Enter the extension to the phone number, if applicable.
•	Email Address: Enter the email address of the contact.
•	Mailing Address 1: Enter the mailing address of the contact. This is a required field.
•	Mailing Address 2: Enter the second line of the mailing address of the contact, if applicable.
•	City: Enter the city of the mailing address of the contact. This is a required field.
•	State: Select the state of the mailing address of the contact. This is a required field if 'United
States' is identified as the country.
•	Postal Code: Enter the postal code of the mailing address of the contact. This is a required
field.
•	Country: Select the country of the mailing address of the contact from the drop-down menu.
Selecting a non-US country generates the 'United States Agent' screen. This is a required
field.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
90

-------
CDXr
Exhibit 7-1 shows a screen capture of the 'Contact' screen (EPA Initiated Risk Evaluation)
(Scroll 1):
Exhibit 7-1 EPA Initiated Risk Evaluation - Contact Screen (Scroll 1)
USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized Official)
TSCA Risk Evaluation EIRE-20191219-10:40:30
Step 1	Step 2	Step 3	Step 4
Step 5
Step 6
Contact
1 Chemical Substance or
Document Upload
Fees Certification
Submitting Official Information
Certification

Category
(Optional)



Contact
*	Submission Alias
EIRE-20191219-10:40:30
Please do not include CBI information in the Submission Alias field.
O N/A
O This is a submission on behalf of a consortium
Contact (U.S./non-U.S.)	~ CBI
Copy From CDX
*	First Name
*	Last Name
Position
*	Company Name
Hsave ~Validate Q Preview ฉSubmit	Raise a Bug CDX Links-. CDX Helpdesk: (888) 890-1995
Exhibit 7-2 shows a screen capture of the 'Contact' screen (EPA Initiated Risk Evaluation)
(Scroll 2):
Exhibit 7-2 EPA Initiated Risk Evaluation - Contact Screen (Scroll 2)
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
91

-------
crosr


X Jane Doe, Jane's Company (Primary Authorized Offk
+ Company Name
Additional Companies
If the contact identified on this page represents more than one company,
enter additional company names below. Please note that listing company
names in this field does not constitute a consortium submission.
Add
Additional Company Name
'z Action
No additional companies found

* Phone Number
I	1
Phone Number must be at least 10 digits and contain only numbers.
Phone Number Extension
*	Email Address
*	Mailing Address 1
Hsave ~Validate A Preview ฉSubmit	Raise a Bug CDX Links - CDX Helpdeslc (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
92

-------
CDXr
Exhibit 7-3 shows a screen capture of the 'Contact' screen (Scroll 3):
Exhibit 7-3 EPA Initiated Risk Evaluation - Contact Screen (Scroll 3)
HOME USER MANAGEMENT
hone Number
X Jane Doe, Jane's Company (Primary Authorized C
Phone Number must be at least 10 digits and contain only numbei
Phone Number Extension
Email Address
Mailing Address 1
Mailing Address 2
City
State
Please select a state..
0
Country
United States	[v]
H Save ~ Validate Q Preview Q Submit
Raise a Bug CDX Links CDX Helpdesk (888) 890-1995
Navigation: Click the 'Continue' button to navigate to the 'Chemical Substance or Category'
screen if a U.S. contact is identified and the request is submitted on behalf of the reporting
organization. Click the 'Continue' button to navigate to the 'Submitting on Behalf of
Consortium' screen if the request is submitted on behalf of a consortium. You can also access
this screen by clicking the 'Chemical Substance or Category' or 'Submitting on Behalf of
Consortium' link, respectively, within the navigation header. Click the 'Continue' button to
navigate to the 'United States Agent' screen if a non-U. S. contact is identified. You can also
access this screen by clicking the 'U.S. Agent' link within the navigation header.
7.3 Submitting on Behalf of Consortium
You can navigate to the 'Submitting on Behalf of Consortium' screen by selecting the 'This is a
submission on behalf of a consortium' radio button and clicking the 'Continue' button on the
'Contact' screen.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
93

-------
CDXr
The 'Submitting on Behalf of Consortium' screen provides fields to capture consortium
information and individual consortium members. The user populating the form is identified as a
consortium member by default upon navigating to the 'Submitting on Behalf of Consortium'
page. A minimum of two consortium members is required.
•	Consortium Name: Enter the name of the consortium. This is a required field.
•	Consortium CBI: Check the 'CBI' checkbox to claim the consortium as confidential.
•	Add Consortium Member: Click the 'Add Consortium Member' button to generate a pop
up with an additional set of consortium input fields. At least two (2) consortium members are
required to be identified.
•	Case Number: Enter the case number of the Initial Response form. The case number must
be in the format 'IR-YY-####.' Enter 'N/A' if the consortium member did not submit an
Initial Response. This is a required field.
•	First Name: Enter the first name of the consortium member. This is a required field.
•	Last Name: Enter the last name of the consortium member. This is a required field.
•	Position: Enter the job title of the consortium member
•	Company Name: Enter the company name of the consortium member. This is a required
field.
•	Phone Number: Enter the phone number of the consortium member. This is a required field.
•	Phone Number Extension: Enter the extension to the phone number, if applicable.
•	Email Address: Enter the email address of the consortium member. This is a required field.
•	Mailing Address 1: Enter the mailing address of the consortium member. This is a required
field.
•	Mailing Address 2: Enter the second line of the mailing address of the consortium member,
if applicable.
•	City: Enter the city of the mailing address of the consortium member. This is a required
field.
•	State: Select the state of the mailing address of the consortium member. This is a required
field.
•	Postal Code: Enter the postal code of the mailing address of the consortium member. This is
a required field.
•	Country: Select the country of the mailing address of the consortium member. This is a
required field.
•	My company is a "small business concern" as defined under 40 CFR 700.43: Select the
radio button to indicate that the consortium is a small business concern. A fee certification
statement is required to be selected
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
94

-------
CDXr
• My company is not a "small business concern" as defined under 40 CFR 700.43: Select
the radio button to indicate that the consortium member does not represent a small business
concern. A fee certification statement is required to be selected.
Exhibit 4-114 shows a screen capture of the 'Consortium Member' pop-up window (Scroll 1):
Exhibit 7-4 EPA Initiated Risk Evaluation - Consortium Member Pop Up Window (Scroll 1)
Consortium Member
CBI	0	A
*	Case Number
Enter the case number of the Initial Response form.
Please enter 'N/A' if the consortium member did not submit an Initial Response.
*	First Name
* Last Name
Position
Company Name
Save changes
C ose
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
95

-------
CDXr
Exhibit 7-5 shows a screen capture of the 'Consortium Member' pop-up window (Scroll 2):
Exhibit 7-5 EPA Initiated Risk Evaluation - Consortium Member Pop Up Window (Scroll 2)
Phone Number must be at least 10 digits and contain only numbers
Phone Number Extension
*ฆ Email Address
*ฆ Mailing Address 1
Mailing Address 2
Consortium Member
* Phone Number
City
v
Close
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
96

-------
CDXr
Exhibit 4-6 shows a screen capture of the 'Consortium Member' screen (Scroll 3):
Exhibit 7-6 EPA Initiated Risk Evaluation - Consortium Member Screen (Scroll 3)
Consortium Member
state
Please select a state .
0
* Postal Code
* Country
Please select a country...
0
* Fees Certification
As required by 40 CFR 700.45, fees are applicable to any person who manufactures (including imports) a
chemical substance that is the subject of a risk evaluation under TSCA section 6(b).
Select the following Fees Certification statement that applies to the selected consortium member:
O My company is a "small business concern" as defined under 40 CFR 700.43.
O My company is not a "small business concern" as defined under 40 CFR 700.43.
*The criteria for a "small business concern" has been changed in the final fees rule. View the updated definition of a small business
concern.
A PDF version of the final fees rule is available at https://www.regulations.goWconten1Streamer?documentld=EPA-HQ-OPPT-20"I6-
0401-0072&contentType=pdf.
Save changes
Close
Navigation: Click the 'Save Changes' button to save the consortium member information. Click
the 'Continue' button to navigate to the 'Chemical Substance or Category' screen if the request
is submitted on behalf of the reporting organization. You can also access this screen by clicking
the 'Chemical Substance or Category' link within the navigation header. Click the 'Continue'
button to navigate to the 'U.S. Agent' screen if a non-U.S. contact is identified. You can also
access this screen by clicking the 'U.S. Agent' link within the navigation header.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
97

-------
CDXr
7.3.1 Small Business Concern Definition
Click the 'View the updated definition of a small business concern' link to generate the 'Small
Business Concern Definition' window. This window displays a table of the North American
Industry Classification System (NAICS) codes, NAICS descriptions, and applicable small
business concern size in number of employees.
As noted in the definition, if there are codes that are not listed within the NAICS table, a small
business definition applies to 500 or fewer employees that a company "owns or controls."
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
98

-------
CD)fr
Exhibit 7-7 shows a screen capture of the 'Small Business Concern Definition' window (Scroll
1):
Exhibit 7-7 EPA initiated Risk Evaluation - Small Business Concern Definition Window
(Scroll 1)
Small Business Concern Definition
40 CFR 700.43

Small business concern means a manufacturer or processor who meets the size
standards identified in the table below. The number of employees indicates the
maximum allowed for a manufacturer or processor to be considered small. If the
North American Industry Classification System (NAICS) code of a manufacturer or
processor is not represented in the table below, it will be considered small if it has
500 or fewer employees. When calculating the number of employees, a
manufacturer or processor must include the employees of all of its "parent
companies" and all companies it "owned or controlled," as defined by 40 CFR
704.3. The number of employees are calculated as the average number of people
employed for each pay period of the business" latest 12 calendar months,
regardless of hours worked or temporary status.
Potentially Affected
NAICS
NAICS Description
Small Business
Concern Size
Standards (# of
employees)
324110
Petroleum Refineries
1500 or fewer
325110
Petrochemical
Manufacturing
1000 or fewer
325120
Industrial Gas
Manufacturing
1000 or fewer
325130
Synthetic Dye and
Pigment Manufacturing
1000 or fewer
325180
Other Basic Inorganic
Chemical Manufacturing
1000 or fewer
325193
Ethyl Alcohol
Manufacturing
1000 or fewer



Exhibit 7-8 shows a screen capture of the 'Small Business Concern Definition' window (Scroll
2):
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
99

-------
CDXs
Exhibit 7-8 EPA Initiated Risk Evaluation - Small Business Concern Definition Window
(Scroll 2)
325194
Cvclsr Crude,
fnerrreciiate. and Gurr
ana Wo^d Cnercai
l^anufactur; io
1250 or fewer
3251K
Al" Other gast Organic
C^em'cai Manufactumg
1
32521>
32S212
325.220
325311
325312
325314
Plas:ins I,'atrial and
ResM f larufsctinna
S,otheic Ruster
Manj*a:tu\ta
Artifr el aid Svnfhet'c
Fibe s arc! ~ilamen:;
i.'arwfa;tur"ig
Nrrogemits -eric?'
Manufacturing
12oG or f^Wcf
Phospnat\ Fen :zer
r,g
Pert 'irer ilf\l
-------
CD*
Exhibit 7-9 shows a screen capture of the 'Small Business Concern Definition' window (Scroll
3):
Exhibit 7-9 EPA Initiated Risk Evaluation - Small Business Concern Definition Window
(Scroll 3)
325414
325510
32552G
325511
325513
*<25520
32591C
325920
32595*.
325952
325998
Biologca> ?icQiปa
except C agnostic t
,'anjtactur >ig
Paint and Coating
MetnufactLT-ng
Adhesive Ma ijfactiiring
Soap and Other
Detergent Manufactunnc
pj.sh ana Ctnei
SaVatior Gao.i
Vr.u'actt. ig
Surface Ac five Agen1
s.!anj'ac!tr ig
Toilet -'leoaiaticn
',"3fLraCTlf !1Q
Pnniing Ink
Ktanu'actur-ic!
E^'csnes
1 'an.-faiti/ac1
C'jstorr Conpovincrg. o*
Pupinasea Res ns
-hctographfC F.m
Paper, Plate arc
Cnern ca! ViamifaciJivia
A? cthei viiscellanecus
Chemical Product arc
-reparation
'.'ana'atturoa
"ฆ 2d0 or fewer
* 000 e-r fewer
500 or *ev, er
";00Q of fewer
750 c fewer
750 of 'ewer
*250 erfev.er
500 cป" fewer
750 c-r fev,er
500 cr *ev;ei
J dOO cr fevyet
500 cr fewer
Exhibit 7-10 shows a screen capture of the 'Small Business Concern Definition' window (Scroll
4):
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
101

-------
CDXs
Exhibit 7-10 EPA Initiated Risk Evaluation - Small Business Concern Definition Window
(Scroll 4)
325613
325620
325910
325920
325951
325952
32d99S
•>24690
t24?10
24?20
Surface Active Agent
f^anifefunig
Toilet - reseia'ion
"i.a.u'attu >n j
Print ng Ink
r-arufactunrig
ca? CSIV65
'?nra;tu
Custom Compcunemg of
Purchaser: Res-ns
^ne'orrafjhc *v:m.
-?pet. Plate and
Chcirvg "'lanufactinng
Aii O'fier Miscellaneous
Ctie-Tiical Product and
Preparation.
iV'jJiJ'actuf.'ng
Other Cnenrfc-g- and
Alfted Products Merchant
Wholesale's
Petrcseum Bulk Stations
and Terminals
Peiroieun and
Petroleum Products
Met ham Wholesalers
fexcept Bulk Stations
and TerniP.atSf
7d0 c fewer
1250 or fewer
j 00 cr fewer
750 c fewer
SOD c' fewer
15UQ cr fewer
500 O' fewer
150 cr fewer
200 cf fewer
200 cr fewer
Navigation: Click the 'X' icon in the upper right-hand corner to close the 'Small Business
Concern Definition' window.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
102

-------
CDXr
7.3 United States Agent
You can navigate to the 'United States Agent' screen by identifying a non-U. S. contact and
clicking the 'Continue' button on the 'Contact' screen.
The 'United States Agent' screen provides fields to input identifying information for a U.S.
agent.
•	CBI: Check the 'CBI' checkbox to claim the agent information as confidential.
•	First Name: Enter the first name of the agent. This is a required field.
•	Last Name: Enter the last name of the agent. This is a required field.
•	Position: Enter the job title of the agent.
•	Company Name: Enter the company name of the agent. This is a required field.
•	Phone Number: Enter the phone number of the agent. This is a required field.
•	Phone Number Extension: Enter the extension to the phone number, if applicable.
•	Email Address: Enter the email address of the agent. This is a required field.
•	Mailing Address 1: Enter the mailing address of the agent. This is a required field.
•	Mailing Address 2: Enter the second line of the mailing address of the agent, if applicable.
•	City: Enter the city of the mailing address of the agent. This is a required field.
•	State: Select the state of the mailing address of the agent. This is a required field.
•	Postal Code: Enter the postal code of the mailing address of the agent. This is a required
field.
•	Country: Displays 'United States.'
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
103

-------
CDXr
Exhibit 7-11 shows a screen capture of the 'United States Agent' screen (Scroll 1):
Exhibit 7-11 EPA Initiated Risk Evaluation - United States Agent Screen (Scroll 1)
Ksy
USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized Official)
TSCA Risk Evaluation EIRE-20191212-10:58:25
Step 1	Step 2	Step 3	Step 4
Step 5
Step 6
Step 7
Contact
Submitting on Behalf
U.S.
Chemical Substance or
Document
Submitting Official
Certification

of Consortium
Agent
Category
Upload
Information





(Optional)


United States Agent
~ CBI
*	First Name
*	Last Name
Position
*	Company Name
*	Phone Number
Phone Number must be 10 digits and contain only numbers.
Phone Number Extension
H Save ~Validate O Preview CJ Submit	Raise a Bug CDX Links ^ CDX Helpdesk: (888)890-1995
Exhibit 7-12 shows a screen capture of the 'United States Agent' screen (Scroll 2):
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
104

-------
CDXr
Exhibit 7-12 EPA Initiated Risk Evaluation - United States Agent Screen (Scroll 2)
USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized C
Phone Number must be 10 digits and contain only numbe
Phone Number Extension
Email Address
Mailing Address 1
Mailing Address 2
City
State
Please select a state..
0
Postal Code
Country
United States
Previous
H Save ~Validate O Preview CS Submit	Raise a Bug CDX Links ฆป CDX Helpdesfc (888) 890-199ฃ
Navigation: Click the 'Continue' button to navigate to the 'Chemical Substance or Category'
screen if the request is submitted on behalf of the reporting organization. You can also access
this screen by clicking the 'Chemical Substance or Category' link within the navigation header.
7.4 Chemical Substance or Category
You can access the 'Chemical Substance or Category' screen by clicking the 'Continue' button
from the 'Contact' screen if identifying a U.S. contact. If identifying a non-U.S. contact within
the 'Contact' screen, you can access this screen by clicking the 'Continue' button from the
'United States Agent' screen. You can also access this screen by clicking the 'Chemical
Substance or Category' link within the navigation header.
The 'Chemical Substance or Category' screen displays the following fields and columns of
information:
• Risk Evaluation Notice: Select the Risk Evaluation Notice to which you are responding.
This is a required field.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
105

-------
CDXr
•	Chemical Substance Type: Select the chemical substance type from the drop-down menu.
This drop-down is disabled until a Risk Evaluation Notice is selected. Once selection is made
from the drop-down, click 'Add' to add the chemical substance type to the table. At least one
chemical substance or chemical category is required.
•	Chemical Categories: Select the chemical categories from the drop-down menu. This is
disabled until a Risk Evaluation Notice is selected. Once a selection is made from the drop-
down, click 'Add' to add the chemical substance type to the table. At least one chemical
substance or chemical category is required.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
106

-------
CDXr
Exhibit 7-13 shows a screen capture of the 'Chemical Substance or Category' screen (Scroll 1):
Exhibit 7-13 EPA Initiated Risk Evaluation - Chemical Substance or Category Screen
(Scroll 1)
HOME USER MANAGEMENT
TSCA Risk Evaluation EIRE-20191212-10:58:25
Step 1	Step 2	Step 3	Step 4	Step 5
Step 6
X Jane Doe, Jane's Company (Primary Authorized Official)
Step 7
Contact Submitting on
U.S.
Chemical
Document
Submitting Official
Certification
Behalf of
Agent
Substance or
Upload
Information

Consortium

Category
(Optional)


Chemical Substance or Category
Please select the Risk Evaluation Notice you are responding to in the drop-down below
* Risk Evaluation Notice
0
Chemical Substance
0
ฉ
<
Chemical Substance
No chemical information found
Chemical Categories
0
Chemical Category
1
No chemical information found

<

>
Previous
H Save Validate O Preview C$ Submit
Raise a Bug CDX Links * CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Next' button to navigate to the 'Document Upload' screen. You can also
access this screen by clicking the 'Document Upload' link within the navigation header.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
107

-------
CDXr
7.5 Document Upload (Optional)
You can access the 'Document Upload' screen by clicking the 'Next' button from the 'Chemical
Substance or Category' screen. You can also access this screen by clicking the 'Document
Upload' link within the navigation header.
A condition of use rationale document is required to be uploaded within a Risk Evaluation
request.
•	Condition of Use: Enter text including a rationale for the conditions of use. The term
'condition of use' means the circumstances, as determined by the Administrator, under which
a chemical substance is intended, known, or reasonably foreseen to be manufactured,
processed, or distributed in commerce, used or disposed of.
•	CBI: Check the box to indicate the confidentiality status of the Condition of Use.
•	Hazard Studies / Information: Enter text of all existing information that is relevant to
whether the chemical substance, under the conditions of use identified by the manufacturer,
presents an unreasonable risk of injury to health or the environment. At minimum this must
include:
-	hazard and exposure potential,
-	persistence and bioaccumulation,
-	potentially exposed or susceptible subpopulations the requester believes to be relevant,
-	whether there is any storage of the chemical substance near significant sources of drinking
water (including storage facilities),
-	production volume or significant changes to the production volume, and
-	any other information relevant to the potential risks of the chemical substance.
•	CBI: Check the box to indicate the confidentiality status of the Hazard Studies/ Information.
•	Additional Information: Enter text for any additional information.
•	CBI: Check the box to indicate the confidentiality status of the Additional Information.
•	Search: Enter criteria to filter the uploaded document(s).
•	Document Type: Displays the document type of the uploaded document.
•	Document Subtype: Displays the document subtype of the uploaded document.
•	File Name: Displays the file name of the uploaded document.
•	File Description: Displays the description of the uploaded document.
•	Page Count: Displays the number of pages in the uploaded document.
•	Date: Displays the date that the uploaded document was attached.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
108

-------
CDXr
•	CBI: Displays a ' Y' or an 'N' to indicate the confidentiality status of the uploaded
document.
•	Action: Click the 'Delete' icon ( <ฆ) to remove the uploaded document.
•	Attach Document: Click the 'Attach Document' link to generate the 'Attach Document'
window. Refer to Section 4.5.1 for further details on the 'Attach Document' window.
•	Information Submitted: Enter text regarding the type of information that has been included
in the risk evaluation form.
•	CBI: Check the box to indicate the confidentiality status of the information submitted.
Exhibit 7-14 shows a screen capture of the 'Document Upload' screen (Scroll 1):
Exhibit 7-14 EPA Initiated Risk Evaluation - Document Upload Screen (Scroll 1)
HOME USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized C
TSCA Risk Evaluation EIRE-20191212-10:58:25
Step 1	Step 2	Step 3	Step 4
Contact
Submitting on Behalf of
U.S. Agent Chemical Substance or
Document
Submitting Official
Certification

Consortium
Category
Upload
(Optional)
Information

Document Upload (Optional)
Please upload all necessary information for EPA to conduct the risk evaluation.
Condition of Use
~ CBI
Upload a document identifying the conditions of use for which the risk evaluation is requested including a rationale for
their consideration.
Hazard Studies I Information ~ CBI
Each risk evaluation request must include a list of all the existing information that is relevant to whether the chemical
substance, under the conditions of use identified by the manufacturer, presents an unreasonable risk of injury to health
or the environment. The request does not need to include copies of the information; citations are sufficient, if the
information is publicly available. The request must include or reference all available information on health and
environmental hazard(s) of the chemical substance, human and environmental exposure(s), and exposed population^),
as relevant to the conditions of use identified in the request. At a minimum this information must include: hazard and
exposure potential, persistence and bioaccumulation, potentially exposed or susceptible subpopulations the requester
believes to be relevant, whether there is any storage of the chemical substance near significant sources of drinking water
(this could include a storage facility), production volume or significant changes to production volume, and any other
information relevant to the potential risks of the chemical substance.
HSave Validate O Preview G Submit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-199E
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
109

-------
CDXr
Exhibit 7-15 shows a screen capture of the 'Document Upload' screen (Scroll 2):
Exhibit 7-15 EPA Initiated Risk Evaluation - Document Upload Screen (Scroll 2)
I H0ME USER MANAGEMENT

X Jane Doe, Jane's Company (Primary Authorized Officiau
Additional Information ~ CBI


Each risk evaluation request must include a list of all the existing information that is relevant to whether the chemical
substance, under the conditions of use identified by the manufacturer, presents an unreasonable risk of injury to health or the
environment. The request does not need to include copies of the information; citations are sufficient, if the information is
publicly available. The request must include or reference all available information on health and environmental hazard(s) of the
chemical substance, human and environmental exposure^), and exposed population(s), as relevant to the conditions of use
identified in the request. At a minimum this information must include: hazard and exposure potential, persistence and
bioaccumulation, potentially exposed or susceptible subpopulations the requester believes to be relevant, whether there is any
storage of the chemical substance near significant sources of drinking water (this could include a storage facility), production
volume or significant changes to production volume, and any other information relevant to the potential risks of the chemical
substance.
Document Upload


Search:
Document Type 1= Document Subtype File Name File Description
Page Count
Date CBI Action
No document information found
<

>
O Attach Document
Information Submitted ~ CBI


Enter text regarding the type of information that has been included in the risk evaluation form.
| Previous jjj



| H Save ~ Validate Q Preview CS Submit

Raise a Bug CDX Links - CDX Helpdesk: (888) 890-199C |
Navigation: Click the 'Next' button to navigate to the 'Submitting Official Information' screen
if this form is submitted on behalf of a consortium. You can also access this screen by clicking
the 'Submitting Official Information' link within the navigation header. Click the 'Next' button
to navigate to the 'Fees Certification' screen if this form is submitted on behalf of the reporting
organization. You can also access this screen by clicking the 'Fees Certification' link within the
navigation header.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
110

-------
CD)fr
Exhibit 7-16 shows a screen capture of the 'Attach Document' window:
Exhibit 7-16 EPA Initiated Risk Evaluation - Attach Document Window
CBI claims for information found within documents attached to support the request for risk
evaluation must be substantiated when the information is submitted. Any substantiation of
confidential information included in an attached document should be included in the
substantiation document required on the Instructions for Substantiating Confidential
Business Information (CBI) Claims' screen.
~ CBI
* Document Type
Condition of Use Rationale	_vj
The term 'conditions of use" means the circumstances, as determined by the Administrator,
under which a chemical substance is intended, known, or reasonably foreseen to be
manufactured, processed, or distributed in commerce, used1 or disposed of. 15 U.S.C. 2602
Attach Document
(4).
Description
Page Count
* Attachment
Browse.
Save Document
Close
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
111

-------
CDXr
Navigation: Click the 'Save Document' button to upload the selected attachment to the
'Documents' table.
7.6 Fees Certification
The 'Fees Certification' screen presents radio buttons to indicate the applicable fee certification
statement.
You can access the 'Fees Certification' screen by selecting the 'N/A' radio button within the
'Contact' screen and clicking the 'Continue' button from the 'Chemical Substance or Category'
screen.
The purpose of the 'Fees Certification' screen is to inform EPA of the fee amount that a primary
submitter pays on behalf of the reporting organization based on the business size. The
certification statement selected on the 'Fees Certification' screen is non-editable when amending
a Risk Evaluation Request. See Section 4.3.1 for additional information regarding the definition
of a small business concern.
Exhibit 7-17 shows the fee structure implemented for Risk Evaluation Requests:
Exhibit 7-17 EPA Initiated Risk Evaluation - Risk Evaluation Request Fee Structure
Business Concern
Fee Category
Fee Amount
Not a small business
concern
| EPA-initiated Risk
| Evaluation
• $1,350,000

| Manufacturer-requested
| risk evaluation on a
I chemical in the TSCA
I Work Plan
• Initial $1,250,000 payment + final invoice to recover
50% of Actual Costs

| Manufacturer-requested
I risk evaluation on a
| chemical not in the TSCA
| Work Plan
• Initial $2,500,000 payment+ final invoice to total 100%
of Actual Costs
Small business
| EPA-initiated Risk
| Evaluation
• $270,000

| Manufacturer-requested
| risk evaluation on a
| chemical in the TSCA
| Work Plan
• Initial $1,250,000 payment + final invoice to recover
50% of Actual Costs

| Manufacturer-requested
| risk evaluation on a
| chemical not in the TSCA
| Work Plan
• Initial $2,500,000 payment+ final invoice to total 100%
of Actual Costs
The following certification statements display:
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
112

-------
CDXr
•	My company is a "small business concern" as defined under 40 CFR 700.43: Select this
radio button to indicate that the reporting organization is a small business concern.
•	My company is not a "small business concern" as defined under 40 CFR 700.43: Select
this radio button to indicate that the reporting organization is not a small business concern.
Exhibit 7-18 shows a screen capture of the 'Fees Certification' screen:
Exhibit 7-18 EPA Initiated Risk Evaluation - Fees Certification Screen
HOME USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized Official)
TSCA Risk Evaluation EIRE-20191212-10:58:25
Step 1	Step 2	Step 3	Step 4
Step 5
Step 6
Step 7
U.S. Agent
Chemical Substance or
Category
Document Upload
(Optional)
Fees Certification
Submitting Official
Information
Fees Certification
As required by 40 CFR 700.45, fees are applicable to any person who manufactures (including imports) a chemical substance that is the subject of a risk evaluation under TSCA section 6(b).
Fees Certification
Select the following Fees Certification statement that applies. This selection cannot be modified after initial submission.
O My company is a "small business concern" as defined under 40 CFR 700.43.
O My company is not a "small business concern" as defined under 40 CFR 700.43.
'The criteria for a "small business concern" has been changed in the final fees rule. View the updated definition of a small business concern.
A PDF version of the final fees rule is available at https://www.regulations.gov/contentStreamer?documentld=EPA-HQ-OPPT-2016-0401-0072&contentType=pdf.
Previous

H Save */ Validate O Preview CS Submit	Raise a Bug CDX Links CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Next' button to navigate to the 'Submitting Official Information' screen.
You can also access this screen by clicking the 'Submitting Official Information' link within the
navigation header.
7.7 Submitting Official Information
You can access the 'Submitting Official Information' screen by clicking the 'Next' button from
the 'Fees Certification' screen if the request is submitted on behalf of the reporting organization.
You can also access this screen by clicking the 'Submitting Official Information' link within the
navigation header.
The information below has been pre-populated from CDX registration. If the information listed
is incorrect please make the appropriate edits to your user information in CDX registration.
Risk Evaluation Rule User Guide	January 16, 2020
Primary Authorized Official	113

-------
CDXr
•	Submitter is CBI: Check the 'CBI' checkbox to claim the submitter information as
confidential.
•	First Name: Displays the first name of the submitter.
•	Middle Initial: Displays the middle initial of the submitter.
•	Last Name: Displays the last name of the submitter.
•	Company Name: Displays the company name of the submitter.
•	Phone Number: Displays the phone number of the submitter.
•	Email Address: Displays the email address of the submitter.
•	Mailing Address 1: Displays line 1 of the mailing address of the submitter.
•	City: Displays the city of the mailing address of the submitter.
•	State: Displays the state of the mailing address of the submitter.
•	Postal Code: Displays the postal code of the mailing address of the submitter.
•	Country: Displays the country of the mailing address of the submitter.
•	This confirmation is required to proceed with the submission process: Check the legal
verification checkbox to begin the submission process; this is required and gets reset when
accessing the form.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
114

-------
CDXr
Exhibit 7-19 shows a screen capture of the 'Submitting Official Information' screen (Scroll 1):
Exhibit 7-19 EPA Initiated Risk Evaluation - Submitting Official Information Screen
(Scroll 1)
X Jane Doe, Jane's Company (Primary Authorized Official)
TSCA Risk Evaluation EIRE-20191212-10:58:25
Step 1	Step 2	Step 3
Contact
U.S. Agent
Chemical Substance or
Document Upload
Fees Certification
Submitting Official
Certification


Category
(Optional)

Information

Submitting Official Information
The information below has been pre-populated from CDX registration. If the Information listed is incorrect please make the appropriate edits to your user information in CDX registration.
Check the associated checkbox to confirm your acknowledgement of the legally responsible certification statement and activate the 'Continue' button.
~ Submitter is CBI
First Name:	Jane
Middle Initial:	J
Last Name:
Company Name:
Phone Number:
Email:
Mailing Address 1:
City:
State:
Postal Code:
Country:
Doe
Jane's Company
5555555555
JaneDoe@test.com
123 Fake Street
Lafayette
LA

This confirmation is required to proceed with the submission process
Please confirm that you are the legally responsible party from the submitting company. ~

H save ~ Validate Q Preview (3 Submit
Raise a Bug
CDX Links -
CDX Helpdesk: (8
8)890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
115

-------
CDXr
Exhibit 7-20 shows a screen capture of the 'Submitting Official Information' screen (Scroll 2):
Exhibit 7-20 EPA Initiated Risk Evaluation - Submitting Official Information Screen
(Scroll 2)
HOME USER MANAGEMENT
ฑ Jane Doe; TEST ORGANIZATION LLC (Primary Authorized Official)
infonffation in CDX registration.
Check the associated checkbox to confirm your acknowledgement of the legally responsible certification statement and activate the 'Continue' button.
~ Submitter is CBI

First Name:
Jane
Middle Initial:
E
Last Name:
Doe
Company Name:
TEST ORGANIZATION LLC
Phone Number:
5555555555
Email:
Jane.Doe@test.com
Mailing Address 1:
1025 LEESBURG PIKE
City:
FALLS CHURCH
State:
VA
Postal Code:
22033
Country:
US
This confirmation is required to proceed with the submission process
Please confirm that you are the legally responsible party from the submitting company. @
H Save ~ Validate Q Preview C5 Submit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Continue' button to navigate to the 'Submission of Referenced
Information' screen. You can also access this screen by clicking the 'Certification' link within
the navigation header.
7.8 Submission of Referenced Information
You can access the 'Submission of Referenced Information' screen by clicking the 'Continue'
button from the 'Submitting Official Information' screen. You can also access this screen by
clicking the 'Certification' link within the navigation header.
The purpose of the 'Submission of Referenced Information' screen is for users to commit to
providing EPA referenced information contained in this Risk Evaluation request.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
116

-------
CDXr
Exhibit 7-21 shows a screen capture of the 'Submission of Referenced Information' screen:
Exhibit 7-21 EPA Initiated Risk Evaluation - Submission of Referenced Information
Screen
HOME USER MANAGEMENT



X Jane Doe, Jane's Company (Primary Authorized Official)






TSCA Risk Evaluation EIRE-20191212-10:58:25



Step 1 Step 2
Step 3
Step 4
step 5
Step 6
Step 7 Step 8
Contact U.S. Agent
Chemical Substance or
Category
Document
Upload
(Optional)
Fees Certification
Submitting Official
Information
ฆ Substantiating CBI Claims
Submission of Referenced Information
Upon request, I commit to provide to EPA any referenced information contained in this request.
I certify that to the best of my knowledge and belief:
1.	The company (or companies) named in this request manufactures the chemical substance identified for risk evaluation.
2.	All information provided in the notice is complete and accurate as of the date of the request.
3.	I have either identified or am submitting all information in my possession, control, and a description of all other data known to or reasonably ascertainable by me as required for this request
under this part. I am aware it is unlawful to knowingly submit incomplete, false and/or misleading information in this request and there are significant criminal penalties for such unlawful
conduct, including the possibility of fine and imprisonment.
This confirmation is required to proceed with the submission process
I certify to the above statements. ~
~
H save ~ Validate Q Preview CS Submit
Raise a Bug CDX Links •ป CDX Helpdesk: (888) 890-1995
Navigation: If any CBI claims were made, check the certification checkbox and click the
'Continue' button to navigate to the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen. You can also access this screen by clicking the
'Substantiating CBI Claims' link within the navigation header. If no CBI claims were made,
check the certification checkbox and click the 'Start Submission Process' button to initiate the
submission process.
7.9 Instructions for Substantiating Confidential Business Information (CBI) Claims
EPA modified the electronic reporting applications for TSCA submissions to accept CBI
substantiations for CBI claims made during the creation of electronic submissions. Other than
information exempt from substantiation under TSCA Section 14(c)(2), users who wish to assert
CBI claims for data within a submission must substantiate those claims at the time of submission
as required by TSCA Section 14(c)(3).
You can access the 'Instructions for Substantiating Confidential Business Information (CBI)
Claims' screen by claiming information as CBI within a form and clicking the 'Continue' button
from the 'Submission of Referenced Information' screen. You can also access this screen by
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
117

-------
CDXr
clicking the 'Substantiating CBI Claims' link within the navigation header. This screen will not
generate until a CBI claim is made within a submission. Information claimed CBI must either be
substantiated or claimed exempt pursuant to TSCA Section 14(c)(2) at the time of submission.
To substantiate a CBI claim, upload documentation asserting your claim(s) on the 'Instructions
for Substantiating CBI Claims' screen within the form. You may also opt-out of substantiation
on the 'Instructions for Substantiating CBI Claims' screen if, for example, you believe your CBI
claim is exempt under TSCA Section 14(c)(2). Common exemption reasons can be found at
https://www.epa.gov/tsca-cbi/what-information-include-cbi-substantiations. To opt-out of
substantiation at the time of submission, all CBI claims within a submission must be exempt.
•	Substantiation Opt-Out: Check this checkbox to opt out of providing CBI substantiation.
You will be required to provide reasoning if you choose to opt out.
•	Substantiation Opt-Out Reason: Enter reasoning for opting out of CBI substantiation. This
is a required field.
•	Attach Document for CBI Substantiation: Click the 'Attach Document for CBI
Substantiation' link to generate the 'Attach Documents for CBI Substantiation' pop-up
window.
If you are unfamiliar with substantiating CBI claims or require assistance preparing
substantiation documents, EPA offers a link to templates and other information for substantiating
CBI claims on the 'Instructions for Substantiating Confidential Business Information (CBI)
Claims' screen. It is suggested that you right-click the link and open in a new tab or new window
so you do not leave your submission as this may affect your saved data.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
118

-------
CD)fr
Exhibit 7-22 shows a screen capture of the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen (Scroll 1):
Exhibit 7-22 EPA Initiated Risk Evaluation - Instructions for Substantiating Confidential
Business Information (CBI) Claims Screen (Scroll 1)

HOME USER MANAGEMENT
X Jane Doe, Jane's Company (Primary Authorized C
TSCA Risk Evaluation EIRE-20191212-10:58:25
Step t	Step 2	Step 3	Step 4
U.S. Agent
Chemical Substance or
Category
Document
Upload
(Optional)
Step 5
Fees Certification
Submitting Official
Information
Step 7	Step 8
Certification
Substantiating CBI Claims
Instructions for Substantiating Confidential Business Information (CBI) Claims
The Frank R. Lautenberg Chemical Safely for the 21st Century Act created a number of new requirements for those making confidential business
information (CBI) claims in TSCA submissions. Among these requirements is an obligation to substantiate most CBI claims at the time of submission.
Information which may be claimed as CBI without substantiation is identified at TSCA 14(c)(2). This Information Includes:
A.	Specific information describing the processes used in manufacture or processing of a chemical substance, mixture, or article;
B.	Marketing and sales information;
C.	Information identifying a supplier or customer;
D.	In the case of a mixture, details of the full composition of the mixture and the respective percentages of constituents;
E.	Specific information regarding the use. function, or application of a chemical substance or mixture in a process, mixture, or article;
F.	Specific production or import volumes of the manufacturer or processor; and
G.	Prior to the date on which a chemical substance is first offered for commercial distribution, the specific chemical identity of the chemical substance,
including the chemical name, molecular formula, Chemical Abstracts Service number, and other information that would identify the specific chemical
substance, if the specific chemical identity was claimed as confidential at the time it was submitted in a notice under TSCA 5.
For other submissions where the submitter has claimed information as CBI, the submitter will be required to upload a document substantiating those CBI
claims at the time of submission. The substantiation document should provide EPA any information believed to support the validity of the CBI claims. In order
to assist submitters in substantiating their CBI claims, EPA has developed substantiation templates that may be used as a starting point in preparing their
CBI substantiations. Submitters are encouraged to use these substantiation template documents, but are not required to do so. The templates and other
information relating to substantiating CBI claims can be found at https://www.epa.gov/tsca-cbl/what-information-include-cbi-substantiatjons.
The Agency is required to review and make a determination on the validity of many CBI claims. Failure to substantiate a CBI claim or a substantiation that
does not adequately justify the claim may result in a denial of claims and subsequent public release of information. If you have any questions concerning the
options or the substantiation process, please contact:
•	Scott Sherlock, 202-564-8257, sherlock.scott@epa.gov
•	Jessica Barkas, 202-250-6880. barkas-jessica@epa.gov
If you believe all of the information you have claimed as CBI is exempt from substantiation under TSCA section 14(c)(2) or has been previously
substantiated, select the following "Substantiation Opt Out" checkbox and provide a detailed explanation why you believe substantiation Is not required.
H Save ~ Validate Q Preview ฉ Submit
Raise a Bug CDX Links- CDX Helpdesk: (888)890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
119

-------
CD)fr
Exhibit 7-23 shows a screen capture of the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen (Scroll 2).
Exhibit 7-23 EPA Initiated Risk Evaluation - Instructions for Substantiating Confidential
Business Information (CBI) Claims Screen (Scroll 2)

HOME USER MANAGEMENT

X Jane Doe, Jane's Company (Primary Authorized OfficiaS
(Optional)
Instructions for Substantiating Confidential Business Information (CBI) Claims
The Frank R, Lautenberg Chemical Safety for the 21st Century Act created a number of new requirements for those making confidential business
information (CBI) claims in TSCA submissions. Among these requirements is an obligation to substantiate most CBI claims at the time of submission
Information which may be claimed as CBI without substantiation is identified at TSCA 14(c)(2)- This information includes:
A- Specific information describing the processes used in manufacture or processing of a chemical substance, mixture, or article;
B.	Marketing and sales information;
C.	Information identifying a supplier or customer;
D In the case of a mixture, details of the full composition of the mixture and the respective percentages of constituents;
E.	Specific information regarding the use, function, or application of a chemical substance or mixture in a process, mixture, or article;
F.	Specific production or import volumes of the manufacturer or processor; and
G.	Prior to the date on which a chemical substance is first offered for commercial distribution, the specific chemical identity of the chemical substance,
including the chemical name, molecular formula, Chemical Abstracts Service number, and other information that would identify the specific chemical
substance, if the specific chemical identity was claimed as confidential at the time it was submitted In a notice under TSCA 5.
For other submissions where the submitter has claimed information as CBI, the submitter will be required to upload a document substantiating those CBI
claims at the time of submission. The substantiation document should provide EPA any information believed to support the validity of the CBI claims. In order
to assist submitters in substantiating their CBI claims, EPA has developed substantiation templates that may be used as a starting point in preparing their
CBI substantiations. Submitters are encouraged to use these substantiation template documents, but are not required to do so. The templates and other
information relating to substantiating CBI claims can be found at https://www.epa.gov/tsca-cbi/what-information-lnclude-cbi-substantiations .
The Agency is required to review and make a determination on the validity of many CBI claims. Failure to substantiate a CBI claim or a substantiation that
does not adequately justify the claim may result in a denial of claims and subsequent public release of information. If you have any questions concerning the
options or the substantiation process, please contact
•	Scott Sherlock, 202-564-8257, sherlock.scott@epa.gov
•	Jessica Barkas, 202-250-8880, barkas.jessica@epa.gov
If you believe all of the information you have claimed as CBI is exempt from substantiation under TSCA section 14(c)(2) or has been previously
substantiated, select the following "Substantiation Opt Our checkbox and provide a detailed explanation why you believe substantiation is not required.
~ Substantiation Opt-Out
O Attach Document for CBI Substantiation
Start Submission Process
H Save ~ Validate O Preview CJ Submit
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-199E
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
120

-------
CDXr
Exhibit 7-24 shows a screen capture of the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen (Scroll 3):
Exhibit 7-24 EPA Initiated Risk Evaluation - Instructions for Substantiating Confidential
Business Information (CBI) Claims Screen (Scroll 3)
I*
X Jane Doe, Jane's Company (Primary Authorized C
Instructions for Substantiating Confidential Business Information (CBI) Claims
The Frank R. Lautenberg Chemical Safely for the 21st Century Act created a number of new requirements for those making confidential business
information (CBI) claims in TSCA submissions. Among these requirements is an obligation to substantiate most CBI claims at the time of submission.
Information which may be claimed as CBI without substantiation is identified at TSCA 14(cX2). This information includes:
A.	Specific information describing the processes used in manufacture or processing of a chemical substance, mixture, or article;
B.	Marketing and sales information;
C.	Information identifying a supplier or customer;
D.	In the case of a mixture, details of the full composition of the mixture and the respective percentages of constituents;
E.	Specific information regarding the use, function, or application of a chemical substance or mixture in a process, mixture, or article;
F.	Specific production or import volumes of the manufacturer or processor; and
G.	Prior to the date on which a chemical substance is first offered for commercial distribution, the specific chemical identity of the chemical substance,
including the chemical name, molecular formula, Chemical Abstracts Service number, and other information that would identify the specific chemical
substance, if the specific chemical identity was claimed as confidential at the time it was submitted in a notice under TSCA 5.
For other submissions where the submitter has claimed information as CBI, the submitter will be required to upload a document substantiating those CBI
claims at the time of submission. The substantiation document should provide EPA any information believed to support the validity of the CBI claims. In order
to assist submitters in substantiating their CBI claims, EPA has developed substantiation templates that may be used as a starting point in preparing their
CBI substantiations. Submitters are encouraged to use these substantiation template documents, but are not required to do so. The templates and other
information relating to substantiating CBI claims can be found at https://www.epa.gov/tsca-cbi/what-information-include-cbi-substantiations .
The Agency is required to review and make a determination on the validity of many CBI claims. Failure to substantiate a CBI claim or a substantiation that
does not adequately justify the claim may result in a denial of claims and subsequent public release of information. If you have any questions concerning the
options or the substantiation process, please contact:
•	Scott Sherlock, 202-564-8257, sherlock.scott@epa.gov
•	Jessica Barkas, 202-250-8880, barkas.jessica@epa.gov
If you believe all of the information you have claimed as CBI is exempt from substantiation under TSCA section 14(c)(2) or has been previously
substantiated, select the following "Substantiation Opt Out" checkbox and provide a detailed explanation why you believe substantiation is not required.
Uploaded File Name: Test Document3.txt
CBI: N
Action: Edit | Delete
Start Process

| H Save ~ Val date Q Preview ฉ Subm t
Raise a Bug
CDX Links
CDX Helpdesk: (8J
58) 890-1991
1
Navigation: Click the 'Start Submission Process' button to begin the submission process.
7.10 Attach Documents for CBI Substantiation
You can access the 'Attach Documents for CBI Substantiation' window by clicking the 'Attach
Document for CBI Substantiation' link within the 'Instructions for Substantiating Confidential
Business Information (CBI) Claims' screen.
•	Document Type: 'CBI Substantiation' is stored in the 'Document Type' drop-down menu.
•	Page Count: Enter the number of pages in the attached document.
•	Attachment: Click the 'Browse' button to search for and select a document to attach. This is
a required field.
•	I claim the attachment as CBI: Check the 'I claim the attachment as CBI' checkbox to
claim the document as confidential.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
121

-------
CDXr
•	Sanitized Attachment: Click the 'Browse' button to search for and select a sanitized
document to attach. This is a required field, if it displays.
•	Save Document: Click the 'Save Document' button to save the uploaded CBI substantiation
document(s).
•	Close: Click the 'Close' button to close the 'Attach Documents for CBI Substantiation'
window without saving any uploaded attachment information.
Exhibit 7-25 shows a screen capture of the 'Attach Documents for CBI Substantiation' window:
Exhibit 7-25 EPA Initiated Risk Evaluation - Attach Documents for CBI Substantiation
Window
Attach Documents for CBI Substantiation

- Document Type
CBI Substantiation
Page Count
ซ Attachment
•/ I claim the attachment as CBI
Sanitized Attachment
Save Document
Close
Navigation: Click the 'Save Document' button to upload the substantiation document and
navigate back to the 'Instructions for Substantiating Confidential Business Information (CBI)
Claims' screen.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
122

-------
CDXr
8 Preview
The system provides the option to preview a form during the submission process. Click the
'Preview' link, located within the bottom action bar, to preview a PDF file of the regular or
sanitized version of the form. After you choose either the 'Regular' or 'Sanitized' PDF, the
application generates a watermarked PDF draft of the form.
The watermark reads 'Not For Submission' and displays across each page in the background.
The form preview displays the entire form in a printable format. The preview functionality
provides the flexibility to track the status of the form and see the entire form in a single
viewpoint.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
123

-------
CDXr
Exhibit 8-1 shows a screen capture for the 'Preview Risk Evaluation' PDF:
Exhibit 8-1 Preview Risk Evaluation PDF
NOfซHl$Lli\
-------
CDXr
9 Validate
You can click the 'Validate' link located within the bottom action bar at any stage of completing
a Risk Evaluation request. The 'TSCA Risk Evaluation' window displays when you click the
'Validate' link. Disable the pop-up blocker within your internet browser so that the 'TSCA Risk
Evaluation' window displays correctly. The 'TSCA Risk Evaluation' window displays a report
of all validation errors. During the validation process, the application validates each screen of the
Risk Evaluation request to find missing and invalid data.
Validation Errors: Errors can be fixed by clicking the error link. The links will display the
Screen Title Name (e.g., Chemical Substance or Category) and the associated error. After you
click a link, the main application screen will display the section where the error occurred so you
can easily fix the error. Once you have fixed the error(s), click the 'Validate' link again to
refresh the 'TSCA Risk Evaluation' window. If the information you fixed passes validation, the
error will be removed from the 'TSCA Risk Evaluation' window. You must fix all validation
errors to submit the form to CDX successfully.
Click the 'X' button, located at the upper right-hand corner of the window, to close the 'TSCA
Risk Evaluation' window.
Exhibit 9-1 shows a screen capture for the 'TSCA Risk Evaluation Validation' window:
Exhibit 9-1 TSCA Risk Evaluation Validation Window
TSCA Risk Evaluation	x
•	Chemical Substance or Category	a
ฐ Please add at least one chemical.
•	Document Upload
ฐ A rationale for the consideration of uploaded documents identifying the
conditions of use is required.
ฐ Additional Information text is required.
ฐ Information Submitted text is required.
ฐ Please add a condition of use rationale document.
ฐ A document must be attached providing hazard information, or text must be
entered into the 'Hazard Studies/ Information' text box
•	Fees Certification
• Fees Certification is required
•	Submitting Official Information
ฐ Legal Verification is required.
•	Certification
v
ฐ Referenced information certification is required.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
125

-------
CD)fr
10 Submit to EPA via CDX
As a Primary AO, you have the ability to sign and submit a Risk Evaluation request to EPA via
CDX. You can save your form at any point during the data entry process. Any assigned Supports
for your form cannot submit the Risk Evaluation request. The save functionality will allow you
to return to that same form at any point in the future.
Once you complete all required information and correct all items failing validation, the system
will allow the Risk Evaluation request to be successfully submitted.
10.1 TSCA Certification
Click the 'Start Submission Process' button from the 'Submission of Referenced Information'
screen if there are no CBI claims, or the 'Instructions for Substantiating Confidential Business
Information (CBI) Claims' screen if there are CBI claims, to access the 'TSCA Certification'
screen.
Exhibit 10-1 shows a screen capture of the 'TSCA Certification' screen:
Exhibit 10-1 TSCA Certification Screen
HOME USER MANAGEMENT
Jt Jane Doe. TEST ORGANIZATION LLC (Primary Authorized Official)
TSCA Risk Evaluation RER-20170912-16:21:24
TSCA Certification
Risk Evaluation Certification
Validation
Review & Submit
TSCA Certification
I hereby certify to the best of my knowledge and belief that all information entered on
this form is complete and accurate.
I further certify that, pursuant to 15 U.S.C. ง 2613(c), for all claims for protection for
any confidential information made with this submission, all information submitted to
substantiate such claims is true and correct, and that it is true and correct that the
person submitting the claim has:
i.	taken reasonable measures to protect the confidentiality of the information;
ii.	determined that the information is not required to be disclosed or otherwise
made available to the public under any other Federal law;
iii.	a reasonable basis to conclude that disclosure of the information is likely to
cause substantial harm to the competitive position of the person; and
iv.	a reasonable basis to believe that the information is not readily discoverable
through reverse engineering.
Any knowing and willful misrepresentation is subject to criminal penalty pursuant to 18
U.S.C. ง1001.
Raise a Bug CDX Links * CDX Helpdesk: (888) 890-1995
January 16, 2020
126
Risk Evaluation Rule User Guide
Primary Authorized Official

-------
CDXr
Navigation: Click the 'Continue' button to certify regarding the contents of the form and
navigate to the 'Risk Evaluation Certification' screen.
10.2 Risk Evaluation Certification
Click the 'Continue' button from the 'TSCA Certification' screen to access the 'Risk Evaluation
Certification' screen.
Exhibit 10-2 shows a screen capture of the 'Risk Evaluation Certification' screen:
Exhibit 10-2 Risk Evaluation Certification Screen
iw
HOME USER MANAGEMENT
ฑ. Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
TSCA Risk Evaluation RER-20170912-16:21:24
Step 1	Step 2	Step 3
TSCA Certification	Validation
Step 4
Review & Submit
Risk Evaluation Certification
I certify under penalty of law that this document and all attachments were prepared
under my direction or supervision and the information contained therein, to the best of
my knowledge is, true, accurate, and complete. I am aware there are significant
penalties for submitting incomplete, false and/or misleading information, including the
possibility of fine and imprisonment for knowing violations.
Raise a Bug CDX Links * CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Continue' button to navigate to the 'Validation' screen.
10.3 Validation
Click the 'Continue' button from the 'Risk Evaluation Certification' screen to access the
'Validation' screen.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
127

-------
CDXr
Exhibit 10-3 shows a screen capture of the 'Validation' screen:
Exhibit 10-3 Validation Screen
HOME USER MANAGEMENT
TSCA Risk Evaluation RER-20170823-11:37:06
Step 1	Step 2
TSCA Certification	Risk Evaluation Certification
X Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
Step 4
Review & Submit
No Validation Errors!
Congratulations! Your Risk Evaluation form has passed the validation check.
Please click the 'PDF Generation' button to continue the submission process.
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Navigation: Click the 'PDF Generation' button to navigate to the 'PDF Generation' screen.
10.4 Risk Evaluation PDF Generation
Click the 'PDF Generation' button from the 'Validation' screen to access the 'PDF Generation'
screen.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
128

-------
CDXr
Exhibit 10-4 shows a screen capture of the 'PDF Generation' screen:
Exhibit 10-4 PDF Generation Screen
HOME USER MANAGEMENT
TSCA Risk Evaluation RER-20170823-11:37:06
Step 1	Step 2
TSCA Certification	Risk Evaluation Certification
Step 3
Validation
X Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
Step 4
Review & Submit
PDF Generation
Click the "Regular PDF" or "Sanitized PDF" button to view a PDF of the Risk
Evaluation form. If you make no CBI claims, the two versions will be the same. Please
do NOT send a copy of the PDF to the EPA. Click the "Sign, Enciypt, and Submit"
button to complete the submission process.
li Regular PDF I h Sanitized PDF I Sign, Encrypt and Submit
Raise a Bug CDX Links -• CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Regular PDF' button to generate a regular version of the Risk Evaluation
PDF. Click the 'Sanitized PDF' button to generate a sanitized version of the Risk Evaluation
PDF. Click the 'Sign, Encrypt and Submit' button to begin the CROMERR certification process.
10.5 CROMERR Certification
Click the 'Sign, Encrypt and Submit' button from the 'PDF Generation' screen to generate the
'CROMERR Certification' window.
Exhibit 10-5 shows a screen capture of the 'CROMERR Certification' window:
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
129

-------
CDXr
Exhibit10-5 CROMERR Certification Window
I certify, under penalty of law that the information provided ii
this document is, to the best of my Knowledge and belief
true, accurate, and complete. I am aware that there are
significant penalties for submitting false information,
including the possibility of fines and imprisonment for
knowing violations.
Accept Decline
Navigation: Click the 'Accept' button to agree to the certification statement and generate the
'eSignature Widget.'
10.6 eSignature Widget
Click the 'Accept' button on the 'CROMERR Certification' window to accept the certification
statement and generate the 'eSignature Widget.' The 'eSignature Widget' will prompt for the
CDX login password and an answer to one of your security questions. Click the 'Sign' button on
the 'eSignature Widget' to navigate to the 'Submission Finished' screen.
Exhibit 10-6 shows a screen capture of the 'eSignature Widget' window:
Exhibit 10-6 eSignature Widget Window







eSignature Widget



1. Authentication
Log into CDX
User:
2. Verification
Question:
What is your Favorite hobby?
Answer:
3. Sign File



JANE DO EO PPT


Password:
• ••••



Show Answer D


Show Password D
Correct Answer


Welcome Jane Doe



Navigation: Click the 'Sign' button on the 'eSignature Widget' to navigate to the 'Submission
Finished' screen.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
130

-------
CDXr
10.7 Submission Finished
Click the 'Sign' button on the 'eSignature Widget' to navigate to the 'Submission Finished'
screen.
Exhibit 10-7 shows a screen capture of the 'Submission Finished' screen:
Exhibit 10-7 Submission Finished Screen


HOME
USER MANAGEMENT ฑ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
TSCA Risk Evaluation RER-20170823-11:37:06
Step 1 Step 2 Step 3 Step 4
TSCA Certification
Risk Evaluation Certification Validation
Review & Submit
Submission Finished
The submission was sent to the EPA. The link to allow for the download of the Copy
of Record and signature for this submission will appear in the forms list when EPA
receives your submission. Click the "Home" button to go back to the home screen.
# Home
Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Home' button to navigate back to the TSCA Risk Evaluation 'Home'
screen.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
131

-------
CDXr
11 Download Copy of Record
To download a Copy of Record, navigate to the Risk Evaluation 'Home' screen and locate a
form alias for which you have successfully completed a submission and which has a status of
'Completed.'
Click the 'Copy of Record' icon (i) from the 'Submission History' section of the Risk
Evaluation 'Home' screen to navigate to the 'Enter Passphrase' screen to login into CDX. The
'Enter Passphrase' screen requires you to enter the passphrase originally associated with the
form. If the passphrase is entered correctly, you will view the 'CROMERR Certification'
message where you can acknowledge the certification. Once you accept the certification, the
'eSignature Widget' displays where you provide the correct CDX password, answer the 20-5-1
question, and click the 'Sign' button. The copy of record .zip file generates on the current page.
Exhibit 11-1 shows a screen capture of the 'Download Copy of Record' screen:
Exhibit 11-1 Download Copy of Record Screen
Lw
HOME USER MANAGEMENT
A Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
Risk Evaluation RER-20181024-14:10:06
Form Alias
RER-20181024-14:10:06
Enter Passphrase
Download Copy of Record:
File Name	File Size Action
RiskevalSubmission_COR_fa1d3db4-8b28-4ea6-af94-4966a85db496.zip	75887
Download Communication Documents:
You have no communications so far.
Raise a Bug CDX Links CDX Helpdesk: (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
132

-------
CDXr
The screen displays the 'File Name,' 'File Size,' and 'Action' columns in a table format. The
screen also displays a section for communication documents. Click the 'Copy of Record' icon
( ) to automatically download the .zip file containing the individual regular and sanitized
PDFs.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
133

-------
CD)fr
12 EPA Communications
EPA may send electronic communications related to specific CDX submissions. In the event
EPA sends an electronic communication, the original submitter will receive a notification to both
their registered email address and inbox within CDX. The notification will inform the user that
there is a new, submission-specific communication available from EPA. Example of EPA
communications include a Notice of Deficiency or an Invoice.
Exhibit 12-1 shows a screen capture of a sample Notice of Deficiency (Email Notification) from
CDX:
Exhibit 12-1 New EPA Communication Email Notification
ฆ, ' . ฆ] Thu 10/25/2018 12:38 PM
noreply@epacdx.net
Notice of Deficiency for CBI Claims or a Generic Chemical Name in a TSCA Submission from U.S. EPA
Date: 10/25/2018 12:38:22
You have received a new Notice of Deficiency Concerning CBI Claims or a Generic Chemical Name in a TSCA Submission
communication in your CDX account from the U.S. EPA related to CDX transactionld: _ccc0c206-d7ac-46bb-b0a8-ccded89f3bl3.
If you can identify your TSCA submission using this CDX transaction ID, originally provided with the 'Copy of Record' XML file, you
can use this identifier to quickly access the communication by following these steps:
1.	Log into CDX.
2.	Navigate to the appropriate CSPP module for the submission related to CDX transactionld: _ccc0c206-d7ac-46bb-b0a8-
ccded89f3bl3. You will need to know the submission type related to previously referenced transactionID before selecting the
CSPP module.
3.	Select the Forms/Submissions tab or link to view the table of submissions.
4.	Locate the submission related to CDX transactionld: _ccc0c206-d7ac-46bb-b0a8-ccded89f3bl3. Performing a 'Find' operation by
clicking 'Ctrl+F' and entering either the related case number or submission alias is an easy way to locate the submission if you
have many in your table.
5.	After you locate the related submission, click on the envelope icon found in the Action column at the end of the submission row.
6.	Follow the steps to access the Copy of Record.
7.	Click on the green download arrow for the desired communication within the 'Download EPA Communications' section.
If you cannot identify your submission using this CDX transaction ID. you can obtain more information about how to access this
communication by following these steps:
1.	Log into CDX.
2.	Click on the 'Inbox' tab from your 'My CDX Screen' from your 'My CDX Screen'.
3.	Search your CDX inbox for a message with the same subject line as this email. This message will provide additional instructions
for accessing the Notice of Deficiency communication.
Exhibit 12-2 shows a screen capture of a sample CDX Inbox Notification:
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
134

-------
CD)fr
Exhibit 12-2 New EPA Communication CDX Inbox Notification
Home About Recent Announcements Terms and Conditions FAQ Help
CDX? Central Data Exchange
S Contact Us
Logged in as JANEDOEOPPT (Log out)
MyCOX
My Profile Role Sponsorship Submission History
Payment History
E-Enterprise Portal
Notice of Deficiency for CBI Claims or a Generic Chemical Name in a TSCA Submission from U.S. EPA
From	noreply@epacdx.net
Date
10/25/2018 12:38:22 PM
Date: 10/25/2018 12:38:22
You have received a Notice of Deficiency communication from the EPA regarding your TSCA RER submission. You can retrieve
this communication by following these steps:
1.	Copy the submission alias identified below.
2.	Navigate to the appropriate CSPP module for the TSCA section indicated.
3.	Select the Forms/Submissions tab or link to view the table of submissions.
4.	Perform a 'Find1 operation by clicking 'Ctrl+F.
5.	Paste Submission Alias 'RER-20181024-14:10:06' into the navigation box and click return. The submission alias will be
highlighted.
6.	Click on the envelope icon found in the Action column at the end of the submission row.
7.	Follow the steps to access the Copy of Record.
8.	Click on the green download arrow for the desired communication within the 'Download EPA Communications' section.
If you have any difficulty locating the communication, please refer to the 'EPA Communications' section of the application user
guides found in the 'Resources' tabs provided in each CSPP module or contact the CDX helpdesk between 8:00 am to 6:00 pm
(EST/EDT) at 888-890-1995 (Domestic) or (970) 494-5500 (International callers).
ฆ
Print
ฆ
Delete
Users can access EPA communications by logging into CDX and navigating to the CSPP
application to which a communication applies. Within the Risk Evaluation Request application,
users should navigate to the TSCA Risk Evaluation 'Home' screen, to access EPA
communications. A 'Closed Envelope' icon ( I) appears under the 'Action' column for a
submission that contains a new EPA communication, and an 'Open Envelope' icon (Q) displays
for a submission that contains a previously downloaded EPA communication. To access a
communication, click either the 'Closed Envelope,' 'Open Envelope,' or 'Copy of Record' icon.
To ensure EPA communications are not improperly viewed, access to EPA communications is
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
135

-------
CDXr
restricted to users who may access the copy of record for a submission. Additionally, EPA
captures and stores CDX user and timestamp data each time an EPA communication is accessed.
Users can also access the invoice sent by personnel on the TSCA Risk Evaluation Home' screen.
A red 'Unpaid Invoice' icon (:) appears within the 'Action column for a submission that is
awaiting payment. The invoice icon no longer appears after an invoice has been paid.
Exhibit 12-3 shows a screen capture of the TSCA Risk Evaluation 'Home' screen:
Exhibit 12-3 TSCA Risk Evaluation Home Screen
HOME USER MANAGEMENT
TSCA Risk Evaluation
Create New Request or Response
Submission History
X Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Officials
Create a Risk Evaluation Request or Response to an EPA Request
Initial Response: Select this form type if you are manufacturer/importer required to
respond to a preliminary list published by EPA in the Federal Register Please note
that consortium leaders who are not a manufacturer/importer do not need to submit
this form.
EPA Initiated Risk Evaluation: Select this form type if you are
manufacturer/importer and/or consortium leader responding to the finalized Risk
Evaluation Request published by EPA in the Federal Register.
Manufacturer Requested Risk Evaluation: Select this form type to begin creating a
request for EPA to conduct a Risk Evaluation on the chemical(s) you
manufacture/import.
Withdrawal Request: Select this form type to begin creating a request for
withdrawal of an EPA Initiated Risk Evaluation or Manufacturer Requested Risk
Evaluation. Please note that you may withdraw your request at any time after the
request is made, and within 30 days of receiving EPA's notification that the request is
granted.
Please select the appropriate form type and click the 'Create' button.
EPA Initiated Risk Evaluation
Useful Resources
•	Risk Evaluation User Guide
ฆ Risk Evaluation Rule
•	Risk Evaluations for Existing Chemicals under TSCA
•	TSCA Risk Evaluation Guidance
Show 10 [v] entries
Form Alias U
Form Type
Case
Number
Submission
Date
Status
Action
RER-
20170608-
16:14:24
Manufacturer
Requested Risk
Evaluation
MRRE-17-
0053
07/19/2017
In Progress

RER-
20170823-
11:37:06
Manufacturer
Requested Risk
Evaluation
Processing
ฑ
RER-
20170911-
09:47:09
Manufacturer
Requested Risk
Evaluation
MRRE-17-
0071
09/11/2017
Completed

RER-
20180907-
10:48:16
Manufacturer
Requested Risk
Evaluation
MRRE-18-
0183
09/07/2018
Completed -
Awaiting
Payment
ฑ $ S3
RER-
20180919-
16:18:15
Manufacturer
Requested Risk
Evaluation
MRRE-18-
0215
09/19/2018
Completed -
Payment
Received
ฑ m
RER-
20181024-
Manufacturer
Requested Risk
Evaluation
MRRE-18-
0256
10/25/2018
Completed -
Awaiting
Payment
ฑE3$ a
14:10:06


RER-
20181025-
11:51:53
Manufacturer
Requested Risk
Evaluation
MRRE-18-
0257
10/25/2018
In Progress
ฑ as
RER-
20181105-
10:32:09
Manufacturer
Requested Risk
Evaluation
In Progress
X
WR-20171109-
Withdrawal Request


In Progress
X
Raise a Bug CDX Links - CDX Helpdesle (888) 890-1995
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
136

-------
CD)fr
Navigation: Click the 'Copy of Record' or 'Unpaid Invoice' icon to navigate to the 'Enter
Passphrase' screen.Exhibit 12-4 shows a screen capture of the 'Enter Passphrase' screen:
Exhibit 12-4 Enter Passphrase Screen
HOME USER MANAGEMENT
X Jane Doe, TEST ORGANIZATION LLC (Primary Authorized Official)
Risk Evaluation RER-20181024-14:10:06
Form Alias
RER-20181024-14:10:06
Enter Passphrase
Raise a Bug CDX Links
CDX Helpdesk: |
Navigation: Enter the passphrase associated to this submission and click the 'Continue' button
to generate the 'CROMERR Certification' window.
Exhibit 12-5 shows a screen capture of the 'CROMERR Certification' window:
Exhibit 12-5 Cross-Media Electronic Reporting Regulation (CROMERR) Certification
Window
I certify, under penalty of law that the information provided i
this document is, to the best of my knowledge and belief,
true, accurate, and complete. I am aware that there are
significant penalties for submitting false information,
including the possibility of fines and imprisonment for
knowing violations.

ccept i Decline
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
137

-------
CDXr
Navigation: Click the 'Accept' button to generate the 'eSignature Widget' window.
Exhibit 12-6 shows a screen capture of the 'eSignature Widget' window:
Exhibit 12-6 eSignature Widget
eSignature Widget
1. Authentication
Log into CDX
User:
JANEDOEOPPT
2. Verification
Question:
What is your favorite book?
Answer:
3. Sign File
Password:
Show Answer D
Show Password D
Correct Answer
Welcome Jane Doe
Navigation: Click the 'Sign' button on the 'eSignature Widget' window to navigate to the
'Download Copy of Record page.
The 'Download Communication Documents' table is located in the middle of the 'Download
Copy of Record' screen and displays EPA communications associated with all versions of the
selected submission. The 'Download Communication Documents' table includes the following
columns of information:
•	Communication Type: Displays the type of EPA communication.
•	File Name: Displays the file name of the EPA communication.
•	File Size: Displays the file size of the EPA communication.
•	Status: Displays the status of the EPA communication. The 'Closed Envelope' icon (ซ-o)
indicates an un-accessed EPA communication, and the 'Open Envelope' icon (l .) indicates
an accessed EPA communication.
•	Download: Click the 'Download' icon ( ) to download an EPA communication. The
communication file downloads as a PDF.
The 'Payments' table is located at the bottom of the 'Download Copy of Record' screen and
displays invoices sent to a Risk Evaluation Request. The 'Payments' table displays 'Payment
Communication Type,' 'File Name,' 'File Status,' 'Download,' 'Payment Amount,' 'Due Date,'
'Payment Status,' Payment Received Date,' and Make a Payment' columns.
•	Payment Communication Type: Displays 'Invoice' or 'Cancelled Invoice.'
•	File Name: Displays the file name of the fee invoice PDF.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
138

-------
CDXr
•	File Status: Displays an icon that indicates the status of the invoice; a closed envelope icon
displays with a status of 'New Communication Documents' when a user initially accesses the
'Download Copy of Record' page.
•	Download: Displays a green arrow for a user to download the invoice PDF.
•	Payment Amount: Displays the amount of the invoice.
•	Due Date: Displays the invoice due date.
•	Payment Status: Displays the status of the payment; i.e. 'Unpaid,' 'Payment Received,' or
'Invoice Cancelled.' The status displays 'Invoice Cancelled' if an invoice has been cancelled
by EPA personnel.
•	Payment Received Date: Displays the date of payment, if the invoice has been paid. 'No
Payment Information Available' displays if an invoice is unpaid
•	Make a Payment: Displays a 'Pay Your Invoice Now' button; click the 'Pay Your Invoice
Now' button to generate the 'CSPP Payment Processor' window to remit a payment to the
invoice. The 'Pay Your Invoice Now' button is not displayed if a user has paid the invoice or
the invoice was cancelled.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
139

-------
CDX.
Exhibit 12-7 shows a screen capture of the 'Download Copy of Record' screen:
Exhibit 12-7 Download Copy of Record Screen

USER MANAGEMENT
ฑ Jane Doe, TEST ORGANIZATION LLC (Primary Authorized OfficiaG

Download Copy of Record:
File Name
File Size
Action
RiskevalSubmission_COR_99cb5793-42d1 -4049-bfab-986f12c512e1 zip
75887
ฉ
Download Communication Documents:
Communication Type
File Name
File
Size
Status
Download
Deficiency or Notice to
Comment (Substantiation)
CdxCommunication590ff196-f4ac-47bc-
a62c-60bdfec1ce6c.pdf
104600
Eg
ฉ
Payments:
Payment
Communication
Type
File Name
File
Status
Download
Payment
Amount
Due
Date
Payment
Status
Payment
Received
Date
Make a
Payment
Invoice
CdxCommunication63db048b-
2917-49e1-8e69-
dbb710e62cac.pdf

ฉ
$10,000.00
2019-
02-22
Unpaid
No
Payment
Information
Available
Pay
Your
Invoice
Now


Invoice
CdxCommunicationaddd464l -

ฉ
$1,250,000.00
2019-
Paid
2018-10-


4843-4535-a97e-



01-25

25


03f1f066039e.pdf







Raise a Bug CDX Links - CDX Helpdesk: (888) 890-1995
Navigation: Click the 'Download' icon ( ) under the 'Download Communication Documents'
table to download an EPA communication file. Click the 'Pay Your Invoice Now' button to
generate the 'CSPP Payment Processor' window.
12.1 CSPP Payment Processor
The 'CSPP Payment Processor' window provides functionality for you to remit your fee via
debit/credit card or Automatic Clearing House (ACH) payment.
•	Credit/Debit Card: Select the radio button to display the credit/debit card fields. This option
is only available for payment amounts less than or equal to $24,999.99.
•	Payment Amount: Displays the fee amount the user will be paying.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
140

-------
CDXr
•	Card Number: Enter the credit/debit card number. This is a required field.
•	Expiration Date: Select the month and date of the expiration date of the credit/debit card.
This is a required field.
•	Security Code: Enter the security code/CCV of the credit/debit card. This is a required field.
•	First Name: Enter the first name of the cardholder. This is a required field.
•	Last Name: Enter the last name of the cardholder. This is a required field.
•	Billing Address 1: Enter line 1 of the billing address. This is a required field.
•	Billing Address 2: Enter line 2 of the billing address, if applicable.
•	City: Enter the city of the billing address. This is a required field.
•	State: Select the state of the billing address from the drop-down menu. This is a required
field.
•	Zip: Enter the zip code of the billing address. This is a required field.
•	ACH Payment: Select the radio button to display the ACH fields.
•	Account Type: Select 'Business Checking,' 'Business Savings,' 'Personal Checking,' or
'Personal Savings' to indicate the account type that will be used to remit the fee. This is a
required field.
•	Check Number: Enter the check number.
•	Use a Company Name: Check the check box to generate a 'Company Name' field and pay
on behalf of the reporting company's name.
•	Company Name: Enter the name of the company that is submitting the payment. This is a
required field.
•	Routing Number: Enter the routing number of the bank account. This is a required field.
•	Account Number: Enter the account number of the bank account. This is a required field.
•	Confirm Account Number: Re-enter the account number of the bank account. This is a
required field.
•	Submit Payment: Click the button to submit the payment credentials.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
141

-------
CD)fr
Exhibit 12-8 shows a screen capture of the 'CSPP Payment Processor' window (ACH Payment):
Exhibit 12-8 CSPP Payment Processor (ACH Payment)
CSPP Payment Processor
ALERT: You may not use a card for this payment. Your payment exceeds the
maximum allowed amount for credit cards ($24999.99).
Bank Account Transaction
Payment Amount
$1250000
Account Type *
Business Checking
Check Number
Account Holder Name *
First Name
Last Name
~Use a company name
Routing Number *
Account Number *
Confirm Account Number *
Submit Payment
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
142

-------
CDX.
Exhibit 12-9 shows a screen capture of the 'CSPP Payment Processor' window (Credit/Debit
Card):
Exhibit 12-9 CSPP Payment Processor (Credit/Debit Card)
CSPP Payment Processor
Payment Method


ฎ Credit/Debit Card
O ACH Payment

Payer Information
Payment Amount
$10000
Card Number *
Expiration Date *
01
V
/
2018
V
Security Code *
Account Holder Name *
First Name
Last Name
~use a company name
Billing Address *
Address 1*
Address 2
City/State/Zip Code *
City
AK ^

Zip

Submit Payment
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
143

-------
CD)fr
Exhibit 12-10 shows a screen capture of the payment successful message:
Exhibit 12-10 Successful Payment
-T.
HOME USER MANAGEME
CSPP Payment Processor
v Submitting your payment. Please wait...
Download Copy of Record:
File Name
File Size
Action
RiskevalSubmission_COR_f17b4224-877b-463c-9e75-4324e507d1b3.zip
75887
ฉ

Download Communication Documents:
Communication Type
Deficiency or Notice to Comment CdxCommunicationS
(Substantiation)	60bdfe
Payments:
Message from webpage
rm
!
Payment successfully posted.
Payment information:
Tracking Number: DPSTSCA000787
Transaction Id: 3FPE3LNN
i ฐ' i
Payment
Communication
Type
Invoice
File
Status Download
Payment
Amount
Payment
Due Payment Received
Date Status Date
ANIZATION LLC (Prtmary Authorized Official
Make a
Payment
CdxCommunicationaddd4641- E3
ฉ
$1,250,000.00 2019-
Unpaid No
4843-4535-a97e-

01-25
Payment
03f1f066039e.pdf


Information



Available
Pay
Your
Invoice
Now
CDX Helpdesle (888) 890-19
Navigation: Click the 'Submit Payment' button to submit the payment. The application displays
a payment successful message and sends a payment receipt to the submitter. Click the 'OK'
button on the payment successful message to return to the 'CSPP Payment Processor' window.
Click the 'Close Widget' button on the 'CSPP Payment Processor' window to navigate back to
the 'Copy of Record' screen.
12.2 Invoice Communications
EPA may send an invoice communication related to a specific CDX submission. In the event
EPA sends an electronic communication, the original submitter will receive a notification to both
their registered email address and inbox within CDX. The notification will inform the user that
there is a new, submission-specific invoice communication sent from EPA.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
144

-------
CDXr
Exhibit 12-11 shows a screen capture of the email for Risk Evaluation Request Invoice Email:
Exhibit 12-11 Invoice Communication Email
Date: 10/25/2018 13:08:31
You have received a new Invoice communication from EPA. To obtain more information on the specific submission related to the notice,
please review the corresponding email found in your CDX inbox. Your inbox can be accessed by logging into your CDX account and
clicking on the 'Inbox' tab from the 'MyCDX' screen.
CDX transactionld: ccc0c206-d7ac-46bb-b0a8-ccded89f3b!3
Thu 10/25/2018 1:09 PM
noreply@epacdx.net
New Invoice Communication Received from EPA
To
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
145

-------
CD)fr
Exhibit 12-12 shows a screen capture of the CDX Inbox text for Risk Evaluation Request
Invoices:
Exhibit 12-12 CDX inbox Invoice Communication
CDX; Central Data Exchange
3 Contact Us
Logged in as JANEDOEOPPT (Log out)
MyCDX
My Profile Role Sponsorship Submission History
Payment History
E-Enterprise Portal
New Invoice Communication Received from EPA
From	noreply@epacdx.net
Date
10/25/2018 1:08:31 PM
Date: 10/25/2018 13:08:31
You are receiving this message because the U.S. Environmental Protection Agency delivered an invoice communication to your
Central Data Exchange (CDX) account associated with a Toxic Substances Control Act (TSCA) submission. The invoice
communication can be accessed within the Risk Evaluation reporting module. You can retrieve this communication by
following these steps:
1.	Copy the submission alias identified below.
2.	Navigate to the appropriate CSPP module for the TSCA section indicated.
3.	Select the Forms/Submissions tab or link to view the table of submissions.
4.	Perform a 'Find' operation by clicking 'Ctrl+F.
5.	Paste Submission Alias 'RER-20181024-14:10:06' into the navigation box and click return. The submission alias will be
highlighted.
6.	Click on the dollar sign icon found in the Action column at the end of the submission row.
7.	Follow the steps to access the Copy of Record.
8.	Click on the green download arrow for the desired communication within the 'Payments' section.
If you have any difficulty locating the communication, please refer to the 'EPA Communications' section of the application user
guides found in the 'Resources' tabs provided in each CSPP module or contact the CDX helpdesk between 8:00 am to 6:00 pm
(EST/EDT) at 888-890-1995 (Domestic) or (970) 494-5500 (International callers).
CDX transactionld: _ccc0c206-d7ac-46bb-b0a8-ccded89f3bl3
Submission Alias: RER-20181024-14:10:06
Back to Inbox ฆ Print H Delete
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
146

-------
CD)fr
Exhibit 12-13 shows a screen capture of the Risk Evaluation Request Invoice PDF:
Exhibit 12-13 Risk Evaluation Request Fee Invoice PDF
/q\ UNITED states environmental protection agency
WASHINGTON D.C. 20460
\
October 25, 2018
Offee of
Chemical Safety and
Polutton Prevention
Fee Invoice
Jane Doe
TEST ORGANIZATION LLC
1025 LEESBURG PIKE
FALLS CHURCH, VA 22033 US
Subject: Fee Invoice Notice
Dear Submitter,
As required by 40 CFR 700.45, your organization is subject to a fee in the amount of
$1,250,000.00 for the manufacture (including import) of a chemical substance that is the
subject of a risk evaluation under TSCA section 6(b). Payment in full is due by January 25,
2019.
You may make a payment by clicking the Pay Your Invoice Now button on the Copy of Record
screen within the TSCA Risk Evaluation application. To access the Copy of Record screen,
click the payment communication icon associated with your submission within the TSCA Risk
Evaluation application in CDX.
TEST
CBI Case Number	Chemical ID
N	437-17-2 - MethySum, triphenyh hexafluorophosphate(l-) (1:1)
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
147

-------
CDXr
Exhibit 12-14 shows a screen capture of the Payment Receipt:
Exhibit 12-14 Risk Evaluation Request Payment Receipt

Thu 10/25/2018 207 PM
noreply-dev 
Payment Receipt
Payment Receipt
Payee Information
•	John Doe
Receipt Details
Your payment has been submitted.
•	Date: 10/25/2018 2:06 PM
. Tracking Number: DPSTSCA000787
Total: $1,250,000.00
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
148

-------
CDXr
13 Create An Amendment
To amend a submitted Risk Evaluation request, navigate to the Risk Evaluation 'Home' screen
and locate a submission that you previously submitted with a status of 'Completed' within the
'Submission History' table. In addition to displaying a status of 'Completed' under the 'Status'
column, the 'Lock' icon ( • ) will be displayed under the 'Action' column. Click the 'Lock' icon
( ) under the 'Action' column to start an amendment.
A pop-up window will appear after clicking the 'Lock' icon ( ! ), confirming that you wish to
begin the amendment process. After you click the 'OK' button, you will be taken to the 'Enter
Passphrase' screen. You must enter the passphrase originally associated with the submission to
start the amendment process. After you enter the passphrase and click the 'Next' button, you will
be taken to the first screen in the specific Risk Evaluation request. Refer to Section 3.6 for
further instructions on the 'Enter Passphrase' screen.
After a submission has been unlocked, the Risk Evaluation 'Submission History' screen will
display a status of 'In Progress' under the 'Status' column, and the 'Unlocked' icon ( ' ) will
display under the 'Action' column; however, you will not see these changes until you navigate
back to the Risk Evaluation 'Submission History' screen. The only way to lock the submission
again is by resubmitting it to EPA.
•	Refer to Section 4 through Section 4.11 for instructions on editing a revised Risk Evaluation
request.
•	Refer to Section 5 through Section 5.5 for instructions on editing a revised Risk Evaluation
request.
•	Refer to Section 6 through Section 6.9 for instructions on editing a revised Risk Evaluation
request.
•	Refer to Section 7 through Section 7.10 for instructions on editing a revised Risk Evaluation
request.
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
149

-------
CDXc
14 Appendix A. Document Types and Subtypes
The following appendix displays the document types and document subtypes available within the
'Attach Document' window.
Document Type
Document Subtype
Aquatic Ecotoxicity
Algae Toxicity
Fish Acute Toxicity
Fish Chronic Toxicity
Invertebrate Acute Toxicity
Invertebrate Chronic Toxicity
Chemical Category Rationale
N/A
Chemical Category Substance
List
N/A
Chemical Structure Diagram
N/A
Condition of Use Rationale
N/A
Construct
Construct Data
Construct Methodology
Gene Sequence Data
Correspondence
N/A
Effects
Antibiotic Resistance
Environmental Effects
Human Health Effects
Metabolism
Pathogenicity Data
Fate
BCF/BAF
Biodegradation
Fugacity
Hydrolysis
Monitoring Data (e.g., air, water, soil, biota, human)
Partitioning (e.g., Koc, Kd, Kow, Koa, Henry's law constant)
Photolysis
Genetic Toxicity
Chromosomal Aberrations Assay
Unscheduled DNA Synthesis
Genetic Mutation Assay
GPC
N/A
Health Toxicity
Acute Toxicity
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
150

-------
CDXc
Document Type
Document Subtype

Carcinogenicity
Combined Repeated-Dose/Development/Reproductive Toxicity
Dermal Irritation
Developmental Toxicity
Eye Irritation
Immunotoxicity
Neurotoxicity
Pharmacokinetics/Metabolism
Repeated-Dose Toxicity
Reproductive Toxicity
Sensitization
i5Z IUCLID
N/A
i6Z IUCLID
N/A
ID
ID Sequence Data
Other ID Data
Strain History
IES Report
N/A
Inactivation Data
N/A
Interstate Commerce
N/A
Main Submission
N/A
Manufacturing Details
N/A
MSDS
N/A
OECD Harmonized Templates
N/A
Other
A free text field generates for a user to provide a description of the document
type.
Process Diagram-Other
N/A
Process Diagram-Submitter
N/A
Published Literature
N/A
Regs and Certifications
N/A
Safety Datasheet (MSDS)
MSDS/SDS
Technical Datasheet
Terrestrial Ecotoxicity
Avian Toxicity
Invertebrate Toxicity
Plant Toxicity
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
151

-------
CDXc
Document Type
Document Subtype
Use Details
N/A
Risk Evaluation Rule User Guide
Primary Authorized Official
January 16, 2020
152

-------